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Transcriptome analysis of bovine day 16 conceptus derived after transfer of blastocyst 
from somatic cell nuclear transfer or in vitro production 
 
In vitro embryo production (IVP) and somatic cell nuclear transfer (SCNT) have been used as 
tools of assisted reproductive technology to produce bovine pre-implantation embryos 
independent of the maternal environment. However, the embryonic and fetal losses after 
transfer of SCNT and IVP derived embryos is higher compared to the in vivo (AI) 
counterparts. This may be associated with the alterations in the molecular signatures and 
pathways at any stage of embryonic and /or fetal development. Therefore, to identify the 
molecular changes that could occur at day 16 SCNT and IVP derived embryos, large scale 
transcriptomic analysis was performed using Affymetrix-Bovine Genome Array. For this, day 
7 blastocysts derived from SCNT, IVP and AI were transferred to oestrus synchronized 
Simmental heifers. Recipients were then slaughtered at day 16 of gestation and conceptuses 
were retrieved. Following morphological examination, filamentous embryos with visible 
embryonic disc were subjected to global tanscriptome analysis. The result demonstrated 
comparable in vivo development rate in SCNT (72.7%), IVP (62.2%) and AI (77.3%) embryo 
groups. However, considerable reduction in the trophoblast elongation size was observed in 
SCNT (93.3mm) compared to IVP (186.6mm) and AI (196.3mm) derived embryos. In 
addition, more than 20% of SCNT (10.7 mm ± 1.08) and IVP (20.1 mm ± 0.15) conceptuses 
had tubular shape, suggesting a delay in recapitulating filamentous morphology. Gene 
expression profiling analysis revealed that the transcript levels of 477 genes, which are 
involved in various pathways including arginine and proline, glycerolipid and fatty acid 
metabolism, were significantly altered in SCNT embryos compared to AI. Similarly, 365 
genes were differentially expressed in IVP embryos compared to AI. Thus, several canonical 
pathways including TNRF-1 and tight junction signalling pathways were affected in IVP 
derived conceptuses. To predict whether the altered transcripts were associated with pre-
elongation in vitro culture environment or errors in transcriptional reprogramming, unique or 
commonly differentially expressed genes were analyzed in SCNT and IVP embryos compared 
to AI or donor cells (fibroblast). Accordingly, 71 transcripts including (FOLR1, MYO1B, 
RCN2, H2AFJ, HSPB1 and GATM) were found to be not transcriptionally reprogrammed as 
their expression resembled more the donor cells than AI embryos. The remaining transcripts 
were either partially or incompletely reprogrammed. In addition, quantitative real time PCR 
(qPCR) based expression profiling of candidate transcripts in developmentally delayed SCNT 
or IVP embryos showed low mRNA levels of IFNt, FGFR2, CLDN1 and ARHGEF2 in 
developmentally lagging IVP and SCNT embryos compared to their respective elongated 
counterparts. In conclusion, the present study identified deviation in elongation size, gene 
expression and the corresponding molecular pathways in day 16 SCNT and IVP conceptuses 
compared to their AI counterparts which may subsequently be associated with fetal 
development. 
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Transkriptom-analyse von bovinen 16 Tage alten Embryonen, gewonnen durch den 
Transfer von Blastozysten aus klonierten somatischen Zellen sowie der in vitro 
Produktion  
 
In vitro Embryo Produktion (IVP) und somatischer Kerntransfer (SCNT) sind Werkzeuge der 
assistierten Reproduktionstechnologien und finden ihren Einsatz um bovine Präimplantations- 
embryonen unabhängig von der mütterlichen Umwelt zu erzeugen. Allerdings sind 
embryonale und fetale Verluste nach dem Transfer von SCNT und IVP gewonnenen 
Embryonen höher im Vergleich zu in vivo (AI) erzeugten Embryonen. Dies kann mit den 
Veränderungen der molekularen Signaturen sowie Signalwegen in den unterschiedlichen 
Stadien der embryonalen und/oder fetalen Entwicklung zusammenhängen. Um molekulare 
Veränderungen zu identifizieren, die am Tag 16 von SCNT und IVP gewonnene Embryonen 
auftreten können, wurde mit Affymetrix-Bovine Genome Arrays eine Transkriptomanalyse 
durchgeführt. Hierzu wurden Tag 7 Blastozysten von SCNT, IVP und AI erzeugten 
Embryonen in Östrus synchronisierte Fleckviehfärsen übertragen. Am Tag 16 der 
Trächtigkeit wurden die Rezipienten geschlachtet und die Embryonen entnommen. Nach 
morphologischen Untersuchungen wurden filamentöse Embryonen mit sichtbarer 
Keimscheibe einer globale Tanskriptomanalyse unterzogen. Das Ergebnis zeigte in den 
verschiedenen Embryogruppen SCNT (72,7%), IVP (62,2%) und AI (77,3%) eine 
vergleichbare in vivo Entwicklung. Allerdings konnte eine erhebliche Verringerung in der 
Größe der Trophoblasten Elongation in SCNT (93,3 mm) im Vergleich zu IVP (186,6 mm) 
und AI (196,3 mm) Embryonen beobachtet werden. Darüber hinaus wiesen mehr als 20% der 
SCNT (10,7 mm ± 1,08) und IVP (20,1 mm ± 0,15) Embryonen eine Röhrenform auf, was auf 
eine verzögerte rekapitulierte filamentöse Morphologie hindeutet. Die Auswertung der 
Transkriptomanalyse zeigte beim Vergleich von SCNT mit AI 477 signifikant unterschiedlich 
expremierte Gene, die in verschiedenen Signalwegen beteiligt sind, einschließlich Arginin 
und Prolin, Glycerolipid und Fettsäure-Metabolismus. Des Weiteren wurden 365 signifikant 
unterschiedlich exprimierte Gene beim Vergleich von IVP Embryonen mit AI Embryonen 
identifiziert.  Relevante Signalwege dieser Gene waren unter anderem TNRF-1 und Tight-
Junction Signalisierung. Um festzustellen, ob die veränderten Transkripte mit der in in vitro 
Kultur bedingten Präelongation oder mit Fehlern der transkriptionellen Reprogrammierung 
assoziiert sind, wurden  einzigartige oder häufig unterschiedlich exprimierte Gene in SCNT 
und IVP Embryonen gegenüber AI oder Donorzellen (Fibroblasten) analysiert. 
Dementsprechend zeigten 71 Transkripte einschließlich FOLR1, MYO1B, RCN2, H2AFJ, 
HSPB1 und GATM keine transkriptionelle Reprogrammierung, da deren Expressionprofil 
mehr dem der Donorzellen als dem der AI Embryonen ähnelte. Die restlichen Transkripte 
waren entweder teilweise oder vollständig reprogrammiert. Zusätzlich, zeigten auf 
quantitative Real Time PCR (qPCR) basierende Kandidatengenexpressionsprofile in 
entwicklungsverzögerten SCNT oder IVP Embryonen niedrigere mRNA Spiegel in IFNtau, 
FGFR2, CLDN1 und ARHGEF2 im Vergleich zu ihren elongierten Gegenstücken. 
Schlussfolgernd konnten mit dieser Studie Abweichungen in den Elongationsgrößen, den 
Expressionsprofilen und den entsprechenden molekularen Signalwegen in Tag 16 SCNT und 
IVP produzierten Embryonen im Vergleich zu AI produzierten Embryonen beobachtet 
werden. Diese Ergebnisse könnten in Zusammenhang mit den weiteren fötalen Entwicklung 
gebracht werden. 
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1. Introduction  
 
The possibility of in vitro production of fertilized or cloned embryos has improved our 
understanding the molecular and biochemical mechanisms involved in mammalian 
embryogenesis, nuclear reprogramming and cell fate determination as well as the effect of 
embryo manipulation and in vitro culture on pre-implantation embryo development. The 
lessons accumulated so far showed that, despite their autonomy, pre-implantation embryos 
from IVP and SCNT are under the influence of confounding factors of nuclear transfer and /or 
culture environment, which subsequently affect their pre- and post-hatching development.  
Bovine embryo development begins with unification of differentiated gamet as to form a 
single united and embryonic totipotent genome. Within that genome the correct temporal 
pattern of gene expression that will lead to the appropriate differentiative and formative 
events are expected to happen (Latham 2005). In mammals, the maternal RNA and the 
proteins present in the oocyte's cytosol are responsible for early embryonic development. 
These maternal components govern the first embryo cleavages and as they drop by 
degradation or usage, the zygote nuclei start transcription and taking control of embryonic 
development (Memili and First 1999, Minami et al. 2007). This process is called embryonic 
genome activation (EGA). For mice, bovine and human, major EGA takes place at the 2-cell, 
8-cell and 4- to 8-cell stage, respectively (Telford et al. 1990). In the case of SCNT the oocyte 
executes its normal functions, but with an alternative substrate, the donor somatic cell 
nucleus, in place of the normal sperm and egg genomes (Latham 2005). Thus, SCNT embryos 
have additional challenges of dedifferentiating the differentiated donor somatic cell to a 
totipotent embryonic state (Yang et al. 2007). This requires the stage specific activation of  
transcripts important for early development and at the same time silencing of genes associated 
with differentiation (Hochedlinger and Jaenisch 2003). In other words, the donor nucleus is 
expected to reprogram to a state equivalent to the zygotic one, which entails expression of the 
correct genes at the right times as it occurs during normal embryogenesis (Kanka et al. 1991).  
Several studies (Beyhan et al. 2007, Niemann et al. 2010, Rodriguez-Osorio et al. 2009, Smith 
et al. 2005) have reported the occurrence of global transcriptional reprogramming at the 
bovine blastocyst stage by comparing the SCNT blastocyst gene expression with that of the 
AI or IVP origin and donor cells. In addition to the efficient reprograming at the balstocyst 
stage, the blastocyst formation rate from cloned bovine oocytes ranges from 20% to 60% 
(Choi et al. 2002, Forsberg et al. 2002, Liu et al. 2001, Rodriguez-Alvarez et al. 2010b). 
However, to term development after SCNT does not exceed 10% in cattle (Heyman 2005, 
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Yang et al. 2006), suggesting no direct association between the development of 
reprogrammed blastocyst and full-term developmental capacity. 
On the other hand several studies have shown deregulation of developmentally important 
genes in SCNT embryos (Dean et al. 2001, Enright et al. 2003, Han et al. 2003, Li et al. 2006) 
which may be associated with the reported lower success rate of pregnancy establishment, as 
well as postnatal abnormalities. Failure to express the normal array of embryonic genes may 
also result from culture condition of the embryo prior to transfer to the uterus of the surrogate 
mother. For instance, the common placental pathologies which are collectively designated as 
large offspring syndrome LOS in SCNT and IVP embryo pregnancies are believed to be a 
result of suboptimal embryo culture environment (Farin and Farin 1995, Kruip and Den Daas 
1997, Walker et al. 1996, Yang et al. 2005). Nevertheless, the extent and magnitude of 
abnormal phenotypes such as congenital anomalies and perinatal death (Heyman et al. 2002a) 
in SCNT derived pregnancies can not only be associated with in vitro culture condition 
(Chavatte-Palmer et al. 2012). In support of this, recently Salilew-Wondim et al. (2012)  
showed that more than 90% affected transcripts in day 50 SCNT placenta weren’t 
significantly altered in IVP placenta compared to AI implicating the presence of additional 
contributing factors associated with SCNT. One of these factors could be errors in nuclear 
reprogramming, in which small reprogramming errors accrued up to the blastocyst stage may 
be magnified in subsequent developments (Smith et al. 2005) especially during the peri-
implantation period, where the majority of embryo losses occurres (Clemente et al. 2011, 
Grealy et al. 1996).  
During the period of peri-implantation (between day 15 and 17 of pregnancy), the bovine 
blastocyst undergoes a process of elongation and the trophectoderm occupies sufficient area 
for uptake and secretion of protein, allowing for communication with or modification of the 
maternal system by changing the morphology and biochemical activity of the uterine 
epithelium (Godkin et al. 1982, Spencer and Bazer 2004). The trophectoderm of the 
conceptus then begin to produce IFNt that prolongs the lifespan of the corpus luteum (CL) to 
maintain the secretion of progesterone necessary for the maintenance of pregnancy (Mann et 
al. 1999, Song et al. 2011, Spencer and Bazer 2004, Thatcher et al. 2001). Likewise, the 
endometrium fine-tunes its physiological response to the presence of the embryo (Bauersachs 
et al. 2009, Forde et al. 2011, Mansouri-Attia et al. 2009) and these responses can reflect the 
type of conceptus present. Altered immune responses of the endometrium were observed  for 
the SCNT-derived conceptus compared to in vitro produced counterparts as early as day 18 
(Bauersachs et al. 2009). Similarly, numerous biological functions and several canonical 
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pathways with a major impact on metabolism and immune function are found to be 
significantly altered in caruncles and intercaruncular areas of the endometrium with SCNT as 
compared to AI pregnancies at the onset of implantation (Mansouri-Attia et al. 2009). Such 
responses of the maternal environment may depend on the intrinsic characteristics of the 
embryos themselves whether they are in vivo, in vitro or SCNT derived and consequently 
result in differences in the expression of sets of genes that modulate the uterine response.  
In this regard except analysis of few markers of trophoblast or innercell mass, insulin-like 
growth factor (IGF)-related genes (Arnold et al. 2006a, Fujii et al. 2010, Sawai 2009, Smith et 
al. 2010) and a single homologous custom bovine array based (Rodriguez-Alvarez et al. 
2010b) study on day 17 of IVF and SCNT embryos, data on large scale gene expression 
analysis of cloned embryos at peri- implantation stage is scarce.  
 
Therefore, the aim of this study was  
 
I) To investigate the inherent molecular characteristics of day 16 embryos derived 
from SCNT, IVP and AI pregnancies. 
II) To determine the transcriptional reprogramming status of a donor genome in 
SCNT derived elongated embryos. 
III) To characterize the expression of selected candidate genes with respect to 
elongation size of embryos from various sources. 
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2. Literature review 
 
2.1 Bovine pre-implantation embryo development  
 
Fertilization marks the beginning of pre-implantation development that corresponds to the 
cleavage of the zygote into smaller and smaller blastomeres (Dard et al. 2008).  Following 
fertilization, the embryo goes through stages of division, modelling and cellular compaction 
(morula stage). This is the first critical stage of embryo development and is an essential step 
for differentiation and blastocyst formation (Larue et al. 1994). Then “blastocyst stage” 
occurs when the embryo develops a fluid-filled central cavity, the “blastocoel”, which is 
surrounded by a single layer of cells, the “trophectoderm” (Schlafer et al. 2000). Before it 
reaches to blastocyst stage (at day 7), and despite cell division, the overall diameter of the 
embryo remains virtually unchanged from the zygote until blastocyst expansion, estimated to 
be 150 to 190 µm including a zona pellucida thickness of approximately 12 to 15 µm 
(Lindner and Wright 1983). At the blastocyst stage the true growth commences, with rapid 
cell division and differentiation. The process gives rise to two different cell types, namely the 
inner cell mass (ICM) and the trophoblast cells. The trophoblast cells (TE) give rise to the 
tissues of the fetal placenta and associated extraembryonic membranes, (Schlafer et al. 2000), 
whereas the ICM develops into the three germ layers of the developing embryo (endoderm, 
mesoderm and ectoderm) (Schlafer et al. 2006).  
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Figure 1. Development of pre-implantation embryo within the zona pellucida. The single-
celled embryo (zygote) undergoes cleavage (mitotic division) to give rise to two daughter 
cells called blastomeres. Mitotic divisions continue until a morula is formed. The morula 
develops into a blastocyst consisting of an inner cell mass (ICM), a blastocoele cavity and a 
trophoblast. Finally, the rapidly growing blastocyst “hatches” from the zona. Adapted from 
http://www.animal.ufl.edu/ans3319/Notes/Chpt9_ANS3319CFetalplacentaLab_10.pdf.  
 
2.2 Post-hatching progresses /embryo elongation 
 
Before the blastocyst can expand and implant, it needs to hatch from the zona pellucida (ZP). 
Hatching involves the embryonic production of proteases that will digest the ZP 
(Sathananthan et al. 2003). At about day 8 the zona pellucida begins to fragment and the 
blastocyst ‘hatches. Once the blastocysts have escaped from the ZP, the hatched blastocyst 
has re-expanded, the inner cell mass bulges to the outside of the sphere while still confined 
within the zona pellucida until about  day 12 (Betteridge et al. 1980) (Figure 1). Soon after 
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hatching the ICM of the blastocyst forms the hypoblast (sometimes referred to as the 
primitive endoderm) (Maddox-Hyttel et al. 2003) that extends to cover the inside of both the 
ICM and the trophoblast (Cremonesi et al. 2011, Maddox-Hyttel et al. 2003, Vejlsted et al. 
2006). After formation of the hypoblast is completed, the remaining cells of the former ICM 
are referred to as the epiblast (Cremonesi et al. 2011, Vejlsted et al. 2006). The shape of 
hatched blastocysts is then transformed from spherical to ovoid during a transitory phase 
preceding the obvious elongation that usually begins after day 12  (Betteridge et al. 1980).  
Following that blastocyst undergoes rapid elongation increasing from less than 1 cm on day 
12 to more than 10 cm by day 16 (Robinson et al. 2006).  
                                       
 
 
Figure 2. Schematic view of embryo elongation from spherical blastocysts to a tubular and 
then a filamentous form due to rapid elongation of trophectoderm. Adapted from (Bazer et al. 
2009).  
 
2.3 Physiological significance of embryo elongation 
 
Expansion of conceptus from spherical to a tubular and then filamentous form allows the 
embryo to acquire sufficient trophoblast tissue needed to establish intimate embryo-maternal 
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contact. By day 16, the embryo is sufficiently developed to signal its presence to the maternal 
system  and  recognized through its secretion of interferon tau (IFNt) (Imakawa et al. 1987),  
which is the pregnancy recognition signal, that prevents development of the endometrial 
luteolytic mechanism. Interferon tau is secreted by embryonic trophoblast cells and acts in the 
uterus and prevents luteolysis by inhibiting PGF2_ release, resulting in the maintenance of CL 
function (Robinson et al. 2008). This antiluteolytic effect of IFNt results in the maintenance 
of a functional CL and, hence, secretion of progesterone (P4) that is essential to maintain a 
uterine environment that supports events critical to successful development of the conceptus 
to term (Spencer and Bazer 2004). This period is therefore defined as the maternal recognition 
period for maintenance of CL (Spencer and Bazer 2004). It can be defined as the 
physiological process whereby the conceptus signals its presence to the maternal system and 
prolongs lifespan of the CL and stimulate the endometrial functions necessary to the survival 
of the conceptuses and suppress the immune rejection of the conceptus by the uterus at 
implantation (Hansen 2011).  
In addition to the embryo capacity to direct the maternal system to produce a local 
environment that serves the needs of the embryo, as long as embryo development played out 
in the reproductive tract the mother has a major impact on embryonic survival. 
 
2.4 Uterine environment  
 
Prior to the blastocyst stage, the embryo is relatively  autonomous (i.e., the embryo may not 
be entirely dependent upon the uterine environment) as evidenced by the fact that blastocysts 
can be successfully developed in vitro in large numbers using in vitro fertilization (IVF) 
technology and transferred to synchronized recipients (Clemente et al. 2011). However, after 
hatching embryo survival and elongation depend on maternal environment and uterine glands’ 
secretions (Gray et al. 2002). The endometrial glands synthesize, secrete and ⁄ or transport a 
complex mixture of amino acids, ions, glucose, transport proteins and growth factor called 
histotroph (Bazer 1975). These secretions are essential for the development of the blastocyst, 
which is free living during the pre-attachment period.  
Ovarian steroids, especially progesterone (P4) is a key player in regulating endometrial 
secretions (Robinson et al. 2008) for conducive attachment and survival of the conceptus 
(Garrett et al. 1988). Evidence from cattle studies has demonstrated a correlation between 
progesterone concentrations in milk and blood during the first few days after conception and 
the likelihood of embryo survival (Butler et al. 1996, Green et al. 2005, Mann and Lamming 
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1995, McNeill et al. 2006). Elevated P4 concentrations lead to an  increase in interferon-tau 
production (Mann and Lamming 2001) resulting in enhanced conceptus elongation (Carter et 
al. 2008, Satterfield et al. 2006). On the other hand, lower consentrations of circulating P4 are 
also associated with reduced embryo/conceptus development and survival (Diskin and Morris 
2008). It was suggested that the most likely route by which P4 affects embryo survival is 
through an indirect effect on the uterus (Morris and Diskin 2008). This raises the possibility 
that P4 can modulate events including changes in gene expression in the tissues of the uterus 
(Forde et al. 2009) resulting in changes in the composition of histroph to which the 
developing embryo is exposed. Therefore, it is important to understand the precise 
relationship between maternal hormone environment and embryo development.  In an attempt 
to answer this question experiments were done on embryos cultivated in vitro with or with out 
exogenous P4 supplementation and in the presence and absence of oviduct epithelial cells. 
Following blastocyst transfer, the effect of in vitro P4 supplementation on in vivo embryo 
survival and elongation was measured (Clemente et al. 2009). The results showed that 
addition of P4 to culture medium affected neither the blastocyst rate nor conceptus elongation 
following transfer to synchronized recipient heifers. The next question was whether P4 
induced changes on endometrium enhanced embryo development. The same authors showed 
that a modified uterine environment induced by artificially elevated circulating P4 is capable 
of advancing the post-hatching elongation of day 7 blastocysts (Clemente et al. 2009).  What 
is clear from this study is that progestrone modulated endometrium promotes conceptus 
elongation.  
 
2.5 Early embryonic development and transcription 
 
Maternal mRNAs and proteins which oocyte synthesize and accumulate during oogenesis, 
implement basic biosynthetic processes in the early embryo, direct the first mitotic divisions, 
and specify initial cell fate and patterning. As development proceeds, different processes are 
triggered that together form the maternal-to-zygotic transition (MZT): i) subset of the 
maternal mRNAs  degradation ii) beginning of transcription of the zygotic genome iii) rising 
of novel embryo-specific transcripts (Minami et al. 2007). 
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2.5.1 Maternal mRNAs store and its utilization 
 
It is likely that oocytes of all animals contain an abundance of dormant or masked mRNA that 
is translated only when the cell re-enters the meiotic divisions (oocyte maturation) or after 
fertilization (Richter 2007). In mammals, these maternal mRNAs are degraded shortly after 
fertilization and can’t direct more than the first few cell divisions. However, in drosophila and 
xenopus, mRNAs stored in an oocyte are stable after fertilization and regulate many aspects 
of embryonic development (Akam 1987, Duval et al. 1990). Translation control of maternal 
transcripts in these organisms during the time of transcriptional quiescence is, it is because the 
maternal RNA is stored using a specific configuration. The mRNA is de-polyadenylated at the 
3' end and capped at the 5' end (Gebauer and Richter 1996). The dominant hypothesis is that 
cap ribose methylation is facilitated during the process of polyadenylation, and the interaction 
between the modification machinery at the 3'- and 5'-UTRs of these transcripts underlies 
translational control at this time in development (Kuge and Richter 1995).  
The translational potential of a maternal mRNA transcript is determined by the length of the 
poly (A) tail. Accordingly an increase in translation is associated with poly(A) tail elongation 
(80–150 and longer), whereas translational repression correlates with shortening of the poly 
tail (A) (~20–40 nucleotides long)  (Richter 1999). Just as polyadenylation is important for 
the translation of mRNAs, removal of the poly (A) tail is a key step in mRNA degradation.  
Shortening of the mRNA 3′ poly (A) tail, deadenylation is often a rate-limiting step for 
mRNA degradation and translational silencing. In the 3'-to-5' mRNA decay pathway, the 
deadenylation facilitates degradation of the mRNA from the 3' end by enzyme exosome 
(Mitchell and Tollervey 2000, van Hoof and Parker 1999). Removal of the 5′-monomethyl 
guanosine cap (decapping) renders mRNA susceptible to the 5′→3′ degradation pathway by 
exposing them to exonucleases (e.g., XRN1) that rapidly degrade the mRNA from the 5′ end 
(Barckmann and Simonelig 2013, Chen and Shyu 2011). Studies of xenopus oocyte and 
embryonic development revealed what molecular entities are involved in the regulation of the 
polyadenylation and deadenylation in the cytoplasm of oocytes. One such protein is maskin, 
which associates with the cytoplasmic polyadenylation element binding protein (CPEB) 
located in the 3' UTR region on mRNAs that contains a cytoplasmic polyadenylation element 
(CPE). This complex represses translation through the inhibitory action of maskinelF4E 
located at the 5' end of the RNA (Richter 2007). Translation of specific mRNAs then proceeds 
according to a combination of cytoplasmic codes acting on RNA associated proteins 
interacting with the 3' UTR sequence of the stored RNAs (Piccioni et al. 2005).  
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Role of miRNAs in maternal genome degradation 
 
Recent progress in the regulation of mRNA stability concerns the role of small non-coding 
RNAs. MicroRNAs (miRNAs) are about 22-nucleotide noncoding RNAs, which in general 
are known to regulate gene expression by targeting their 3' untranslated regions (3 UTRs). 
MicroRNAs biogenesis starts from transcription of miRNA genes by either RNA polymerase 
II or RNA polymerase III to primary miRNA transcripts (pri-miRNA). The pri-miRNA is 
next endonucleolytically cleaved by the nuclear microprocessor complex formed by the 
RNase III enzyme Drosha (RNASEN) and the DGCR8 (DiGeorge critical region 8) which 
liberates a 60–70nt stem loop intermediate, known as the miRNA precursor, or the pre-
miRNA. This pre-miRNA is actively transported from the nucleus to the cytoplasm. The pre-
miRNA is further chopped by Dicer to produce the double-stranded miRNA duplex (Bartel 
2004, Winter et al. 2009, Zamore and Haley 2005). The duplex is unwound by a helicase and 
the mature strand is incorporated into the RNA-induced silencing complex (RISC). 
Depending on miRNA complementarity to a target mRNA, the RISC mediates down-
regulation of gene expression by either translational repression or deadenylation and 
subsequent mRNA degradation (Chekulaeva and Filipowicz 2009, Filipowicz et al. 2008). 
The role of miRNA as a control mechanism in the degradation of maternal mRNAs has been 
implicated in recent studies. MicroRNA-dependent mRNA decay was first identified in 
zebrafish, where miR-430 expressed in the embryo at the onset of zygotic transcription was 
shown to mediate deadenylation and clearance of hundreds of maternal mRNAs (Giraldez et 
al. 2006). Taking the advantage of this temporal expression pattern, of miR-430, Bazzini et al. 
(2012) addressed repression of maternal mRNAs by miR-430. The results revealed that both 
translational repression and deadenylation are induced by miR-430, as the cause and effect of 
miR-430 mediated gene silencing during early fish development. A similar temporal 
regulation by miRNAs exists in Xenopus where the miR-430 ortholog miR-427 leads to the 
de-adenylation and distruction of hundreds of maternal mRNAs in the frog embryo (Lund et 
al. 2009). In mammals, the roles of miRNA in maternal RNA degradation are not well 
understood. In addition, the findings have been equivocal with some studies, reporting the 
possible role of miRNA,  as dicer null mouse oocytes and embryos are unable to precede 
development and arrested at the first meiosis and die before gastrulating at day 7.5 (Bernstein 
et al. 2003; Harfe et al. 2005) yet others reporting minimal or no impact of miRNA as 
evidenced by defective spindle phenotype of Dcr1−/− and Ago2−/− oocytes, which is absent in 
Dgcr8−/− oocytes (Ma et al. 2010). The later group suggested RNA interference (RNAi)  as 
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the dominant RNA silencing pathway essential for oocyte-to-zygote transition OZT (Ma et al. 
2010) and the lethal phenotype observed  by Dicer KO could be explained by deregulation of 
the biogenesis of siRNAs (Bernstein et al. 2003, Ma et al. 2010).  
 
2.5.2 Onset of embryonic genome activation 
 
The oocyte-to-zygote transition entails coordinate removal of the maternal transcriptome and 
its replacement with a zygotic transcriptom (Ma et al. 2012). Timing of the major embryonic 
genome activation (EGA) is somewhat different from species to species. In mice, EGA occurs 
rapidly (in late one–cell embryos), whereas in bovine and ovine, EGA is more delayed (eight 
- to 16 - cell stage) (Telford et al. 1990). During this time the differentiated oocyte and sperm 
nuclei become reprogrammed to be the active genome of the now totipotent embryo (Oh et al. 
2000). Genome activation initiates transcriptional activity within the embryonic nucleus, and 
subsequent development is dependent upon newly synthesized mRNA and protein. To 
understand the onset of embryonic transcription, generally, two approaches have been used: 
(1) comparing transcript profiles of oocytes and two- to four-cell stage embryos with 
blastocyst profiles and (2) blocking transcription by addition of α-amanitin to the culture 
medium. Alpha - amanitin is a specific inhibitor of RNA polymerase II and blocks de novo 
mRNA synthesis (Goddard and Pratt 1983, Golbus et al. 1973). The later approach in 
combination with large scale gene expression profiling of oocytes (MII) and 8-cell-stage 
embryos using Affymetrix Bovine Genome Array revealed  a set of 258 up regulated genes  in 
8 cell embryos as compared to MII (Misirlioglu et al. 2006). Ontology analysis of these genes 
identified regulators of transcription ( NFYA , USF2 ), cell adhesion ( DSC2 , COL12A1 ), 
signal transduction ( PTGER4 , ADRBK1 ), transporters ( CRABP1 ), metabolism - related 
genes, and immune response - related genes. In another study using the same array platform a 
total of 12,000 to 14,500 transcripts were identified in bovine oocytes and early embryos 
including 1-cell, 2-cell, 8-cell, morula and blastocyst (Kues et al. 2008). Of  these, a total of  
9,263 genes which met a criterion of P ≤ 0.05 and a minimum cut off of 2-fold between the 
maternal and embryonic stages, were subjected to K means clustering method and clustered 
into different groups based on their expression pattern. The first group comprised the maternal 
transcript and contained 4,173 genes and was characterized by a drop of transcription levels 
between the 4- and 8-cell stages. A second group showed embryonic transcription and 
represented 3,505 genes. Significantly increased transcript levels were found from the 4-cell 
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to 8-cell stage onwards, indicating genes (ID2, ZO3, CLDN4, TP53, etc.) transcribed during 
major embryonic activation. 
In addition, in recent years, investigative attention has turned to analyzing profiles of small, 
non-coding RNAs including miRNAs (microRNA), during the MZT (Ma et al. 2010, Suh et 
al. 2010, Tang et al. 2007). In the mouse, the expression patterns of miRNAs are divided into 
three classes: maternal, maternal-to-zygote and zygote patterns (Tang et al. 2007). De novo 
synthesis of miRNAs commences at the two-cell stage. This includes expression of miR-290 
to miR-295, which are the first embryonic miRNAs to be detected. Very few studies have 
investigated the role of miRNAs during the bovine maternal-to-zygotic transition. 
Quantification of miR-21 and miR-130a in early bovine development showed a significant 
rise in expression level from zygote until the 8-cell stage (Yamada et al. 2009). Similarly 
quantification of miR-10 and miR-424 in early bovine development showed a steady 
expression level from the GV oocyte until the 16-cell.  In addition, increased expression level 
of miR-127 and miR-145 was also detected at 4-cell and 8-cell stages during pre-implantation 
bovine embryo development (Tesfaye et al. 2009). These studies suggested the possible role 
of miRNAs in maternal transcript turn over and maternal-to-zygotic transition.  
 
 2.5.3 Novel embryo-specific transcripts 
 
In bovine pre-implantation embryos development two major transient ‘waves of de novo 
transcription’ occur in two phases. The first wave during the 2- to 4-cell stage corresponds to 
minor genome activation (minor ZGA) and the second wave, during the 4- to 8-cell stage, 
known as major genome activation (major ZGA) (Barnes and First 1991, Memili and First 
1999, Viuff et al. 1996).  ZGA promotes a dramatic reprogramming of gene expression 
pattern, coupled with the generation of novel transcripts that are not expressed in oocytes 
(Kanka 2003). This delineates the totipotent state of each blastomere at the cleavage stage of 
embryogenesis, and these steps are prerequisite for future cell lineage commitments and 
differentiation (Yamada et al. 2009). In the mouse transcriptome analysis of late zygotes 
indicated that approximately 60% of de novo transcripts are novel for the embryos, (Hamatani 
et al. 2004). This is again reflected by more than 37% increment in protein synthesis through 
out the 2-cell stage while another 6 % undergo transient increases at the mid 2-cell stage 
(Latham et al. 1991). It is thought that the first period of transcription is to direct the synthesis 
of these mid 2-cell stage proteins, which could promote the transcription of other genes, 
leading to the second burst of transcription (Latham et al. 1991). Consistent with this notion 
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using suppression subtractive hybridization (SSH) technique, 310 unique transcripts were  
expressed de novo in bovine late eight cell embryos (Vigneault et al. 2009). A very high 
proportion of these genes have a demonstrated involvement in gene transcription or RNA 
processing.  Using qPCR expression profiling, many of these transcripts were shown to be 
expressed in the six and very early eight-cell-stage embryos. This implied that these early 
transcripts in cattle may play a key role in the activation of the major transcriptional burst 
detected at the 8- to 16-cell stage. This is likely to be the case for genes such as 
HNRNPA2B1, RBMX, KLF10, ZNF41, DDX5, and DDX39 (Frei et al. 1989, Natale et al. 
2000, Telford et al. 1990) which are related to transcription, either directly by binding DNA 
or indirectly through RNA processing (Carson et al. 2001, Franze et al. 1991).  
As soon as the embryo reaches the major EGA, the embryonic program designed to bring it to 
the blastocyst stage is launched (Wang et al. 2004). For instance, at 8- to 16-cell stages, 
CDX2 is detectable at various levels in the nuclei of most blastomeres, regardless of their 
external or internal location. However, in the mouse during the transition from 16- to 32-cell 
stage, the level of CDX2 becomes stronger in the external blastomeres and weaker in the 
internal blastomeres, eventually establishing the TE-specific expression at the blastocyst stage 
(Dietrich and Hiiragi 2007). In contrast, the pluripotency markers OCT4 and NANOG 
become restricted to influence ICM fate (Yamanaka et al. 2006).  
The establishment of the pluripotent lineage proceeds differently in different species. 
NANOG protein is found to be ICM specific in bovine blastocysts (Kuijk et al. 2008) while 
OCT4 is expressed in the ICM and TE of bovine and porcine blastocysts (Berg et al. 2011, 
Shi et al. 2003). In addition the transcripts of OCT4 arise from both the maternal and 
embryonic genomes, while NANOG is synthesized by the embryo alone (Khan et al. 2012). 
This suggested that NANOG could be a likely candidate for pluripotent lineage specification 
in the bovine species.  
 
2.5.4 Zygotic gene activation in nuclear transferred embryos 
 
Somatic cell nuclear reprogramming in cloning experiments represents an interesting tool to 
study the important events during embryonic development. In nuclear transplantation 
(cloning), a differentiated somatic cell nucleus is transformed into an undifferentiated 
totipotent (capable of developing into a whole individual) state when inserted in an enucleated 
oocyte (Hochedlinger and Jaenisch 2006). This requires huge epigenetic changes that result in 
a transition from a somatic to an embryonic gene expression pattern and is referred to as 
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“nuclear reprogramming”. Nuclear reprogramming in cloning experiments is equivalent to 
ZGA in a context of natural fertilization insofar as both result in establishment of totipotency 
(Suzuki et al. 2006, Zhao et al. 2010). Therefore, nuclear transplantation could potentially be 
used to study the factors involved in and the permanence of the switch from maternal to 
embryonic control of development (Telford et al. 1990).  
It has been widely assumed that the nuclear reprogramming that makes cloning possible 
occurs during the period immediately following nuclear transfer (Latham 2004). This means 
that the donor nucleus requires to shut down the donor's cell-type-specific RNA transcription 
pattern and begin to transcribe embryo-specific genes in a fashion that resembles EGA (Wang 
et al. 2011). However, cloned mice probed for the occurrence of this event are demonstrated 
to be defective in recapitulating the correct stage-specific gene expression. The first 
transiently induced genes transcribed from the embryonic genome were absent or greatly 
reduced in cloned two-cell embryos (Vassena et al. 2007). Similarly qPCR based expression 
profiling of selected zygotically activated genes at 2-cell stage of mouse cloned embryos 
showed repression of 35-65% analyzed genes in SCNT compared to IVP embryos (Suzuki et 
al. 2006). Another study showed  punctual onset of embryonic gene expression in cloned 
mouse 1-cell, 2-cell, 4-cell, morulae, and blastocysts with high degree of transcript abundance 
variability as compared to non manipulated control groups (Sebastiano et al. 2005). In bovine, 
quantification of a total of 13 maternally and embryonically expressed genes in SCNT 8-cell 
embryos constructed from two donor cell lines namely cumulus and fibroblast showed 
differences in mRNA levels of Cx43, GLUT-1, IGF-1R and E-cad between the two types of 
NT embryos (Amarnath et al. 2007). However, these differences decreased and the expression 
levels did not differ from their in-vitro produced counterparts at the blastocyst stage. Given 
these observations, it appears likely that nuclear reprogramming is a slow, ongoing process in 
the early cloned embryos and does not occur within the hours immediately following SCNT, 
but occurs progressively during cleavage, and likely continues after implantation (Campbell et 
al. 1996a, Latham 2004).  
 
2.6 Maternal environment transcriptom landscape 
 
Establishment of pregnancy in ruminants requires blastocyst growth to form an elongated 
conceptus that produces interferon tau (IFNt), the pregnancy recognition signal, and initiates 
implantation. In ruminants, conceptus growth and elongation clearly depend on the uterine 
milieu, because hatched blastocysts and trophoblastic vesicles do not elongate in vitro 
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(Flechon et al. 1986, Heyman et al. 1984) or fails to occur in vivo in the absence of uterine 
glands (Gray et al. 2002). For example, ewes that lack uterine glands and histotroph failed to 
maintain pregnancy beyond day 14. The implication is that any disruption in the physiological 
regulation of uterine function, either due to intrinsic errors (Hansen 2002) or abnormal 
embryo–maternal communication during the peri-implantation period (Bauersachs et al. 2009) 
compromises development of embryos. Nearly 40% of pregnancy losses in cattle is associated 
with a failure of maternal recognition of pregnancy before day 18 of gestation (Farin et al. 
2001). Those embryos lagging in development fail to signal to the mother in sufficient time or 
in a suitably robust manner (Roberts et al. 1996) are likely destined for loss (Farin et al. 
2004).   
                                     
 
 
Figure 3. Histotroph includes molecules secreated or transported in to the uterine lumen to 
stimulate growth and development of the conceptus during the peri-implantation period. 
Adapted from (Bazer et al. 2012). 
 
In addition to signalling pregnancy recognition in ruminants, IFNt alone or in concert with P4 
regulates uterine gene expression. It is an established fact that the process of elongation is 
exclusively maternally driven (Gray et al. 2002).  Particular emphasis is on P4 modulated 
genes that are expressed in the epithelia and could contribute to uterine luminal fluid when 
conceptus elongation begins after day 12 (Forde et al. 2012). Several studies in sheep and 
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cattle showed how IFNt - stimulated genes (ISGs), (Hansen et al. 1999, Spencer et al. 2004, 
Spencer et al. 2007) and the interaction between IFNt and progesterone regulates uterine gene 
expression (Gray et al. 2004, Song et al. 2005, Song et al. 2006). The majority of studies 
examining the molecular mechanisms of conceptus-endometrial interactions carried out 
during the peri-implantation period of pregnancy have focused on the maternal side, 
describing changes in the transcriptome of the endometrium (Bauersachs et al. 2006, Forde et 
al. 2009).  Recently, Forde et al. (2011) showed how the presence of an embryo contributed 
for differences in the endometrial transcriptome between pregnant and cyclic heifers during 
the period of pregnancy recognition. The authors compared endometrial gene expression 
profiles of pregnant and non-inseminated cyclic controls at day 5, 7, 13 and 16 using the 
Affymetrix array platform. The main finding of the study was, only at pregnancy recognition, 
the hormonal environment and the endocrine mechanisms regulating endometrial gene 
expression, differs between pregnant and cyclic heifers. This suggests that the transcriptomic 
alteration that occur in the endometrium as time from estrous to the luteal phase progresses 
occur in a similar manner irrespective of whether an embryo is present (Bauersachs et al. 
2012, Forde and Lonergan 2012).   
Transcriptomic analysis of the endometrial response of pregnancy has not only been used to 
unravel the molecular events surrounding the process of pregnancy recognition but can reflect 
the type of conceptus present. The recipient’s endometrium reactions for cloned and fertilized 
embryos were different as early as day 18 (Bauersachs et al. 2009). Such differences even 
aggravated at day 20 at caruncles and intercaruncular areas of the endometrium approximately 
5 days after pregnancy signalling commences (Mansouri-Attia et al. 2009). These evidences 
showed that the endometrium is sensitive to manipulations that occur prior to embryo transfer.  
 
2.7 Nuclear transfer technology 
 
One of the most fundamental questions in developmental biology is the control of cellular 
differentiation. In the majority of species, the product of sexual reproduction is the fertilized 
egg or zygote. This single cell inherits a single maternal and a single paternal copy of the 
genome. From this genetic material and the maternally inherited organelles, proteins, RNAs, 
etc., found in the unfertilized egg, an embryo, fetus, and finally an adult animal develop 
(Campbell 1999). During this developmental process, cellular differentiation results in the 
production of all of the tissues and organs that make up the mature adult. The long standing 
question was whether the process of development and cell differentiation requires a loss or 
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stable change in the genetic constitution of cells.  Up until the 1950s, it was thought possible 
that genes could become lost or permanently inactivated in those cells that follow different 
lineages in which certain genes would never normally be required. The original reason for 
wishing to carry out nuclear transfer to eggs was to test the hypothesis whether the genome of 
somatic cell is complete in the sense of containing copies of all genes in the genome 
(Campbell 1999, Colman 1999, Gurdon and Wilmut 2011). 
 
2.7.1 Brief history of cloning  
 
It has now been more than five decades since Briggs and King reported successful production 
of Northern Leopard Frog Rana pipiens, tadpoles via NT (King and Briggs 1956). This study 
was the first to prove that during cell differentiation, inactive nuclear genes were not lost or 
permanently inactivated; in other words, the nuclei retained totipotency. In an extension of 
this experiment,  Gurdon (1966) successfully produce male and female fertile xenopus from  
the intestinal epithelium of feeding tadpoles. However, success with NT in mammals was not 
reported until 1980s’. Historically, a primary difficulty in performing somatic cell nuclear 
transfer in mammals has been the small size of the mammalian egg (McGrath and Solter 
1983). The mammalian egg (in second meiotic metaphase) is <0.1% the volume of an 
amphibian egg. Hence, before nuclear transfer could succeed in mammals, micromanipulation 
techniques were required that could handle, enucleate, and fuse a very small mammalian egg 
with a single somatic cell (Gurdon and Byrne 2003). The first report of mammalian nuclear 
transfer was on rabbit morula cell nuclei into enucleated rabbit eggs (Bromhall 1975). These 
experiment produced embryos that arrested during cleavage, with a low percentage reaching 
the morula stage but not yet an entire organism. The first live birth was reported by using 
somatic cell nuclei was in 1981. Microinjection of inner cell mass (ICM) nuclei into 
enucleated zygotes resulted in successful production of three cloned mice (one male and two 
females) (Illmensee and Hoppe 1981) whereas the transfer of trophectodermal nuclei failed to 
support development. However, the techniques and the results haven’t been reproduced 
(Colman 1999) and modified (McGrath and Solter 1983). Two years later Steen Willadsen 
published a description of the first mammalian clones that resulted from the transfer of the 
nuclei of 8- or 16-cell-stage sheep embryos into an enucleated unfertilized eggs (Willadsen 
1986). The lesson learned  from Willadsen that the enucleated oocyte is a better recipient than 
a zygote because it allows more time for the donor nucleus to adapt and change within the egg 
cytoplasm before having to support the developmental processes (Solter 2000), may have 
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contributed to the change to using oocytes as recipient cells  (Cheong et al. 1993, Kono et al. 
1991). Following that, progress in large animal cloning accelerated rapidly and in the first half 
of the 1990s larger animals became the models of choice for nuclear transfer. However, in all 
cases, embryonic cells were used as nuclear donors. The conceptual breakthrough came with 
the generation of Dolly, the cloned sheep (Wilmut et al. 1997). In this instance, the nuclear 
donor was not an early embryonic cell but a fully differentiated mammary gland cell. Dolly 
was the living proof that the nuclei of a fully differentiated cell still contain all of the 
information required for the development of a full organism if placed in the proper 
environment or “reprogrammed” properly (Piedrahita et al. 2004). Subsequently, the first 
surviving cloned mouse, Cumulina, was also born in the following year (took her name from 
the cumulus cell nucleus from which she was derived) (Wakayama et al. 1998). Dolly and 
Cumulina didn’t remain the only mammals cloned from adult somatic cell for long, with in a 
year Kato et al. (1998) confirmed that cloning using adult somatic cells was indeed possible in 
cattle. To date sheep, cattle, mice, rabbit, goat, cat, pig, dogs, buffalo, camel and monkey are 
not the only species to join the list of the adult somatic cell cloned.  
 
2.7.2 Technical procedures of SCNT 
 
Somatic cell cloning (cloning or nuclear transfer) is a technique in which the nucleus of a 
metaphase-II oocyte is replaced by the nucleus of a somatic cell for the generation of a new 
individual, genetically identical to the somatic cell donor (Tian et al. 2003). The basic 
procedure, by which a living cell nucleus is transplanted to an egg or oocyte, was established 
by King and Briggs (1952). They used Rana pipiens and sucked a blastula cell into a 
micropipette so that the cell wall was broken but the nucleus remained intact and covered by 
cytoplasm. The whole cell was injected into an unfertilized egg in second meiotic metaphase. 
The egg was enucleated manually by removing the metaphase spindle with its chromosomes 
from the surface of the egg.  
Currently mainly three different SCNT protocols have been developed for the production of 
cloned offspring. The most widely used protocols are the classical cloning method employing 
micromanipulators (Wilmut et al. 1997) and the handmade cloning (Vajta et al. 2001), where 
all steps are performed manually without the aid of micromanipulators. The main difference 
between the two SCNT protocols is that the handmade cloning procedure involves the 
removal of the zona pellucida. Zona pellucida free reconstructed embryos are to be cultured 
under specific in vitro conditions up to the blastocyst stage prior to transfer to recipients. 
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Technical steps of cloning protocol 
 
Enucleation of the recipient oocytes 
Enucleation of the MII oocyte may be achieved by a number of techniques; the most popular 
is capillary incision of the zona pellucida, using a micromanipulator followed by removal of 
the polar body and adjacent metaphase chromosomes by suction into a glass pipette (Hosaka 
et al. 2000). Additional methods include enucleation by centrifugation (Tatham et al. 1995) 
and bisection of the oocyte followed by removal of fragment containing the nuclear material 
(Vajta et al. 2001, Vajta et al. 2003) (the so-called “handmade” cloning method). Although 
this technique has the advantage of simplicity, it does remove more oocyte cytoplasm and 
therefore, it may reduce the amounts of proteins needed for reprogramming and early 
embryonic development.  
 
Donor cell preparation and fusion 
A biopsy of tissue taken from the selected donor animal can be cultured in vitro in order to 
multiply and store at the frozen state. Each individual donor cell isolated from the culture 
plate is inserted into the perivitelline space of the enucleated recipient oocyte by 
micromanipulation and then introduced into the oocyte cytoplasm. Two methods are currently 
employed for somatic nuclear transfer in mammals: electro-fusion (EF) and intra-cytoplasmic 
injection (ICI). The basic differences between ICI and EF is, ICI takes a nucleus isolated from 
the donor cell and introduces it with part of the surrounding cytosol into the recipient 
cytoplast, whereas EF introduces the entire donor cell into the recipient oocyte. Comparison 
of the remodelling pattern of donor nuclei after nuclear transfer by injection or fusion showed 
that a high rate of premature chromosme condensation (PCC) occurred in both cases (Kurome 
et al. 2003). However, observation 1 h after nuclear transfer showed that the resultant nuclear 
configuration using the two transfer methods is different in that for injection the majority 
showed condensed chromosomes while for fusion the majority showed metaphase-like 
chromosomes (Kurome et al. 2003). The authors suggested that using the fusion method 
produces a more rapid formation of the spindle to prematurely condensed chromosomes. 
 
Activation of the reconstructed embryo 
Activation of the reconstructed complexes can either be achieved by short electrical pulses or 
by brief exposure to chemical substances that regulate the calcium influx into the complexes 
and ⁄ or the cell cycle (Niemann and Lucas-Hahn 2012).  
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Temporary in vitro culture of reconstructed embryos 
After fusion and activation, nuclear transfer embryos are developed in vitro up to the 
blastocyst stage using a variety of culture systems routinely used for bovine IVF embryos 
(Niemann and Lucas-Hahn 2012). 
 
2. 8 Efficiency of mammalian cloning 
 
As the ultimate goal of cloning is to obtain healthy fertile offspring, the efficiency of cloning 
should be assessed based on the proportion of healthy offspring produced. Dolly was just one 
cloned offspring that resulted after 277 attempts (Wilmut et al. 1997). The success rate of  the 
first  cloned mouse production from cumulus cell (2-8% ) (Wakayama et al. 1998) seems  
nearly 6 times better than success rate of Dolly production (0.3%). Though, cloning 
technology improves the success rate hasn’t shown dramatic change. After years similar 
inefficiencies are still being described for cloning adult animals. For example the proportion 
of reconstructed 1-cell  cattle embryos that develop to transferable quality blastocysts after 
seven days of culture is comparable to that following in vitro embryo production (IVP) (i.e. in 
vitro matured, fertilised and cultured) with abattoir-derived oocytes (Wells 2005). However, 
the success rate (defined as the percentage of reconstructed embryos that develop to term) 
(Campbell 1999) was low in cloned embryos. Besides, those that survive to term are 
frequently defective (Cezar et al. 2003). Cloning by the transfer of nuclei from adult cells is 
still a hit-and-miss procedure (Solter 2000). In most mammalian species studied thus far, the 
survival rate to birth for cloned is only about 1%–5%, compared with a 30%–60% birth rate 
for IVF blastocysts (Yang et al. 2007). Numerous factors related to cloning procedures such 
as state and source of the donor cell, cytoplast source and quality, timing and methods of 
manipulation and activation and embryo culture conditions contribute to the death of clones, 
both in the embryonic and fetal periods as well as during neonatal life. The following parts 
will discuss some of these factors in detail. 
 
2.8.1 Donor cell contribution  
 
It has been generally believed that the type of nuclear donor cells is an important factor 
influencing cloning efficiency in mammals. To date several somatic cell types such as fetal 
and adult fibroblast, (Cibelli et al. 1998, Kubota et al. 2000) mammary gland cell, (Wilmut et 
al. 1997) cumulus cells, (Akagi et al. 2008) granulosa cells, (Bhojwani et al. 2005, Wells et al. 
1999) blood leukocytes, (Galli et al. 1999) and oviduct cells (Goto et al. 1999)  have been 
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used as a donor for production of SCNT animals. However, it is still unclear which somatic 
cell type is efficient for nuclear transfer (Oback and Wells 2002). As it has mentioned above, 
blastomeres were the first cells to be used in cloning amphibians (King and Briggs 1956). The 
concept of blastomere cloning was that these cells show little or no differentiation and should 
make better nuclear donors (Oback and Wells 2002). This idea is supported by earlier results 
of cloned mice derived from pluripotent mouse blastomeres. Mouse blastocysts derived from 
two-cell, four-cell or eight-cell mouse embryonic blastomeres were shown to develop to term 
at 29%, 22% and 18% efficiency, respectively (Cheong et al. 1993).  In cattle however, the 
comparison of donor cells derived from different stages of development have generated 
controversial findings. The development of SCNT embryos both at blastocyst and post-
implantation stage were similar when fetal, new born and adult female and male donor’s cells 
were compared (Kato et al. 2000). Similarly, no detectable difference at the blastocyst stage 
was observed when somatic cell lines of various sources (fibroblast or granulosa cell) or 
different passages (7th vs. 11th) were used for cloning (Bhojwani et al. 2005). Yet, other 
groups have shown that blastocysts generated from cultured bovine fetal cells have higher 
success rates for both pregnancy and calving compared to those derived from cultured adult 
cells (Forsberg et al. 2002). On the other hand, comparison of bovine embryos reconstructed 
with different adult somatic cells showed that cumulus or ear fibroblast had better competence 
for blastocyst formation than embryos reconstructed with uterine or oviductal cells (Cho et al. 
2002).  
In most experiments involving cloned embryos fibroblasts have been used as donor cell 
(Heyman et al. 2002b). This includes cells isolated from skin, ear, testis and ovaries which are 
probably connective-tissue (stromal) fibroblasts rather than epidermal or germ cells, 
respectively (Wakayama and Yanagimachi 2001). Fibroblast cells are relatively easy to 
isolate culture and replicate in vitro (Iguma et al. 2005, Poehland et al. 2007).  Besides, the 
use of adult somatic cells is more advisable than fetal cells, especially since this option allows 
selection of animals with increased production traits (high milk yield and growth rate) and 
valuable genetic merit, especially those in a transgenic program (Iguma et al. 2005). 
 
2.8.2 Cytoplast source and quality 
 
The quality and source of oocytes is a key factor in determining the proportion of oocytes 
developing to the blastocyst stage and the efficiency at which live offspring are produced 
(Lonergan et al. 2003, Rizos et al. 2002, Wells et al. 1997). Both in vivo- and in vitro- 
Literature review 
___________________________________________________________________________ 
 
22 
 
matured oocytes have been used as recipients for production of cloned animals from 
differentiated cells. In cattle and pigs, in vitro oocyte maturation systems produce an abundant 
and stable supply of recipient oocytes because immature oocytes can be obtained from 
slaughtered animals. The oocyte maturation process is believed to be a crucial step 
influencing the subsequent developmental competence of oocytes (Sirard et al. 2006). In vivo-
matured oocytes have a far higher developmental ability than IVM oocytes (Rizos et al. 
2002). Nevertheless, the in vivo developmental potential of nuclear transfer embryos was not 
shown to be improved by using in vivo-matured oocytes (Akagi et al. 2008, Yang et al. 2008). 
However, owing to the smaller numbers of embryos used for transfer in these studies, further 
comparative studies are needed to fully evaluate the influence of oocyte source and 
maturation method on livestock cloning efficiency.  
Another consideration is the source of oocytes, i.e., derived from prepuberal animals versus 
adult animals. It is accepted that the oocytes from prepuberal animals have reduced 
developmental competence compared with that of oocytes from adult animals, as indicated by 
the decreased blastocyst formation after in vitro fertilization (Marchal et al. 2001, Revel et al. 
1995). In addition, in vitro developmental rates of nuclear transfer embryos involving adult 
cytoplasts were substantially faster than those of embryos produced from calf oocytes 
(Salamone et al. 2001).  
In addition to the source of oocytes, the developmental competence (quality) of the recipient 
oocyte could also affect the cloning outcome, but only very little progress has been made 
about oocyte selection at present. Recently Su et al. (2012) showed the association of brilliant 
cresyl blue (BCB) staining of oocytes with SCNT efficiency. BCB staining has been used for 
selection of competent oocytes in several mammalian species and measured the activity of 
glucose-6-phosphate dehydrogenase (G6PDH), an enzyme which is expected to be high in 
immature oocyte as compared to mature. It was shown that BCB+ oocytes yielded increased 
in vitro and in vivo development rate of SCNT embryos (Su et al. 2012).  
 
Zygote as a cytoplast source for cloning 
The oocyte cytoplasts derived from methaphase II oocytes are almost exclusively used for 
SCNT. Alternatively recent studies focus is also shifted in re-exploring the ability of zygote 
as cytoplast source for SCNT (Egli et al. 2007, Fan et al. 2009, Mezzalira et al. 2011). A 
series of experiments in mice in the mid 1980s showed that donor nuclei could be 
successfully exchanged between fertilized eggs (zygote), with 90 percent reaching the 
blastocyst stage of embryonic development and beyond (McGrath and Solter 1983). Despite 
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nuclei recovered and transplanted from embryos at the two-cell stage could direct 
development to the blastocyst stage, enucleated zygote failed repeatedly to support 
development when later embryonic or somatic donors were used (Wakayama et al. 2000). 
These results led to the conclusion that mouse blastomere nuclei transferred into enucleated 
zygotes cannot support development in vitro (McGrath and Solter 1984). However, the notion 
that zygotes are poor nuclear recipients has been recently revised. Live born pups obtained 
from enucleated pronuclear zygotes reconstructed with interphase nuclei of 8-cell stage 
blastomeres were reported (Greda et al. 2006). Similarly early bovine zygotes were shown to 
support development of transferred somatic G1  phase nuclei when the maternal telophase II 
chromosomes and condensed sperm DNA were removed prior to pronuclei formation 
(Schurmann et al. 2006). These studies unequivocally demonstrated that zygotes retain the 
factors necessary to completely reprogram embryonic and somatic genomes. However, 
whether reprogramming factors in these cells are the same as the factors active in the oocytes 
remained to be elucidated  (Oback 2008). 
In addition to the cytoplast source, studies on mammalian oocyte highlighted the importance 
of the activation signal on cloned embryos subsequent development.  
 
2.8.3 Method of egg activation 
 
Nuclei of mature oocytes are arrested at a particular stage of meiosis that varies from species 
to species (Sagata 1996). Arrest is maintained by stabilisation of M-Phase promoting factor 
(MPF) and mitosis activating protein (MAP) (Haccard et al. 1993, Ruderman 1993). Fusion of 
a spermatozoon with a metaphase II (MII) arrested oocyte alleviate arrest, thereby allowing 
cell cycle progression, cell division, and embryogenesis to proceed (Raz and Shalgi 1998). 
The signal triggered by the sperm, referred to as activation (Horner and Wolfner 2008) and 
the molecular mechanism by which the activating signal is transmitted from the sperm to the 
oocyte is not fully understood. However, it is clear that this signal triggers a large increase in 
the concentration of intracellular free calcium, provoke a cortical reaction (to block 
polyspermy), reduce the levels of maturation-promoting factor (MPF) and mitogen-activated 
protein MAP kinase and releases the oocyte from meiotic arrest and permits resumption of 
meiosis (Ducibella et al. 2002, Moos et al. 1995, Von Stetina and Orr-Weaver 2011).  
Activation can be initiated by fertilization or in the absence of sperm by artificial activating 
agents. Since sperm-mediated activation is absent in SCNT, an artificial activation is needed 
to initiate embryo development. These protocols mainly rely on raising the intracellular free 
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Ca2+ concentration in the ooplasm to mimic sperm-triggered events (Nakada and Mizuno 
1998). Various mechanical, chemical and physical stumili have been used to elicit one or 
several Ca2+ transients in the oocyte. Chemical activation can be induced by exposure to the 
calcium ionophore A23187, (Eusebi and Siracusa 1983, Liu et al. 2002) 7% ethanol, (Eusebi 
and Siracusa 1983) and  ionomycine (Loi et al. 1998, Silvestre et al. 2007). Alternatively, 
calcium stimulation followed by treatment with a protein synthesis inhibitor such as 6-
dimethylaminopurine (DMAP) or phosphorylation inhibitor, cycloheximide (CHX) could also 
cause full activation of the newly matured oocytes (Liu et al. 1998, Soloy et al. 1997, Wells et 
al. 1999). Similarly, because most cell cycle regulators such as MPF and MAPKs are 
phosphorylation-dependent kinases, replacing a protein synthesis inhibitor with a  
phosphorylation inhibitor such as 6-DMAP in the combined treatment with a calcium 
stimulator such as A23187 also equally effective in inducing activation of oocytes (Liu et al. 
1998, Susko-Parrish et al. 1994). 
Electric stimulation is also another way of introducing Ca2+ in to oocyte cytoplasm by making 
the oocyte plasma membrane permeable in the presence of Ca2+ with pulses of electricity. 
This method often referred to as electrical activation involves placing the oocyte between two 
electrodes typically 0.5 to 1 mm apart in a Ca2+ containing sugar based non- electrolyte 
solution of mannitol sucrose or glucose and delivering one or more DC pulses of electricity 
across the electrode (Collas et al. 1993; Rickords and White 1992). A single electric pulse has 
been shown to be enough to induce calcium transit in mouse (Rickords and White 1992), 
rabbit (Fissore and Robl 1992), cattle (Collas et al. 1993) and pig (Sun et al. 1992). The 
physical stimulus used for oocyte activation is the exposure of oocytes to room temperature 
before NT (Stice et al. 1994). 
Oocyte activation is one of the crucial parameters determining the success of nuclear transfer 
and the subsequent development of cloned embryos (Bhak et al. 2006, Motlik et al. 2002). 
Improper oocyte activation may affect the level of nuclear reprogramming following SCNT 
(Ross et al. 2009).  
Usually, activation treatment efficiency has been evaluated by pronuclear formation, cleavage 
and blastocyst rates, blastocyst cell number and ploidy (Van De Velde et al. 1999). However, 
huge variabilities are observed in the obtained results in comparative studies that involved 
different combined oocyte activating agents. For instance, Loi et al. (1998) reported that 
treatment of oocytes with ionomycin 6-DMAP resulted in the highest blastocyst and to term 
development rates. On the other hand, Shen et al. (2008) showed that electrical pulse, A23187 
or ionomycin in combination with 6-DMAP could efficiently activate reconstructed bovine 
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oocytes but not to term development. The same authors showed that only oocytes activated by 
the A23187 and 6-DMAP combined treatment developed to term after transfer to the recipient 
cow (2008). Other groups reported that activation with ionomycin and DMAP enhanced the 
developmental rates in parthenotes and SCNT embryos compared to activation with 
ionomycin and CHX in time-dependent pattern (Bhak et al. 2006). The blastocyst rate of 
bovine reconstructed oocytes activated by ionomycin + 6-DMAP was similar to that of 
ionomycin + CHX activated oocytes, when the interval between fusion and activation was 
less than 1 h. However, a high blastocyst rate and quality in terms of total cell numbers of 
bovine reconstructed embryos was obtained by activation with ionomycin + 6-DMAP for a 
prolonged period of time (3.5-4 h) after fusion (Shin et al. 2001, Van De Velde et al. 1999). It 
has also been reported that a delay of incubation in 6-DMAP later than 6 h following 
treatment with calcium ionophore/ionomycin could induce abnormal ploidy development 
(Rho et al. 1998, Van De Velde et al. 1999). These results suggested that timing of activation 
of NT embryos affect development at the blastocyst stage (Im et al. 2007).  
The timing of activation of recipient MII oocytes can be classified into two protocols as 
follows: (1) activation is performed immediately after fusion (simultaneous fusion and 
activation method, FA), (2) activation is performed several hours after fusion (delayed 
activation method, DA). Donor chromosomes are exposed to factors present in MII cytoplasm 
for only a short time in the FA method and for a long time in the DA method. In bovine NT 
using cultured somatic cells, the DA method has a high in vitro development rate compared 
with the FA method (Akagi et al. 2008, Shin et al. 2001, Wells et al. 1999). Prolonged 
exposure of incoming nuclei to a cytoplasm rich in metaphase-promoting factor (MPF) causes 
chromosome condensation (De Sousa et al. 2002). This condensation is believed to facilitate 
undefined nuclear changes that are essential for development (Campbell et al. 1996b).  
 
2.9 Role of epigenetics during early embryogenesis and SCNT 
 
All cells in an individual organism (with few exceptions) carry identical genetic information. 
Accordingly, functional specialization of cells during development is the outcome of 
differential transcriptional programs, not different genetic information. These programs are 
governed by the transcription/translation machinery, which in turn is guided and controlled by 
epigenetic (i.e., chemical) modifications of both DNA and chromatin (Bird 2007, Bonasio et 
al. 2010). Epigenetics is defined as nuclear inheritance that is not based on differences in 
DNA sequences (Holliday 1987). Epigenetics is believed to involve differential DNA 
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methylation, histone acetylation, chromatin configuration as well as other mechanisms (Tian 
2004).  
 
2.9.1 DNA methylation 
 
In vertebrates, DNA methylation occurs on cytosines in a cytosine-phosphateguanine (CpG) 
context. CpG methylation is catalyzed by DNA methyltransferases (DNMTs), which convert 
S-adenosylmethionine to S-adenosylhomocysteine by the addition of a methyl group to the 
5th position of a cytosine on DNA (Ostrup et al. 2012). CpG islands are frequently located 
within the promoter region of genes and methylation within the islands has been shown to be 
associated with transcriptional inactivation of the corresponding gene (Bird 1996).  
Because pre-implantation reprogramming occurs after fertilization, and in the case of nuclear 
transfer, after fusion of the donor nucleus with the ooplast, it is important to understand 
changes in methylation following these events. Hours after fertilization, but prior to DNA 
replication and cleavage intensive demethylation of the paternal but not the maternal  genome 
is observed in mice, rats, pigs and  cattle (Beaujean et al. 2004, Dean et al. 2001, Fulka et al. 
2004). In mice and cattle, the maternal genome retains its methylation markers during this 
period and the maternal genome is passively demethylated by a replication-dependent 
mechanism after the two-cell embryo stage (Fulka et al. 2008). In the mouse, the 
demethylation is gradual throughout the pre-implantation period up to the blastocyst stage 
(Dean et al. 2001) while in cattle a phase of remethylation occurs in the 8–16-cell stage 
(Santos et al. 2003).  
In embryos derived via nuclear transfer, epigenetic modifications, such as the waves of 
demethylation and de novo methylation observed following fertilization also occurs, but is 
often disturbed in cloned embryos of many species and the level of DNA methylation remains 
much higher than in normal fertilized embryos in most cases (Beaujean et al. 2004, Dean et 
al. 2003, Kang et al. 2001a, Kang et al. 2001b). For instance, in bovine cloned embryos 
despite initial demethylation of the donor genome, passive demethylation does not occur to 
the level seen in normal embryos. Besides, the levels of methylation in the cells of the embryo 
are higher than normal at the four-cell and eight-cell stages (Dean et al. 2001). Moreover, the 
methylation status in pre-implantation cloned embryos, particularly at some repeat sequences, 
closely resembles the methylation levels in the donor cell genome (Kang et al. 2001a).  
 
 
Literature review 
___________________________________________________________________________ 
 
27 
 
2.9.2 Histone modification  
 
DNA in eukaryotic organisms is organized in a nucleoprotein complex called chromatin. The 
basic unit of chromatin is the nucleosome, which is comprised of 147 bp of DNA wrapped 
around an octamer of histones, formed by pairs of each of the four core histones (H2A, H2B, 
H3, and H4) (Davey et al. 2002, Luger et al. 1997). At the entry and exit sites located on the 
surface of the nucleosome core, the DNA is bound by a fifth histone, histone H1, known also 
as linker histone (Martins et al. 2012). Linker histone H1 stabilizes the higher-order folding of 
nucleosomes that defines distinct levels of chromatin organization and gene activity (Figure 
4).  
 
 
 
Figure 4. Open and condensed chromatin. A) The nucleosome structure B) A closed 
(suppressed) and an open (active) chromatin structure. Adapted from 
http://www.abcam.com/index.html?pageconfig=resource&rid=10189&pid=5#mod 
 
The mammalian linker histone H1 family can be subdivided into somatic cell-specific 
subtypes, H1.0–H1.5 and H1x, and germ cell variants specific for sperm, H1t, H1T2 and 
HILS1, and oocytes, H1oo (Happel and Doenecke 2009). Changes in the chromatin histone 
variant composition have been suggested to be involved in genome reprogramming during 
gametogenesis and early embryonic development (Hajkova et al. 2008, Santenard and Torres-
Padilla 2009).  
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During early embryo development, oocyte-specific linker histone transition occurs twice: 
first, shortly after fertilization or nuclear transfer (“H1foo replaces somatic H1); and second at 
around the time of the maternal-zygotic transition/midblastula transition (H1foo is replaced 
by somatic H1) (McGraw et al. 2006, Yun et al. 2012). In  cattle  linker histone H1 becomes 
undetectable in somatic nuclei within 60 min after injection into oocytes, and is completely 
replaced with the highly mobile oocyte-specific H1FOO linker histone variant (Teranishi et 
al. 2004). In contrast, core histones of somatic nuclei, especially H3 and H4, are not removed, 
but remain stably associated with somatic DNA (Misteli et al. 2000). 
In addition to the exchange of proteins between the donor nucleus and oocyte cytoplasm, 
there are modifications to DNA and post-translationally to proteins that occur after SCNT 
(Whitworth and Prather 2010). In chromatin, the extruding tails of the histone proteins are the 
preferential sites for posttranslational modifications. Histone tails are subjected to a wide 
range of postranslational modifications, including  acetylation, methylation, phosphorylation, 
ubiquitylation, sumoylation, ADP-ribosylation, glycosylation, biotinylation and carbonylation 
(Strahl and Allis 2000). The detection of different covalent histone modifications is also often 
used as an indicator of remodeling of the somatic cell nucleus.  Histone acetylation results in 
loss of the positive charges on lysine residues located in the core histone N termini, which 
would weaken the association between histone N-terminal domains and DNA favoring 
transcription factor binding (Zhang et al. 2002). Addition and removal of acetylation at 
histone residues are catalyzed by histone acetyltransferase (HAT) and histone deacetylase 
(HDAC), respectively (Figure 5). Thus, HAT is implicated in creating an “open” chromatin 
environment and HDAC a “closed” one (Hayashi and Masukata 2011). Studies on the 
acetylation of histones in bovine cloned embryos have found aberrancies (Enright et al. 2005, 
Santos et al. 2003). The histone deacetylase (HDAC) inhibitor trichostatin A (TSA) alproic 
acid, scriptaid, and sodium butyrate treatment of reconstructed embryos or donor cell 
increases cloning efficiency including live births (Kishigami et al. 2006). This suggests that 
hypoacetylation may be one limiting factor for the development of cloned embryos 
(Rybouchkin et al. 2006). 
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Figure 5. Hypermethylated DNA recruits silencing transcription chromatin remodeling 
complexes with histone deacetylases (HDACs) and promotes chromatin condensation. 
Hypomethylated DNA unfolds into a 'beads-on-a-string' structure in which histones are 
accessible for chromatin remodeling factors such as histone acetyltransferase (HAT).  
Adapted from (Korzus 2010). 
 
2.9.3 Imprinting 
 
Most autosomal genes are normally expressed from both paternal and maternal alleles, 
whereas imprinted genes are expressed predominantly, or exclusively, from either the 
maternal or paternal allele. Thus, the expression of imprinted genes does not follow a 
Mendelian pattern of inheritance (which indicates the equal participation of the alleles derived 
from both parents) (Tycko and Morison 2002) but instead depends on the parent-of-origin to 
dictate its expression (Ferguson-Smith and Surani 2001). That means genomic imprinting 
results in only one inherited copy of the relevant imprinted gene being expressed in an 
embryo. For paternally imprinted genes, the paternal allele is epigenetically modified to 
prevent transcription, ensuring that the embryo has only mono-allelic expression from the 
maternally inherited copy or, conversely, for maternal imprinted genes the paternal allele is 
expressed while the maternal allele is silenced (Choufani et al. 2010). Genomic imprinting 
could be either maternal or paternal, with the phenotypic consequences manifested relatively 
late in development or even into adulthood (Reik et al. 1993).  
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Imprinting is an epigenetic modulation of transcription and it is mainly due to the differential 
methylation of cytosine residues in CpG nucleotides in specific differentially methylated 
regions (DMRs) (Neumann et al. 1995). DMRs can have different properties: some are 
methylated in the silenced allele, whereas others are methylated on the active copy.  
Imprinted genes account for only 0.1–0.5% of the genome but have a disproportionately 
important influence on early mammalian development (Constancia et al. 2004, Tycko and 
Morison 2002). Many imprinted genes are involved in the control of fetal growth and 
development in mammals (Reik et al. 2003) and dysregulation of their expression by deletion, 
inappropriate silencing or loss of imprinting has been implicated in several pathologies in the 
placenta and fetus, including sporadic, inherited and environmentally induced growth disorder 
(Lim and Ferguson-Smith 2010, Miozzo and Simoni 2002).  
Many of the developmental defects observed in cloned bovine foetuses suggest the 
involvement of growth regulating genes, particularly those known to be imprinted.  Defects 
such as placental and fetal overgrowth and perinatal death may result from deregulation of 
imprinted genes in fetus and placenta (Eggenschwiler et al. 1997). Fetal tissue seems less 
vulnerable to this type of imprinted problem as compared to placenta. In cloned mice several 
imprinted genes show abnormally low expression in the placenta, whereas no differences are 
seen in the fetus (Inoue et al. 2002). Similarly abnormal allelic expression pattern of the 
imprinted IGF2R gene was observed in placentas but not in the organs of cloned bovine 
calves (Yang et al. 2005). Moreover, evaluation of methylation patterns of imprinted genes 
following SCNT indicates that methylation errors at imprinted loci are common (Mann et al. 
2003). In the mouse, only 4% of the SCNT-derived pre-implantation stage embryos 
recapitulate the expression of the imprinted genes H19, MEG3, IGF2R, ASCL2 and SNRPN 
relative to in-vivo-derived blastocysts (Mann et al. 2003).  
Apart from somatic cell transfer, imprinted genes are responsive to a range of environmental 
cues, such as in vitro fertilization and maturation. In vitro environment results in the loss of 
genomic imprinting and biallelic expression (Dean et al. 2001, Dean et al. 2003, Doherty et al. 
2000, Mann et al. 2004) which are subsequently associated with alterations in placental 
growth and development. Imprinting also varies dynamically across gestation in human, 
mouse and bovine placentas (Arnold et al. 2006a, Guillemot et al. 1995, Pozharny et al. 
2010).  In cattle, the imprinted MASH2/ASCL2 gene is biallelically expressed in trophoblast 
before implantation but is paternally silenced thereafter (Arnold et al. 2006a).  
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2.9.4 X chromosome inactivation 
 
Sex chromosome dimorphism leads to a genetic imbalance between the homogametic (XX) 
and heterogametic sexes (XY), which mammals compensate by inactivating one of the two X 
chromosomes during female development in a process called X chromosome inactivation 
(XCI) (Lyon 1961). This epigenetic phenomenon involves non-coding RNAs (ncRNAs), 
antisense transcription, histone modifications, and DNA methylation to distinguish two 
genetically identical X chromosomes as active and silent entities within the same nucleus 
(Erwin and Lee 2008). In mice, the best-studied species two forms of XCI are observed: 
imprinted and random. Imprinted XCI inactivates the paternally inherited X chromosome 
(Xp) and occurs in the extra-embryonic lineages (Takagi and Sasaki 1975, Takagi et al. 
1982). Random XCI occurs in the embryonic lineages in which the X chromosome of either 
parental origin (Xp or maternal X chromosome Xm) can be stochastically chosen for 
inactivation (Okamoto et al. 2005). This pattern persists in the trophectoderm lineage, such 
that only the maternal X chromosome is expressed in the placenta. In the ICM, however, the 
paternal X chromosome is reactivated, after which the paternal and maternal chromosomes 
are subject to random inactivation in the developing embryo (Okamoto et al. 2005). 
In somatic cloning through nuclear transfer, the cloned zygotes receive one active (Xa) and 
one inactive (Xi) X chromosome from the donor cells. The introduction of a somatic cell 
nucleus containing one inactive X chromosome into oocyte cytoplasm creates an unusual 
epigenetic situation different from that in naturally fertilized female zygotes, in which both X 
chromosomes are active (Tian 2004). Using somatic donor cells containing genetically 
marked X chromosomes, it was shown that X inactivation was random in the epiblast lineage 
of cloned mice (Eggan et al. 2000). This means that the epigenetic marks that distinguish the 
active X from the inactive X are removed in somatic cells and reestablished on either X in the 
embryonic lineage after NT (Eggan et al. 2000, Rideout et al. 2001). However, in bovine 
clones aberrant patterns of X chromosome inactivation as well as transcript levels of X-linked 
genes, including XIST, have been found among different tissues (Wrenzycki et al. 2002, Xue 
et al. 2002). Besides, placental samples exhibited random X inactivation as opposed to the 
non-random preferential paternal X inactivation seen in normal controls and healthy SCNT 
calves (Xue et al. 2002). 
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2.10 Differences between cloned and fertilized embryos with respect to the early    
        developmental events 
 
In mammals, oocytes are ovulated at metaphase II and remain arrested at this stage until 
fertilization. The oocyte remains arrested at this stage for months (mouse) or even years 
(cattle) (Hyttel et al. 1997) and decades (humans) (Kishimoto 2003, Whitaker 1996) until a 
preovulatory hormonal surge. Once fertilized, the oocyte completes meiosis with the 
extrusion of the second polar body and the formation of male and female pronuclei. Shortly 
after their formation, DNA replication is initiated in the pronuclei. After DNA replication, 
equal segregation of the genetic material occurs by mitosis and the zygote cleaves to form two 
daughter blastomeres (Campbell et al. 1996a).  
As part of the NT procedure the maternal chromosomes are removed to produce an enucleated 
oocyte. Following donor cell fusion or nuclear microinjection into the enucleated oocyte 
(cytoplast), the donor nucleus undergoes numerous subsequent events. In summary these 
include 1) nuclear envelop break-down (NEBD) followed by 2) premature chromosome 
condensation (PCC) 3) dispersal of nucleoli, 4) reformation of the nuclear envelope, and 5) 
nuclear swelling (Campbell et al. 1993). Nuclear swelling is indicative of extensive exchanges 
of proteins between the cytoplasm and the transferred nuclei and considered as a 
morphological indication of nuclear remodelling in amphibians (Gurdon 1964) and mammals 
including cattle (Sung et al. 2007), rabbit (Stice and Robl 1988), pig (Prather et al. 1987) and 
mice (Czolowska et al. 1984). These series of ultrastructural and biochemical changes 
occuring in activated oocytes after nuclear transfer, result in the formation of pseudo pro 
nucleai which mimic cytophysiologically interphase nuclei which are formed after oocyte 
fertilization (Samiec and Skrzyszowska 2005). 
Although the male and female pronuclei reside in the same ooplasm, several differences 
become established between them during the first cell cycle (McLay and Clarke 2003). The 
origin of the differences between maternal and paternal pronuclei seen in fertilized embryos is 
mechanistically linked to the unique origins and chromatin state of the oocyte- and sperm-
derived chromosomes (Latham 2005). For instance,  in mammals the maternal genome is pre-
packaged with histones in the oocyte, and has a chromatin configuration containing high 
levels of H3 histones methylated on lysines 4, 9 and 27, and trimethlyated histone H4 lysine 
20 (Liu et al. 2004, van der Heijden et al. 2005). Whereas during spermatogenesis spermatids 
completely lack histones repacked their DNA with protamines, which become rapidly 
replaced by maternally provided histones in the zygote (McLay and Clarke 2003, 
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Yanagimachi 2003). This protamine-histone replacement allows the paternal genome to 
acquire a chromatin state that is enriched in hyper-acetylated histones (Adenot et al. 1997). In 
addition to histone modification, the pronuclei appear first few hours after fertilization differs 
markedly in demethylation of their paternal DNA. Before fertilization both gametes are highly 
methylated, with sperm being more methylated than oocyte DNA (Howlett and Reik 1991). 
However, very rapid and active demethylation of the paternal pronucleus oocurs shortly after 
fertilization while the maternal DNA remains methylated during this time (Mayer et al. 2000). 
As mentioned above, normal fertilized embryos possess their two parental sets of 
chromosomes in two distinct pronuclei, and distinct differences have been documented 
between the pronuclei in various epigenetic modifications involving changes in DNA 
methylation and histone acetylation (Kono 1997, Latham 2005). Therefore, it is reasonable to 
assume that if an SCNT-generated embryo has to develop, the chromatin must, at least to 
some extent, recapitulate the normal events taking place during early embryogenesis. When 
SCNT embryos were probed for the presence of this modification, it was observed that the 
pseudo-pronucleus does exhibit characteristics typical neither for the maternal nor for the 
paternal pro-nucleus (Fulka et al. 2008).  This might be due to the nuclease used in nuclear 
cloning comes from a somatic (body) cell that has not undergone the developmental events 
required to produce the egg and sperm (Rideout et al. 2001). For instance the somatic 
genome, already packaged with histones, is unlikely to undergo the massive histone 
replacement process observed with the paternal genome (Lorthongpanich et al. 2010). Besides 
the methylation patterns typical of biparental chromosomes are not reproduced, passive 
demethylation occurres with greatly reduced efficiency in cloned embryos (Bourc'his et al. 
2001).  Thus, somatic cell chromosomes would not exist in those same chromatin states, at 
least not with the same maternal–paternal dichotomy (Latham 2005). Whatever restrictions on 
gene expression may arise normally from differential modifications of maternal and paternal 
chromosomes in the fertilized zygote, these restrictions are probably lacking in cloned 
embryos (Latham 2005).    
 
2.11 Transcriptional reprogramming  
 
It is believed that complete reprogramming of a somatic cell nucleus by the recipient cytoplast 
would result in an embryo with a similar profile of gene transcription as that is seen in vivo. 
Expression profiles of genes provide a primary evaluation on the extent to which the donor 
genome is correctly reprogrammed. In order to address the question of the extent of 
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reprogramming of donor cells and the effects of SCNT on gene-expression patterns in 
blastocysts, Smith et al. (2005) compared gene-expression profiles in donor cells and day-7 
blastocysts produced by artificial insemination (AI), in vitro fertilization (IVF), and SCNT 
using a 7872 element cDNA microarray representing 6300 unique genes. The result showed 
that the vast majority (84.2%) of genes represented on the array were differentially expressed 
in the fibroblast donor cells when compared with the SCNT embryos, with more than 1500 
genes exhibiting more than twofold difference. Besides comparison of the gene-expression 
profiles of AI, IVF, and SCNT 7-day blastocysts revealed that, SCNT embryos had a gene-
expression pattern that was more similar to the AI embryos than the AI were to IVF embryos. 
Though, the source of cDNA clones which Smith and colleagues used consisted 
predominantly of placenta and spleen cDNA libraries which lacked embryonic genes, the 
study was appreciated as the first dramatic demonstration of the extent of nuclear 
reprogramming that occurs during the SCNT process.  
Following that information from multiple transcriptional analyses of transferable bovine 
blastocysts from various origins is starting to accumulate (Long et al. 2007, Pfister-Genskow 
et al. 2005, Somers et al. 2006, Zhou et al. 2008). One such study (Beyhan et al. 2007) 
examined the transcriptional reprogramming  status of blastocysts constructed from two 
female adult ear skin fibroblast lines (LE: low efficiency and HE: high efficiency) that 
differed markedly in their culture characteristics, developmental potential and in the 
expression of over 3000 transcripts prior to NT. Interestingly, comparison of these two cell 
lines derived SCNT blastocysts with that of IVP blastocyst demonstrated indistinguishable 
gene expression profile. However, unlike their similar degree of transcriptional 
reprogramming at the blastocysts stage, the two cell lines showed significantly different 
cloning efficiency in terms  of generating live birth. A possible explanation for this 
phenomenon is global transcriptional profiling at the blastocyst stage may not have a direct 
relationship with to term development capacity. An alternative explanation could be as long 
as there were differentially expressed genes between SCNT and AI blastocysts, it is possible 
that those transcripts may have a pronounced effect on downstream development and 
redifferentiation (Smith et al. 2005).   
Once the step of somatic-to-embryonic nuclear reprogramming has been successfully 
overcome, the difficulty resides in the accurate re-differentiation of the reprogrammed nuclei 
(Yang et al. 2007). Thus, post-hatching development especially between day 7 to 21 SCNT 
conceptuses are therefore, of high interest to decipher how the embryo, the trophoblastic sac 
and the uterus depend on each other and to which extent they tolerate asynchronies (Hue et al. 
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2012).  It is important to note that thus far, all expression profile studies have examined the 
whole blastocyst embryo, so it remains unclear whether the observed differences are in the 
inner cell mass (ICM), the trophectoderm or both lineages (Yang et al. 2007). It is noteworthy 
that 60–80% of cells in the blastocyst are committed to the extraembryonic tissues (Koo et al. 
2002). Thus, aberrantly reprogrammed genes expressed in early trophoblast may not be 
detected at 7 days of development if the resulting differential expression is localized to a 
fractional population of cells fated to form the extra embryonic tissues (Rodriguez-Zas et al. 
2008). Reports in cattle showed that SCNT derived embryos extraembryonic tissues were 
shorter than AI or IVP elongating controls at day 14 of pregnancy (Alexopoulos et al. 2008). 
In an effort to identify putative genes associated to SCNT embryo elonagation process, a 
recent review by Hue et al. (2012) summarized more than 60 genes altered (up- or down- 
regulated) in elongating tissue after SCNT as compared to controls (AI or IVP). The 
transcripts were identified (Arnold et al. 2006a, Fujii et al. 2010, Kato et al. 2007, Rodriguez-
Alvarez et al. 2010a, Sawai 2009, Smith et al. 2010) using  transcriptomic or a candidate gene 
approach and analysed in silico. Interestingly, 89% of the transcripts belonged to networks 
that perfectly matched some of the functions that were previously associated to the elongation 
process namely: “cell cycle” or “cellular development” (Table 1).  
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Table 1. Gene expression on bovine elongating conceptuses after SCNT: IPA analysis on 55 
genes, from 7 studies: Arnold et al. (2006), Kato et al. (2007), Sawai (2009), Fujii et al. 
(2010), Rodriguez-Alvarez et al. (2010) and Smith et al. (2010). Gene names are provided 
according to the referenced HUGO terms. 
ID Molecules in network Score Focus 
molecules Top functions 
1 
Actin, Alpha catenin, Alpha tubulin, ASCL2, 
AURKA, Caspase, CCT2, Cdc2, ERK1/2, Fgf, 
FSH, GNB2L1, hCG, Histone h3, IGF1R, 
Immunoglobulin, Insulin, KRT8, KRT18, Lh, 
NCL, NPM1, PP2A, PTGS2, Ribosomal 40s 
subunit, Rnr, RPS3, RPS11, RPS12, RPS25, 
Rsk, TMPO, TPT1, TUBA4A, Vegf 
38 17 
Cell death, cell cycle, 
DNA replication, 
recombination, and 
repair 
2 
Ap1, Caspase 3/7, CDX2, Collagen Alpha1, 
Collagen type I, Collagen type IV, Cyclin E, 
ELF5, EOMES, FGF4, FURIN, Growth 
hormone, IGF1, IGF2, Igf, IGF2R, IGFBP2, 
IGFBP3, Igfbp, ILF2, Laminin, LDL, N-cor, 
NANOG, NFkB (complex), PDGF BB, 
POU5F1, SOX2, SOX2-OCT4, SOX2-OCT4-
NANOG, SPARC, Stat5 dimer, TEAD4, Tgf 
beta, WEE1 
38 17 
Cellular development, 
embryonic 
development, 
posttranslational 
modification 
3 
60S ribosomal subunit, Akt, Ck2, Creb, ENO1, 
ERK, G-protein beta, GATA3, Gsk3, HAND1, 
Histone h4, IgG, IL1, IL12 (complex), IL12 
(family), Jnk, LOC342994, LOC646875, 
LOC653232, Mapk, P38 MAPK, p85 (pik3r), 
PI3K (complex), Pkc(s), Ras, RNA polymerase 
II, RPL18, RPL23, Rpl36, RPL39, RPL10A, 
RPL35A, Rpl38 (includes others), RPLP2, 
Ubiquitin 
18 9 
Gene expression, 
cellular development, 
hematological system 
development and 
function 
Genes in bold are present in the input data list, adopted from Hue et al. (2012). 
 
This suggests that the SCNT elongated embryos’ transcriptome is not only informative 
because it reveales the prevailing earlier reprogramming errors or explained later placental 
defects but also delivers information on the elongation process (Hue et al. 2012). It is 
therefore critically important to determine the reprogramming status of transcripts 
differentially expressed in elongated SCNT embryos so as to define the role of those genes in 
subsequent embryo development. 
 
 
Literature review 
___________________________________________________________________________ 
 
37 
 
2.12 Effect of culture medium on gene expression of early IVP and SCNT derived embryos 
  
The in vitro production of embryo (IVP) is essentially a three-step process involving in vitro 
oocyte maturation (IVM), in vitro fertilization (IVF) and in vitro culture (IVC). On the other 
hand, the standard SCNT procedure includes enucleation of ova, insertion of the donor cells 
(or nuclei) and activation of the reconstructed embryo and subsequently IVC of constructed 
embryos till blastocyst stage. Despite this autonomy the pre-implantation embryo is highly 
influenced by factors in the external environment such as those presented by embryo culture 
or nuclear transfer, which may contribute for their difference with their in vivo counterparts in 
many respects including having smaller embryonic discs (Bertolini et al. 2002), retarded 
embryonic development (Alexopoulos et al. 2008, Tveden-Nyborg et al. 2005), shorter 
trophoblast size (Alexopoulos et al. 2008) and high incidence of chromosomal abnormalities 
(Slimane et al. 2000). These adverse characteristics are even more pronounced in SCNT 
embryos (Alexopoulos et al. 2008, Booth et al. 2003) which have still unresolved unknown 
problems (De Sousa et al. 2002). In addition, the ability of the embryo to adapt to changing 
environmental conditions can exceed its own adaptive capacity, resulting in aberrant 
embryonic gene expression (Gao et al. 2003, Niemann and Wrenzycki 2000).  
There is a large and continually increasing body of evidence supporting the hypothesis that 
the environment to which embryos are exposed in vitro can perturb gene expression in the 
developing embryo. Several studies have been performed to gauge the effect of the 
environment on gene expression during pre-implantation development. Most of the studies 
looked at the transcription of individual genes, often focusing on stress, imprinting and 
apoptosis related genes. In one such study, McElroy et al. (2008) showed the effect of culture 
conditions and SCNT on the expression of HSP70.2, integrin beta 1 (ITGB1), 
phosphoglycerate kinase 1 (PGK1), BAX and IGF2R in porcine pre-implantation embryos 
(McElroy et al. 2008). The amount of BAX mRNA was higher in IVP and SCNT blastocysts 
cultured in a medium with addition of 10% fetal bovine serum (FBS) on day 4 as compared 
with in vivo blastocysts, whereas the mRNA content was lower for HSP70.2, IGF2R and 
ITGB1 in IVP than in in vivo blastocysts. Given that HSP70.2 is a molecular chaperone that 
is generally up-regulated in response to stress, it is surprising that the transcription of 
HSP70.2 was lower in IVP embryos than in vivo porcine blastocysts (McElroy et al. 2008).  
However, the regulation of expression of heat shock proteins seems complex and sensitive to 
minor changes in environment and manipulation (Wrenzycki et al. 2001).  
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Various studies in cattle and sheep have shown that the production of embryos under specific 
culture environments resulted in not only altered gene expression but also altered conceptus 
and fetal development following transfer. For instance, LOS is often attributed to the culture 
system. LOS is identified by obvious abnormalities, such as increased incidence of oversize 
fetuses and calves, increased fetal myogenesis, dystocia, dysfunctional perinatal pulmonary 
activity, abnormalities in placental development and reduced pregnancy rates (Farin and Farin 
1995, Kruip et al. 1997, Niemann and Wrenzycki 2000, Young et al. 1998). The incidence of 
these phenotypes evidenced the persistence of early molecular deviations and their correlation 
with developmental anomalies (Lazzari et al. 2002).  
Numerous studies aimed to improve the culture medium for preimplantation of embryos that 
can produce cloned offspring after transfer to the recipient. In vitro optimization of embryo 
culture media has revealed that cloned embryos perform better in glucose containing media, 
thus suggesting a possible altered physiological metabolism (Chung et al. 2002) resembling 
that of somatic cells. In the mouse, studies have shown that optimal results are obtained when 
the reconstructed embryo is cultured in the media in which the donor cell was cultured in 
(Gao et al. 2003). With the aim to establish an efficient defined culture medium for bovine 
somatic cell nuclear transfer (SCNT) embryos, Wang et al. (2012a) recently compared various 
media. Modified synthetic oviductal fluid (mSOF) without bovine serum albumin (BSA) was 
used as the basic culture medium (BCM) and with (BSA) as a control.  Defined culture media 
containing each polyvinyl alcohol (PVA), myo-inositol, a combination of insulin, transferrin 
and selenium (ITS), epidermal growth factor EGF or all were added to BCM and the effect in 
terms of blastocyst formation rate, blastocyst cell number and expression of transcripts H19, 
HSP70, BAX and IGF-2 was compared with that of control counterparts. No significant 
differences in expression levels of H19, HSP70 and BAX were found in blastocysts derived 
from optimized medium and undefined medium, although the relative expression abundance 
of IGF-2 was significantly decreased in the former.  
Alternatively, supplementation of hormone such as 10 ng/ml leptin during bovine oocyte 
maturation improved blastocyst rate and reduced the proportion of apoptotic cells through 
transcriptional enhancement of the leptin receptor (LEPR), signal transducer and activator of 
transcription 3 (STAT3), and baculoviral inhibitor of apoptosis protein repeat - containing 4 
(BIRC4) genes (Boelhauve et al. 2005). Similarly, in vitro culture (IVC) medium with 50 
ng/ml leptin during pig partenogenic (PA) and SCNT embryo development showed a stage-
dependent regulatory effect which its primary stimulator effect being observed at the 4-8-cell 
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stage (Wei et al. 2009). These results indicated a positive effect of leptin on pre-implantion 
embryo development.  
Addition of growth factors such as vascular endothelial growth factor (VEGF) at the late 
porcine IVP and SCNT blastocyst development stage was found to have a beneficial effect on 
the blastocyst quality and development rate (Biswas et al. 2011).  It was shown that VEGF 
mRNA along with fetal liver kinase-1/ kinase insert domain-containing receptor mRNA (flk-
1/KDR) was detected in all pre-implantation embryos stages of IVF and SCNT embryos 
indicating that the activity was achieved through VEGF receptors. Similarly, culturing pig 
IVF and SCNT embryos with IGF-I significantly increased the number of total cells in 
blastocysts and decreased the number of apoptotic nuclei (Kim et al. 2006). 
Improvement of somatic cell reprogramming ability was also reported when the donor cells or 
the reconstructed embryos were treated with trichostatin A, an inhibitor of histone 
deacetylases, before or after NT (Ding et al. 2008, Iager et al. 2008, Meng et al. 2009, Zhang 
et al. 2007). Unfortunately, the long-term effects of these reagents on embryo development 
and their safety in therapeutic cloning are not known. One essential difference between the 
IVF and SCNT embryos is that the IVF embryos were fertilized by sperm in vitro, whereas 
SCNT embryos received a diploid nucleus from cultured donor cells. As the underlying 
reprogramming processes could be very different between NT and in vitro fertilized embryos, 
different media systems may be warranted (Dai et al. 2009). 
 
2.13 Application of somatic cell nuclear transfer  
 
Although there are issues concerning the safety of food products derived from clones and 
their offspring and significant animal welfare concerns limiting the acceptability and 
applicability of the technology in its current form, the potential benefits of cloning in 
research, industry and agriculture are vast. The available literature (Bowring 2004, de Oliveira 
Junior and de Oliveira 2012, French et al. 2006, Revel 2000, Yang 2004, Yang et al. 2007) 
categorized these applications in two general areas: Therapeutic and reproductive. Less 
frequently mentioned possibility ‘basic researchs’ is also included in the recent review of 
Niemann and Lucas-Hahn (2012).  
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2.13.1 Reproductive cloning  
 
Reproductive cloning is the formation of one or more animals from a body cell of another 
animal. Thus, the members of a clone are genetically identical to each other and also to the 
donor of the cell from which the clone is derived (Gurdon 2004). 
 
Application of reproductive cloning for rapid multiplication of desired livestock 
Nuclear transfer cloning, especially from somatic cell nuclei, could provide a means of 
expanding the number of chosen livestock. It has a potential to produce a genetic copy (a 
clone) of an already proven adult animal of exceptionally high genetic merit for commercial 
purposes, without recourse to time-consuming progeny testing (Basrur and King 2005). This 
would be particularly relevant in the sheep and beef industries, where cloned sires could be 
used in widespread natural mating to provide an effective means of disseminating their 
superior genetics. It could be used as a substitute for artificial insemination, which in these 
more extensive industries is often expensive and inconvenient (Wells 2005). 
 
 Conservation of endangered species 
Cloning can be used along with other forms of assisted reproduction to help preserve 
indigenous breeds of livestock, which have production traits and adaptability to local 
environments that should not be lost from the global gene pool. Prominent examples are the 
birth of the Sardinian Mufflon which is threatened by extension. It was produced by transfer 
of cloned Sardinian mufflon embryos into domestic sheep foster mothers (Loi et al. 2001). 
 
Cloning for transgenic applications  
A transgene is a foreign deoxyribonucleic acid (DNA) construct containing a sequence that 
codes for a specific protein and a promoter region that confers gene expression in specific 
tissues, along with insulators and other regulatory sequences to protect, enable or enhance the 
expression of the introduced gene (Keefer 2004, Niemann et al. 2003). The so-called 
"transgenic animals" were first developed using mice, by microinjection of DNA into the 
nucleus of the egg (Gordon et al. 1980, Palmiter et al. 1982). Alternatively, transgenic 
offspring can be created by using genetically modified donor cells for nuclear transfer. It is 
possible to remove (knockout) as well as to add genes and facilitates precise modification of 
control regions or addition of genes to specific regions of the genome (knockin) (Campbell 
2002). The biotechnological applications of producing genetically modified cloned offspring 
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are many fold and include those targeting reproductive performance, growth rate, carcass 
quality, milk production, milk composition and disease resistance (Wall 1996, Wheeler et al. 
2003). As such, in the earlier days of domestication, the introduction of superior alleles for 
any of these traits into a new line would have necessitated continued genetic selection, cross-
breeding (hybridisation) and repeated back-crossing to ensure the introgression of the 
introduced allele.  Transgenesis offers a faster method of introducing new and desirable genes 
into domestic animals without recourse to cross-breeding (Wall 1996). 
 
2.13.2 Therapeutic cloning 
 
This term refers to the production of cells by nuclear transplantation or cloning so that they 
can be used for replacement of body cells that no longer function normally (Gurdon 2004). 
 
Pharmaceutical and medical applications of cloning 
SCNT has been proposed as an approach to generate patient specific pluripotent stem cells for 
potential therapeutic applications. Patients with particular diseases or disorders in tissues that 
neither repair nor replace themselves effectively (as occurs, for example, in insulin-dependent 
diabetes, muscular dystrophy, spinal cord injury, certain cancers and various neurological 
disorders, including Parkinson’s disease) could potentially generate their own 
immunologically compatible cells for transplantation, which would offer lifelong treatment 
without tissue rejection (Wells 2005). The embryonic stem cells derived from the SCNT 
embryo, called ntES cells (embryonic stem cells by nuclear transfer), would be isogenic to the 
donor and pose no risk of immune rejection (Pan et al. 2012, Wells 2005). The generation of 
human embryos does (Thomson et al. 1998), however, raise ethical concerns. It is therefore 
important for those advocating the introduction of therapeutic cloning to examine every 
alternative that could achieve similar objectives. One of such breakthrough that could 
potentially resolve the ethical issues and rejection problems associated with the use of human 
ES cells in regenerative medicine (Liu et al. 2008) is forced expression of four transcription 
factors (OCT4, SOX2, NANOG, and LIN28) to reprogram, mouse embryonic fibroblasts to 
ES-like cells (Yamanaka et al. 2006). This technology has since been improved with 
additional factors (Takahashi and Yamanaka 2006, Takahashi et al. 2007) and microRNAs 
[termed induced pluripotent stem (iPS) cells](Anokye-Danso et al. 2011, Miyoshi et al. 2011). 
Though the iPS approach is more practical than SCNT (Dimos et al. 2008), several studies 
have raised concerns about the safety of the iPS cells (Hussein et al. 2011, Taapken et al. 
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2011, Zhao et al. 2011). These concerns renewed the interest in other alternatives such as 
SCNT. Recently, for the first time, human ntES cells were reported to be successfully derived 
from an SCNT embryo (Noggle et al. 2011). In the longer term, however, fundamental 
understanding of reprogramming may enable one cell type to be directly trans-differentiated 
into another cell type specifically required for cell-based therapy (Collas and Hakelien 2003). 
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3. Materials and methods 
 
3.1 Materials 
 
3.1.1 List of chemicals and kits  
 
During this experiment, various chemicals, kits and culture media purchased from different 
manufacturers were used. Besides, during data analysis multifarious software packages, tools 
and databases were utilized. 
 
Chemicals  Manufacturer/Supplier 
10 x PCR buffer                                       Promega, WI, USA 
2-Mercaptoethanol Sigma-Aldrich Chemie GmbH, 
Munich, Germany 
5 x First-Strand buffer Invitrogen Life Technologies, 
Karlsruhe, Germany 
Acetic acid Roth, Karlsruhe, Germany 
Agarose                                                         Sigma-Aldrich Chemie GmbH, 
Munich, Germany 
BME (essential amino acids) Gibco BRL, life technologies, 
Karlsruhe, Germany 
Bovine serum ablbumin (BSA) Promega, Mannheim, Germany 
Dimethyl sulfoxide (DMSO) Roth , Karlsruhe, Germany 
dNTPs Roth , Karlsruhe, Germany 
DTT 
Invitrogen Life Technologies, 
Karlsruhe, Germany 
Dye terminator cycle sequencing (DTCS) Beckman Coulter, Krefeld, 
Germany 
Ethanol Roth, Karlsruhe, Germany 
Ethidium bromide Roth, Karlsruhe, Germany 
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Ethylenediaminetetra acetic acid  Roth , Karlsruhe, Germany 
Eukaryotic poly-A RNA control kit Affymetrix, CA, USA 
ExoSAP-IT USB, Ohio, USA 
FSH Follitropin Vetrepharm, Canada 
GeneChip® Bovine Genome Array  Affymetrix, CA, USA 
GeneChip®3’hybridization, wash and stain kit Affymetrix, CA, USA 
GeneChip®3’ IVT express kit Affymetrix, CA, USA 
Glycogen for sequencing Beckman Coulter, Krefeld, 
Germany 
GnRH Fertagyl®; Intervet, Boxmeer, The 
Netherlands 
Hemi-calcium lactate Promega, WI, USA 
Hepes Sigma-Aldrich Chemie GmbH, 
Munich,Germany 
Hoechst 33342 Invtrogen, Carlsbad, CA, USA 
Hydrochloric acid Roth, Karlsruhe, Germany 
Hydroxylamine Sigma-Aldrich Chemie GmbH, 
Munich, Germany 
Hypotaurin Sigma-Aldrich Chemie GmbH, 
Taufkirchen, Germany 
Ionomycin Sigma-Aldrich, Chemie GmbH, 
Munich, Germany 
L-Glutamine Sigma-Aldrich, Germany 
Magnesium chloride Sigma-Aldrich Chemie GmbH, 
Munich, Germany 
MEM (non essential amino acids) Gico BRL, Life Technologies, 
Karlsruhe, Germany 
Mineral oil Sigma-Aldrich Chemie GmbH, 
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Munich, Germany 
Norgen RNA DNA & protein  isolation kit 
Norgen Bioteck Corporation, 
Ontario, Canada 
Oligonucleotide primers MWG Biotech, Eberberg, Germany 
PGF2α Estrumate®, Intervet, Munich, 
Germany 
PicoPureTM RNA isolation kit  Arcturs, CA, USA. 
Potassium chloride 
Sigma-Aldrich Chemie GmbH, 
Munich, Germany 
Random primer Promega, WI, USA 
Ribo-nuclease inhibitor (RNasin) Promega, WI, USA 
RNAlater Sigma-Aldrich, MI, USA 
RNasin Promega, WI, USA 
RNA 6000 Nano LabChip® kit Agilent Technologies Inc, CA, USA 
RQ1 RNase-free DNase Promega, WI, USA 
Sample Loading Solution (SLS) Beckman Coulter, Krefeld, 
Germany 
Sequagel XR sequencing gel Beckman Coulter, Krefeld, 
Germany 
Sodium acetate Roth , Karlsruhe, Germany 
Sodium bicarbonate Sigma-Aldrich chemie, Steinheim, 
Germany 
Sodium chloride Roth , Karlsruhe, Germany 
Sodium hydrogen sulphate Sigma-Aldrich Inc, MO, USA 
Sodium lactate solution (60%) Sigma-Aldrich Inc, MO, USA 
Sodium pyruvate Sigma-Aldrich Inc, MO, USA 
Trypsin-EDTA Sigma-Aldrich, Chemie GmbH, 
Munich, Germany 
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Streptomycin Sigma-Aldrich, Deisenhofen, 
Germany 
Streptomycin sulphate Sigma-Aldrich Inc, MO, USA 
TCM199 Sigma, Taufkirchen, Germany 
Superscript II reverse transcriptase Invitrogen,  CA, USA 
iTaq SYBR Green Supermix with ROX  Bio-Rad Laboratories, Munich, 
Germany 
Taq DNA polymerase Sigma-Aldrich Inc, MO, USA 
   
Reagents and media  
Agarose loading buffer Bromophenol blue 0.0625 g 
 Xylencyanol 0.0625 g 
 Glycerol 7.5 ml 
 ddH2O added to 25 ml 
3% BSA in PBS BSA 30g 
 10x PBS : added to 1,000.0 ml 
CR1-aa culture medium (50 ml) Hemi-calcium lactate 0.0273 g 
 Streptomycin sulphate 0.0039 g 
 Penicillin G 0.0019 g 
 Sodium chloride 0.3156 g 
 Potassium chloride 0.0112 g 
 Sodium hydrogen carbonate 0.1050 g 
 Sodium pyruvate 0.0022 g 
 L-Glutamine 0.0073 g 
 Phenol red solution (5% in D-
PBS) 
100 µl 
 Sodium hydrogen carbonate 0.080 g 
DEPC-treated water (1000 ml) DEPC 1 ml 
 added to water  1000 ml 
dNTP solution dATP (100 mM) 10 µl 
 dGTP (100 mM) 10 µl 
 dTTP (100 mM) 10 µl 
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 ddH2O added to 400 µl 
Modified parker medium HEPES 0.140 g 
 Sodium pyruvate 0.025 g 
 L-Glutamin 0.010 g 
 Gentamicin 500 µl 
 Medium 199 99 ml 
 Hemi calcium lactate 0.06 g 
 added to water 110 ml 
3M Sodium acetate, pH 5.2 Sodium acetate  123.1 g 
 ddH2O added to 500 ml 
 ddH2O added to 1000 ml 
 
 
3.1.2 Equipments  
 
Equipment Manufacturer 
ABI PRISM® 7000 SDS  Applied Bio Systems 
Affymetrix®GeneChip Hybridization oven 640 Affymetrix, CA, USA 
Affymetrix®GeneChip Fluidics Station 450 Affymetrix, CA, USA 
Agilent 2100 Bioanalyzer Agilent Technologies , CA, USA 
Affymetrix®GeneChip™3000 scanner Affymetrix, CA, USA 
ApoTome microscope  Carl Zeiss Microlmaging, Germany 
Axon GenePix 4000B scanner 
Axon Instruments, Foster City, CA, 
USA 
Centrifuge Hermel, Wehingen, Germany 
CEQTM 8000 Genetic Analysis Beckman Coulter, Krefeld, Germany 
CO2-incubator (MCO-17AI) Sanyo, Japan 
CH15 embryo flushing catheter CH15, Wörrlein, Ansbach, Germany 
Electrofusion machine CFA 400 Kruess Hamburg, Germany 
Electrophoresis  BioRad, Munich, Germany 
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Embryo transfer syringe and sheath IMV, L'Aigle, France 
Nunc four well dishes 
Thermo Fisher Scientific, Roskilde, 
Denmark 
GAPSII Corning, Amsterdam, Netherlands 
Inverted fluorescence microscope DM IRB Leica, Germany 
Nanodrop 8000 spectrophotometer  Thermo Fisher Scientific, DE, USA 
Memmert CO2 incubator  Fischer Scientific, Leicestershire, UK 
Millipore apparatus Millipore Corporation, USA 
MyCycler Thermal Cycler  Bio-Rad Laboratories, CA, USA 
MicroAmp® optical 96-well reaction plate with 
barcode  
Applied Bio Systems 
Stereomicroscope SMZ 645 Nikon, Japan 
StepOnePlus real-time PCR system Applied Bio Systems 
Ultra-low freezer (-80oC) Labotect GmbH, Göttingen, Germany 
 
3.1.3 List of software programs and statistical packages  
 
Programs (software) 
 and statistical packages 
Source of the programs (software) 
 and statistical packages 
Bioconductor packages 
Library (affy), Library (marray) 
Library (GCRMA), Library (LIMMA)  
Library (sma), Library (anotate)  
Library (gostats), Library (Go) 
Library(qualityMetrix) 
Library(gplots) 
http://www.bioconductor.org/ 
Ingenuity's pathway analysis Ingenuity® Systems, www.ingenuity.com 
BLAST program http://blast.ncbi.nlm.nih.gov/Blast.cgi 
EndNote X1 Thomoson 
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Entrez Gene 
http://www.ncbi.nlm.nih.gov/sites/entrez?db=ge
ne 
GeneChip® Operating System  Affymetrix, CA, USA 
Primer Express ® software Applied Biosystems, Foster City, CA, USA 
Primer 3 (version 4) http://frodo.wi.mit.edu/primer3/ 
Prism for windows (ver.5.0) GraphPad software, Inc. 
Principal component analyis (PCA) http://folk.uio.no/ohammer/past 
R statistical computing and graphics 
software 
http://www.r-project.org/ 
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3.2 Methods 
 
3.2.1 Experimental animal handling and management 
 
All experimental animals were heifers of the same breed, Simmental. Heifers were selected 
based on general clinical examination for in vivo embryo production, embryo transfer and 
slaughter. They were fed a total mixed ration and housed in a freestall (cubicles) barn with 
slotted floor lined with rubber mates. All experimental animals were handled and managed 
according to the rules and regulations of the German law of animal protection.  
 
3.2.2 In vitro embryo production (IVP)  
 
In vitro fertilization and in vitro culture was performed according to the protocol described 
elsewhere (Salilew-Wondim et al. 2010b). Briefly, bovine ovaries were obtained from a local 
slaughterhouse and transported in warm (30-35°C) physiological saline solution within 1-3 
hours. Subsequently, cumulus-oocyte complexes (COCs) were aspirated from 2- to 8-mm-
diameter follicles using a 10-ml syringe loaded with an 18-gauge needle. COCs with evenly 
granulated oocyte cytoplasm surrounded by more than three compact layers of cumulus cells 
were selected under microscope. COCs were washed and incubated (in groups of 50)  in four 
well dishes containing 400 µl of maturation medium that consisted of TCM-199 (Sigma, 
Taufkirchen, Germany) with Earle salts buffered, 4.43 mM Hepes and 33.9 mM sodium 
bicarbonate (Sigma-Aldrich chemie, Steinheim, Germany) supplemented with 10% estrous 
cow serum (OCS), 0.5 mM L-glutamine, 0.2 mM pyruvate, 50 mg/ml gentamycin sulphate 
and 10 µl/ml FSH (Follitropin, Vetrepharm, Canada) (Nunc, Roskilde, Denmark) at 38.7 °C 
and 5% CO2 in an humidified air. After maturation (22 h), all COCs were co-incubated with 
sperm of the same bull (1×106 spermatozoa/ml) in a fertilization medium consisting of Fert-
TALP medium supplemented with 10 mM sodium lactate, 1 mM sodium pyruvate, 6 mg/ml 
BSA, 1 µg/mL heparin, 10 µM hypotaurine, 20 µM penicillamine, and 2 µM epinephrine) at 
38.7°C in 5% CO2 in air. At the end of co-incubation about 18 h after fertilization, the 
presumable zygotes were denuded from cumulus cells. Cumulus-free presumptive zygotes 
were washed three times in CR1aa (Rosenkrans et al. 1993) supplemented with 10% OCS and 
then cultured in 400 µl of the same medium in four well dishes (Nunc, Roskilde, Denmark) 
under mineral oil at 38.7°C in 5% CO2 in humidified air until blastocyst stage. 
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 3.2.3 In vivo embryo production 
 
In vivo derived day 7 blastocyst-stage embryos were collected from donor cows following 
superovulation and AI using a similar protocol as described in our previous study (Salilew-
Wondim et al. 2010a). Briefly, Simmental cows were pre-synchronized by intramuscular 
administration of 500 mg of the prostaglandin F2α (PGF2α) analogue cloprostenol (Estrumate, 
Munich, Germany) twice within 11 days. The cows then received 0.02 mg of GnRH-analogue 
buserelin (Receptal) (Intervet, Boxmeer, The Netherlands). Twelve days after the last GnRH 
injection, cows received the first of eight consecutive FSH-injections over 4 days in 
decreasing order. Two PGF2α treatments were performed at 60 and 72 h after the initial FSH 
injection. Finally, 48 h after the first PGF2α application, ovulation was induced by 
administration of 0.02 mg of Buserelin. A total of three artificial inseminations were 
performed within a 12 h interval using the same bull as used for in vitro fertilization. At day 7 
post insemination, embryos were flushed out by draining each uterine horn with 500 ml PBS 
using the CH15 embryo-flushing catheter (Wörrlein, Ansbach, Germany) via a three-way 
connector into an embryo filter (Immuno Systems Inc., WI, USA).  
 
3.2.4 Derivation and preparation of donor cells  
 
Bovine fibroblast cells (FB) were used as a donor cells for production of SCNT blastocysts. 
For this, primary fibroblast cell lines were established from biopsies taken from the ear of the 
bull whose semen was used for in vivo and in vitro embryo production. The biopsies were 
minced into 1-2 mm pieces, were washed several times, and were dispersed in T25 cell 
culture flask. The cells were then cultured in Dulbecco’s Modified Eagles Medium (DMEM) 
supplemented with 2 mM glutamine, 1% non-essential amino acids, 0.1 mM β-
mercaptoethanol, 100 U/ml penicillin, 100 µg/ml streptomycin (Sigma, Deisenhofen, 
Germany) and 10% fetal calf serum (Gibco, Karlsruhe, Germany) in a humidified atmosphere 
of 95% air and 5% CO2 at 37°C. At 90% confluence, the cells were trypsinized (0.05% 
Trypsin/0.53 mM EDTA; Gibco), subpassaged, and frozen stored as aliquots in cell culture 
medium with 10% DMSO until use. Cells of passage 3 were cultured and induced to enter a 
period of quiescence (presumptive G0) by serum starvation (0.5%) for 7 days before nuclear 
transfer.  
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3.2.5 Somatic cell nuclear transfer (SCNT) 
 
To generate SCNT blastocysts, oocytes were matured for 19 h. Metaphase II oocytes were 
enucleated by removal of the polar body and the attached cytoplasm with the metaphase plate 
utilizing a 25-µm beveled glass pipette. The absence of the metaphase plate was confirmed by 
minimum exposure to ultraviolet fluorescence. A single donor cell was placed into the 
perivitelline space of the oocyte in close contact with the oocyte membrane, utilizing a 30-µm 
beveled glass pipette. Fusion was induced within 2 h after complex reconstruction by a single 
electrical pulse of 25 V for 45 µs (Kruess electrofusion machine CFA 400, Hamburg, 
Germany) between two electrodes, with a spacing of 150 µm. Activation of reconstructed 
complexes was performed by incubation in 5 µM ionomycin for 4 minutes followed by 
incubation with 2 mM 6-dimethylaminopurine (DMAP) in CR1aa medim for 3.5 h. 
Subsequently, SCNT derived embryos were cultured in CR1aa medium under mineral oil at 
38.7 °C in 5% CO2 in humidified air until blastocyst stage.  
 
3.2.6 Embryo transfer and day 16 embryo collection 
 
Prior to embryo transfer, recipient cows were estrous synchronized using a similar protocol as 
described above for superovulation except recipient animals did not receive FSH and AI. 
Following this, good quality day 7 blastocysts produced in vitro (IVP), somatic cell nuclear 
transfer (SCNT) and in vivo (AI) were transferred nonsurgical into the uterus at day 7 of the 
estrus cycle. Then recipients of IVP embryos, SCNT embryos and AI were slaughtered 9 days 
later. Elongation stage embryos were flushed out of the uterus by cutting the corpus uteri and 
injection of PBS solution into the oviduct, they were washed twice in PBS and subjected to 
morphometric quality assessment. The entire conceptuse from each pregnancy group was 
measured. On the bases of the conceptus length and presence and abscence of embryonic disc, 
embryos were further classified in to two groups. Filamentous embryos with visible 
embryonic discs were considered as elongated while conceptuses having early tubular shape 
were regarded as developmentally delayed.  All samples were stored immediately in -20 °C 
with RNAlater (Ambion Inc, Austin, TX, USA) for later use. Morphologically similar 
conceptuses were used for large scale gene expression analysis. Conceptuses identified as 
developmentally delayed from IVP and SCNT pregnancies were used for qPCR based 
candidate gene expression analysis.  
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3.2.7 RNA extraction and cDNA synthesis 
Total RNA was isolated from each group of sample namely SCNT, IVP, AI and FBs, three 
biological replicates from each group, using DNA/RNA/protein purification kit (Norgen 
Biotek Corporation, Thorold, Canada) according to methods recommended by the 
manufacturer with slight modification. All centrifugation steps were performed in benchtop 
microcentrifuge at 14, 000 × g except noted. Precisely, individual embryos were lysed in 600 
µl of lysis buffer and centrifuged for 2 min. After the supernatant was transferred to another 
RNase-free microcentrifuge tubes, 600 µl of 70% ethanol were applied and vortexed for 10 s. 
Lysate with ethanol was applied on the provided column and centrifuged for 2 min to retrieve 
the entire lysate volume. In parallel, fibroblast cells were lysed in 350 µl of lysis buffer and 
vortexed for 15 sec. Subsequently, 200 µl of 95% ethanol were applied before transfer to the 
column. Despite slight differences in lysate preparation of fibroblast cells and embryo 
samples, a similar procedure was carried out for RNA isolation. The column was reassembled 
with a new collection tube and washed twice with 400 µl RNA wash solution and placed in a 
fresh 1.7 ml elution tube provided with the kit. RNA was eluted with a total 150 µl of elution 
buffer and centrifuged for 2 min. Following precipitation of RNA, TURBO DNA-free Kit 
(Applied Biosytems) was used to remove carry over DNA. The quality of the resulting RNA 
was verified by the relative intensity of rRNA bands using Agilent 2100 Bioanalyzer with 
RNA 6000 Nano LabChip® Kit (Agilent Technologies Inc, CA, USA), RNA was quantified 
using a NanoDrop 8000 spectrophotometer. For reverse transcription, 1 µg of RNA was used 
in a 20 µl final reaction, containing 1 µl random primer (Promega), 1 µl Oligo dt , 10 mM 
each dNTP, 4 µl 5x first-strand buffer, RNasin, DTT 0.1 M and superscript II in the order of 
0.3 µl, 2 µl and 0.7 µl, respectively. Cycling was performed at 25 °C for 5 min, 42 °C for 90 
min and 70 °C for 15 min. The cDNAs were kept frozen at -20 °C until used in qRT- PCR 
experiments. 
3.2.8 RNA amplification 
RNA amplification, cDNA synthesis, labelling and hybridization was performed according to 
user manual of GeneChip®3’ IVT Express Kit [P/N 702646 Rev. 7 (Affymetrix Inc)]. 
Briefly, total RNA isolated from three biological replicates of AI, IVP and SCNT-derived 
elongated embryos as well as donor fibroblast cells was subjected to global gene expression 
analysis  using the GeneChip Bovine Genome Array (Affymetrix, CA, USA). A total of 250 
ng RNA (to which 2 µl of diluted poly-A RNA controls were added) using T7 oligo (dT) 
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primer was used to generate first strand cDNA. Eukaryotic poly-A RNA control kit was used 
as a SPIKE-IN control to monitor the entire target labelling process. The controls were then 
amplified and labelled together with the samples as each eukaryotic GeneChip ® probe array 
contains probesets for several B. subtilis genes (lys, phe, thr, and dap) that are absent in 
eukaryotic samples. Following this, the first strand cDNA was converted to double strand. 
The resulting double stranded cDNA was in vitro transcribed and biotin- labelled using IVT 
master mix at 37 oC for 16 h. The amplified RNA (aRNA) was then purified to remove 
unincorporated NTPs, salts, enzymes and inorganic phosphate using magnetic-beads. The 
quality of cRNA was assessed on the Agilent 2100 bioanalyzer, and 12 µg of this cRNA was 
fragmented using 5× fragmentation buffer in RNase-free water. The fragmentation reaction 
was carried out at 94 °C for 35 min to generate 35–200 base fragments for hybridization, and 
fragmented aRNA quality was also assessed using the Agilent bioanalyzer.  
3.2.9 Affymetrix array hybridization, washing, staining and scanning 
The GeneChip® Bovine Genome Array (Affymetrix, CA, USA) was used for hybridization. 
For this, a hybridization cocktail consisting of fragmented and labelled cRNA, control 
oligonucleotide B2 (3 nM), 20 x eukaryotic hybridization controls (bioB, bioC, bioD, cre) 
(Affymetrix, CA, USA), DMSO and RNAse free water were mixed to a final volume of 200 
µl. The mix was then heated at 99 °C for 5 min followed by 5 min incubation at 45 °C. 
Hybridization was performed for 16 h. The arrays were then washed and stained using the 
Fluidics Station 450/250 (Affymetrix, CA, USA) and scanned using the GeneChip™3000 
laser confocal slide scanner (Affymetrix, CA, USA) integrated with GeneChip® Operating 
System (GCOS) as recommended in the GeneChip® expression wash, stain and scan user 
manual (P/N 702232 Rev.3) and .cel raw data files were generated.  
 
3.2.10 Data analysis 
 
Data analysis was carried out with “R”, an open-source-interpreted computer language for 
statistical computation and graphics and tools from the Bioconductor project (http://www.r-
project.org) and (http://www. bioconductor.org) were used. Normalization and background 
correction was done using Guanine Cytosine Robust Multi-Array (GCRMA). During 
normalization, the CEL files were pre processed and converted into expression set using the 
GCRMA, considering probe sequence and the GC-content background correction. The CEL 
files and normalized data can be accessed in the Gene Expression Omnibus (GEO) 
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http://www.ncbi.nlm.nih.gov/geo/ with series entry GSE40101, 
http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE40101. For genes with more than 
one probe set mapped to it, the probe set with the largest inter quartile range of expression 
intensity was selected. Non-specific filtering was used to remove genes with low variance 
between arrays using a cutoff of 0.25 (Gregersen et al. 2010). This left 16,020 genes that were 
used for the following analysis. Genes with FDR ≤ 0.2, p≤0.05 and ≥FC ≥ 2 were taken as 
differentially expressed (DEG). Canonical Pathway Analyses were performed using Ingenuity 
Pathway Analysis ([IPA], Ingenuity Systems®, http://www.ingenuity.com) software utilizing 
gene transcripts attaining nominal levels of significance (p < 0.05). 
 
3.2.11 PCR based sex determination assay 
 
Due to the fact that we have not used sexed semen and the donor cell line was obtained from a 
bull, we took advantage of harvested DNA from each embryo sample during RNA isolation to 
use it for PCR based sex determination. The sex of elongated embryos was determined by 
using two sets of primers namely bovine gender-neutral and bovine male-specific primers. 
The sequence of  the bovine gender-neutral primer was: upstream 5′-GCC CAA GTT GCT 
AAG CAC TC-3′ and downstream 5′-GCA GAA CTA GAC TTC GGA GC-3′ (Akyuz et al. 
2010) was used to show the presence of DNA in all samples. The bovine Y-specific primer 
(Accession No. AC234853.4), upstream 5′-TGG ACA TTG CCA CAA CCA TT-3′ and 
downstream 5′-GCT GAA TGC ACT GAG AGA GA-3 was used to distinguish male and 
female DNA. The amplification was carried out for 40 cycles where each cycle consisted of 
template denaturation at 95 oC for 5 min followed by 95 oC for 30 sec, reannealing at 53 oC 
and 55 oC for bovine gender neutral and male-specific primers for 30 sec, respectively and 
primer extension for 72 oC for 1 min followed by a final extension at 72 oC for 10 min. A total 
of 10 µl of the PCR products was electrophoresed on a 2% agarose gel stained with ethidium 
bromide and visualized under ultraviolet light. A single band at size of 102 bp was considered 
as female whereas the presence of two bands at length of 102 bp and 226 bp were referred to 
male embryo.  
 
3. 2. 12 Selected genes for qPCR analysis 
 
Based on the length of extra embryonic tissue, a total of 6 conceptuses which had 
disproportionally short trophoblast size ranging from 1-3 mm (n=3) IVP and 1.25 -5 mm 
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(n=3) SCNT day 16 embryos were identified and selected. RNA isolation was performed 
using the PicoPureTM RNA isolation kit (Arcturs, Munich, Germany) following the 
manufacturer's instruction. Genomic DNA contamination was eliminated by performing on-
column DNA digestion using RNase-free DNase (Qiagen GmbH, Hilden, Germany). 
Candidate genes, trophoblast Kunitz domain protein 2 (TKDP2) and fibroblast growth factor 
receptor 2 (FGFR2) were selected on the bases of their common differential expression in 
both IVP and SCNT elongated embryos. Besides, genes claudin 1 (CLDN1), junctional 
adhesion molecule 2 (JAM2), Rho/Rac guanine nucleotide exchange factor 2 (ARHGEF2) 
and CCAAT/enhancer-binding protein alpha (CEBPA) were selected because these 
transcripts were associated with tight junction signaling pathway which is a common pathway 
affected in both IVP and SCNT embryos. Though interferon tau IFNt was found to be not 
differentially regulated in the three embryos comparison, the level of this transcript was 
quantified. 
 
3.2.13 Quantitative real-time polymerase chain reaction 
 
Quantitative real-time polymerase chain reaction (PCR) was performed to validate the 
microarray data and analyse the expression profile of candidate genes. For this up- and down- 
regulated genes which were randomly selected from each of the three comparisons (SCNT vs. 
AI, IVP vs. AI and IVP vs. SCNT) and candidate genes which were screened on the above 
mentioned criteria were used. All primers were designed using Primer 3 online software 
(http://frodo.wi.mit.edu/primer3/, accessed May 2011) and subsequently entered in the Basic 
local Alignment Search Tool (http://blast.ncbi.nlm.nih.gov/Blast.cgi, accessed May 2011) to 
ensure specificity. An amplified PCR product of each primer was further validated by 
sequencing using CEQ 8000 Genetic Analysis (Beckman Coulter, Krefeld, Germany).  
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Each reaction consisted of cDNA, forward and reverse primers and 10 µl of SYBRgreen 
mastermix (Bio-Rad Laboratories, Munich, Germany) made up to a final reaction volume of 
20 µl with RNase-and DNase-free water. The cycling conditions were 50 oC for 2 min, 95 oC 
for 10 min and 40 cycles of 95 oC for 15 sec followed by 60 oC for 1 min. A dissociation curve 
was included to ensure specifity of amplification. Glyceraldehyde-3-phosphate 
dehydrogenase (GAPDH) was used as a normaliser gene, as it was validated previously in 
pre- and peri-attachment conceptus development in sheep (GAPDH mRNA concentrations 
remained constant as elongation occurs) (Purcell et al. 2009). Quantitative real-time PCR was 
performed on the Step One plus Real-Time PCR System (Applied Biosytems). The 
comparative threshold cycle (CT) method was used to quantify the mRNA abundance. 
 
Table 2. Primers and their sequences used for microarray validation 
 
 
 
 
 
Number Acc no gene Primer Sequence (5’-3’) 
1 NM_001114522 SPINK4 Forward gtcggcagaaaagttggttt 
   Reverse gtcagcatttcccatccttc 
2 NM_001034270 TSPAN1 Forward agaactgtgaagaggcgatg 
   Reverse cttaggggctctggaatagg 
3 NM_175776 TSPO Forward ggtggatctcctgctgact 
   Reverse aggagcacctctggaactg 
4 NM_001080358 TDGF1 Forward ggctaagttgaagggcaagt 
   Reverse ttcccacttttactggacaga 
5 NM_177521   SULT1A1 Forward cataaaggaggaccccaaaa 
   Reverse catgaaggcagagatgctgt 
6 NM_174076 GPX1 Forward aagttccaggagacgtcgtt 
   Reverse atcaggaaaacgccaagaac 
7 NM_001035103 ALAS2 Forward ctgtgatctcctgctctcca 
   Reverse cctcagtccaggcttctagc 
8 NM_175797   ARHGDIB Forward ccagtgatagccgaacaaga 
   Reverse cagcagtaaccaccaggaga 
9 NM_201606 MRPL12 Forward atccaagatgtcgggttgat 
   Reverse tgatcagcttcaccttgtcc 
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3.2.14 Statistical analysis  
Real-time PCR data analysis was performed by comparing ∆Ct values (cycle numbers at the 
threshold level of log-based fluorescence normalized to the GAPDH control gene) by 
student’s t-test, with two-sided P < 0.05 indicating statistical significance. Mean differences 
in ∆Ct (∆∆Ct) were used to calculate fold differences in gene expression by the following 
formula: fold change= 2−∆∆Ct. 
 
10 NM_001038558   CADM1 Forward ttcactcatgaagccaaagg 
   Reverse aaatagggccagttggacac 
11 NM_001076372             CCND2 Forward cgacttcatcgaacacatcc 
   Reverse atctttgccaggagatccac 
12 NM_001012683     TKDP2 Forward gtagctcagctcctggaacc 
   Reverse gaaattccaccttggacacc 
13 NM_001034034 GAPDH Forward gaaattccaccttggacacc 
   Reverse ctgcttcaccaccttcttga 
14 NM_001075194   ADD3 Forward agctttgccctcatgaagta 
   Reverse atgggaacccaacagttaca 
15 NM_001205310.1 FGFR2 Forward tcagatcagcctgcattctc 
   Reverse aacgaacaccatggcagtaa 
16 NM_001001854.2 CLDN1 Forward agccttatctcctttcctca 
   Reverse aggaatgctatctcccctca 
17 NM_001083736.1 JAM2 Forward cagctacatgcaccctctgt 
   Reverse gggtatgagacccattctgc 
18 BC149006.1 CEBPA Forward ccagagggaccgaagttatg 
   Reverse agagcctcattctggcaagt 
19 NM_001098881.2 ARHGEF2 Forward cagcaaccatgacctgaaac 
   Reverse ctgtcctcatcaccagcatc 
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4. Results 
 
4.1 In vivo development of blastocysts derived from SCNT, IVP and AI until day 16 
 
Somatic cell nuclear transfer (SCNT), in vitro produced (IVP) and in vivo developed (AI) 
blastocysts were generated and transferred to synchronized recipients at day 7 of the oestrous 
cycle and retrieved at day 16 of gestation. The number of blastocysts transferred and their 
development in vivo until day 16 is indicated in Table 3. Results showed comparable in vivo 
development rate after SCNT, IVF and AI blastosysts transfer. On the bases of their 
trophoblast elongation size and morphology, filamentous embryos were considered as 
elongated, whereas early tubular shape embryos (<3 mm long) were classified as 
developmentally retarded or delayed. With regard to their size, the SCNT embryos exhibited 
shorter elongation size (93 mm) compared to IVP (186.6 mm) or AI (196.3 mm) embryos. In 
addition, when the elongation status of the SCNT and IVP embryos was compared to AI, 
none of AI embryos displayed a delay in development whereas SCNT (37.5%) and IVP 
(25%) did. Morphologically similar conceptuses with visible embryonic disc derived from 
SCNT, IVP and AI were used for gene expression analysis while impeded embryos were used 
for further characterization of selected candidate genes.  
 
Table 3. Development of somatic cell nuclear transfer, in vitro and in vivo produced    
blastocysts until day 16 
 
               ‘Delayed’ refers to early tubular embryos which were not elongated properly. 
   
 
 
 
 
Recovered day 16 embryos 
Elongated embryos Impeded growth 
 
Transferred Recovery 
 rate 
 
Filamentous Length (mm) 
 
Delayed Length (mm)  
 
Group 
n n (%)  n (%) Mean ± SD  n ( %) Mean ± SD  
AI  22 17 (77.3) 17 (100) 196.3 ± 49.9 - - 
IVP 45 28 (62.2) 21 (75) 186.6 ± 43.2 7 (25) 20.1 ± 0.15 
SCNT 11 8 (72.7) 5 (62.5) 93.3 ± 16.3 3 (37.5) 10.7 ± 1.08 
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4.2 Transcriptome profile analysis of elongated embryos derived from SCNT, IVP and AI 
 
To gain a comprehensive overview of the global wide gene expression in SCNT, IVP and AI 
embryos, the Affymetrix GeneChip® Bovine Genome Array representing more than 23,000 
genes and 19,000 UniGene clusters was used. After removing uninformative probes that show 
little or no variability between arrays, a total of 16,020 probes representing 16,020 genes that 
passed the data filtering process were identified as being expressed. Then the level of gene 
expression in SCNT and IVP elongated embrys were compared with that of the AI 
counterparts. Using the criteria of a fold change ≥ 2, P-value ≤ 0.05 and false discovery rate 
(FDR) ≤ 20%, 477 transcripts were identified as being differentially expressed in SCNT 
conceptuses compared to AI. When the same criteria were applied for the IVP and AI 
embryos comparison, 365 genes were found to be diferentially expressed. In addition, 26 
differentially expressed transcripts were found between SCNT and IVP embryo groups. Of 
these, more than 50% of the differentially regulated genes were down regulated in each 
comparison, namely: 315 transcripts in SCNT vs. AI, 258 transcripts in IVP vs. AI and 19 
transcripts in SCNT and IVP. The overall expression profile comparison of the three embryo 
groups and number of differentially expressed genes is illustrated in Figure 6.  
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Figure 6. A) Heat map of differentially expressed genes in elongated embryos generated by 
artificial insemination (AI), somatic cell nuclear transfer (SCNT) and in vitro production 
(IVP). The numbers following each method of derivation indicate which of the three 
biological replicates is represented. The dendrogram on the top depicts the grouping of 
samples based on the similarity between them. Red colour signifies up-regulated genes, green 
signifies down- regulated genes and black represents intermediate expression as shown by the 
colour bar under the heat-map. B) Venn diagram characterizing differential gene expression 
between and specific to individual embryo types namely comparing SCNT vs. AI, IVP vs. AI 
and SCNT vs. IVP elongated embryos. Each circle represents the differential expression 
between the two indicated embryo types. Arrows represent the up-and down-regulated genes. 
Placenta-expressed transcript 1 (PLET1) gene is differentilly expressed in each embryo 
comparison with varying mRNA amount as indicated by the arrows.  
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4.3 Comparison of donor cell and embryo groups 
 
Comparison of FB donor cells and SCNT embryos revealed differential expression of 3796 
genes, of which nearly equal numbers of transcripts 1893 and 1903 were up- and down- 
regulated, respectively. The heatmap of differentially expressed genes in FB and three embryo 
samples revealed distinct clusters of the donor fibroblast cell in one group and the three 
embryo sources in another group, with expression profile of reproducible results among the 
biological replicates (Appendix 2). To visiualize the global distribution of expressed genes in 
each sample, principal component analysis (PCA) was performed.  As shown in figure 7, the 
SCNT conceptuses samples were clustered away from donor fibroblast cells and situated near 
to IVP samples. This was in turn manifested by a 73.9% difference in gene expression 
between fibroblast donor cell and SCNT embryos. 
                            
 
 
 
 
 
 
 
 
 
Figure 7. The PCA was performed based on all expressed genes in SCNT, IVP, AI and FB   
samples.  
 
4.4 Chromosomal distribution of differentially expressed genes 
 
The chromosomal distribution of differentially expressed genes in SCNT vs. AI, IVP vs. AI 
common to SCNT or IVP vs. AI comparison was investigated using GeneChip Bovine 
Genome Array annotation data 
(http://www.Affymetrix.com/Auth/analysis/downloads/na32/ivt/Bovine.na32.annot.csv.zip). 
Except some genes with unknown location (25 in SCNT vs. AI, 16 in IVP vs. AI and 13 
common DE genes in SCNT and IVP) the majority of DE genes were distributed randomly 
across the chromosomes. However, a large number of differentially expressed genes in each 
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comparison were located on chromosome 1, 3, 5 and 19. Further inspection of the 
differentially expressed genes in these chromosme showed that most of the transcripts were 
down regulated. 
 
                      
 
 
 
Figure 8. Differentially expressed genes and their chromosomal location. A) Differentially 
expressed genes and their chromosomal location in SCNT vs. AI comparison B) 
Differentially expressed genes and their chromosomal location in IVP vs. AI comparsion and 
C) Common differentially expressed genes and their chromosomal location in SCNT or IVP 
vs. AI comparison. The x-axis shows the number of chromosme including X chromosme and 
the y-axis shows the number of differentially expressed genes. Red and green represent, the 
up-and down-regualted genes, respectively. 
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4.5 Embryo sexing 
 
As embryos obtained from SCNT were male in their sex, in order to elucidate a sex dependent 
expression differences between groups we have determined the sex of IVP and AI embryos 
used for gene expression analysis. Accordingly, one from each of IVP and AI groups was 
female while the other two were males (Figure 9). Looking in to the expression profile of all 
individual embryos we couldn not trace a sex dependent expression pattern. 
                        
                                                                                                
Figure 9. Sex determination assay using DNA isolated from SCNT, IVP and AI elongated 
embryos and bovine sex-neutral (102 bp) and male specific (226 bp) primers. Lane 1, 2 and 3 
are SCNT, lane 4, 5 and 6 are IVP and lane 7, 8 and 9 are AI embryo DNA samples, 
individually. The numbered lanes denote the sex neutral product while the neighbouring lanes 
denote male specific product. All samples display 102 bp distinct products but only male 
embryos show 102 bp and 226 bp products. Lane 10 and 13 are negative controls. Lane 11 
and 12 are DNA samples taken from known bull and cow, respectively. 
 
4.6 Transcripts altered both in IVP and SCNT elongated embryos  
 
To better understand pre-elongation culture effect on transcriptome alteration, those genes 
that were commonly altered in IVP and SCNT derived embryos (n=274) were examined 
further using the available bioinformatic tool and literature (Figure 10). Of these 274 genes, 
the expression level of 204 genes was lower in both IVP and SCNT embryos compared to 
their AI counterparts. These include the claudin family gene CLDN1, trophoblast specific 
gene, trophoblast Kunitz domain protein family (TKDP2), genes critical for trophoblast 
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differentiation heart and neural crest derivatives expressed 1 (HAND1), the gap junction 
protein genes known to play a role in uterine development and nutrient supply (GJB2, GJB4 
and GJB5) and STSB and CTSL1 genes. On the other hand, the expression level of 70 
transcripts including imprinted genes (IGF2R and MASH2) and CCND2, HSD17B1, TDGF1, 
SLC27A6, were found to be over represented in both IVP and SCNT embryos when both 
were compared to the AI counterparts.  
 
 
Figure 10. A volcano plot representation of common differentially expressed genes between 
SCNT and IVP elongated embryos. The significance cut-off was set to a FDR of (-log P-value 
≥ 1), the absolute fold-change of all genes are represented by the circle, the three different 
colour codes used to represent insignificant genes (dark), differentially expressed genes being 
up-regulated (red) and differentially expressed genes being down-regulated (green). The list 
of genes on the left and right side of the volcano plot shows the qPCR validated up-and down-
regulated genes, respectively.  
 
4.7 Molecular pathways and gene networks affected in IVP and SCNT elongated embryos  
 
Ingenuity pathway analysis (IPA) was used to characterize the function of differentially 
expressed transcripts in SCNT or IVP embryos, accordingly, the complete set of differentially 
regulated genes in SCNT vs. AI comparison was categorized in to various canonical pathways 
Results 
___________________________________________________________________________ 
 
66 
 
(Table 4). The result showed several genes implicated in metabolic pathways (glycolysis, 
ascorbate and aldarate, arginine and proline, pyruvate, glycerolipid, fatty acid, gluthione, 
linoleic acid and glycerophospholipid metabolism) were significantly altered. On the other 
hand, most genes associated to blood coagulation (coagulation system and extrinsic 
prothrombin activation) were found to be down regulated in SCNT embryos compared to AI. 
Down regulated genes included those that encode coagulation factor, 2, 3 and 5. Similar 
significant down regulation was also observed for genes involved in TNFR1 signalling and 
agrin interaction at neuromuscular junction pathways. Besides, lPS/IL-1 mediated inhibition 
of RXR function, aryl hydrocarbon receptor signalling and immune response pathways like 
MIF regulation of innate immunity were disturbed in SCNT embryos as compared to the 
control AI embryos.  
On the other hand, the top canonical pathways in IVP vs. AI comparisons showed only few 
metabolic pathways to be affected (pyruvate metabolism and arginine and proline 
metabolism) while genes participated in tight junction, agrin interaction at neuromuscular 
junction and TNRF-1 signalling were significantly down regulated (Table 5). Moreover, 
pathway analysis of genes commonly differentially expressed in IVP and SCNT when 
compared to AI revealed their involvement in tight junction signalling and glycolysis 
pathways (Table 6).  
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Table 4. Top canonical pathways affected in SCNT embryos 
               
             The underlined and plain text genes respectively showed up-and down-regulation in each      
             pathway.                    
 
 
 Cannonical pathways 
-log 
(p-value) Ratio Molecules 
LPS/IL-1 inhibition of RXR 
function 5.01 0.071 
ALDH4A1, ABCB1, ACSL3, SLC10A1, 
TNFRSF1A, GSTM3, ACOX1,ALDH9A1, 
ALDH1A1,JUN, FABP5, SCARB1, SULT1A1, 
CAT, SLC27A6, GSTP1 
Glycolysis 4.38 0.075 
ALDH4A1, ALDH2, ACSL3, ALDH1A1, 
DHRS9, ENO3, DLD, ALDH9A1, GALM, 
ALDOC 
Ascorbate and aldarate 
metabolism 3.88 0.063 
ALDH4A1, ALDH2, ALDH1A1, PRHOXNB, 
ALDH9A1 
Arginine and proline 
metabolism 3.87 0.050 
ALDH4A1, ALDH2, ALDH1A1, SAT1, 
PRHOXNB, GOT1, GATM, ALDH9A1, ODC1 
Pyruvate metabolism 3.62 0.059 
AKR7A2, ALDH4A1, ALDH2, ACSL3, 
ALDH1A1,DLD, PRHOXNB, ALDH9A1 
Coagulation system 3.58 0.158 F2R, PROS1, SERPINA5, F5, F3, FGG 
Glycerolipid metabolism 3.57 0.058 
AKR7A2, ALDH4A1, ALDH2, ALDH1A1, 
DHRS9, LPIN2, AGPAT3, MOGAT1, 
ALDH9A1 
Aryl hydrocarbon  
receptor signaling 3.12 0.069 
ALDH4A1, FOS, ALDH1A1, JUN, CCND2, 
GSTM3, CDKN1A, TGFB3, ALDH9A1, 
GSTP1, HSPB1 
Extrinsic prothrombin 
activation pathway 3.04 0.2 PROS1, F5, F3, FGG 
Fatty acid metabolism 3.02 0.048 
ALDH4A1, ALDH2, ACSL3, ALDH1A1, 
DHRS9, ACOX1, SLC27A6, ALDH9A1, 
CYP51A1 
Glutathione metabolism 2.79 0.065 GSTM3, GPX1, GGT1, GSS, ANPEP, GSTP1 
MIF regulation of innate 
immunity 2.61 0.1 FOS, MIF, JUN, NFKBIA, PLA2G12A 
Agrin interactions at 
neuromuscular junction 2.39 0.087 ITGB2, RAC2, JUN, PAK6, ITGA6, ERBB3 
Caveolar-mediated 
endocytosis signaling 2.34 0.082 
B2M, ITGB2, CD55, FLNC, ITGAV, 
ITGA6, CD48 
Linoleic acid metabolism 2.28 0.046 
PLA2G12A, PLA2R1, FADS2, CYP51A1, 
FADS3 
Glycerophospholipid 
metabolism 2.2 0.042 
PLA2G12A, GPD2, GPLD1, PLA2R1, 
GOT1, LPIN2, PLCL2, AGPAT3 
TNFR1 signaling 2.16 0.094 FOS, JUN, NFKBIA, PAK6, TNFRSF1A 
Bile acid biosynthesis 2.16 0.047 
ALDH4A1, ALDH2, ALDH1A1, DHRS9, 
ALDH9A1 
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Table 5. List of top canonical pathways affected in IVP embryos 
 
                            
The underlined and plain text genes respectively showed up- and down- regulation in each 
pathway.               
 
 
 
 
 
 
 
 
 
 
 
Cannonical pathways 
-log  
(p-value) Ratio Molecules 
Pyruvate metabolism 2.873 0.044 
ACSL3, AKR7A2, AKR7A3, ALDH4A1, 
PCK1, PRHOXNB 
LPS/IL-1 inhibition of RXR  
function 2.788 0.045 
ABCB1, ACOX1, ACSL3, ALDH4A1, FABP5, 
SCARB1, SLC10A1, SLC27A6, SULT1A1, 
TNFRSF1A 
TNFR1 signaling 2.749 0.094 CASP3, FOS, NFKBIA, PAK6, TNFRSF1A 
Tight junction signaling 2.546 0.055 
ARHGEF2, CEBPA, CLDN1, F2RL2, FOS, 
JAM2, 
PRKAG2, TGFB3, TNFRSF1A1 
Arginine and proline 
metabolism 2.518 0.034 
ALDH4A1, ARG2, ASS1, GOT1, ODC1, 
PRHOXNB 
Caveolar-mediated 
endocytosis signaling 2.297 0.08 FOS, MIF, NFKBIA, PLA2G12A 
Agrin interactions at  
neuromuscular junction 2.293 0.072 ERBB3, ITGA6, ITGB2, PAK6, RAC2 
Molecular mechanisms of 
cancer 2.090 0.034 
ARHGEF2, BMP7, CASP3, CCND2, 
CDKN1A, FOS, 
GNAI1, NFKBIA, PAK6, PRKAG2, RAC2, 
RHOB, TGFB3 
IL-10 signaling 2.089 0.064 ARG2, BLVRB, FOS, IL6, NFKBIA 
Eicosanoid signaling 2.079 0.056 DPEP1, PLA2G12A, PLA2R1, PTGES 
PTEN signaling 2.033 0.056 
CASP3,  CDKN1A, FGFR2, FOXO4, 
IGF2R, MAGI1, RAC2 
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Table 6. Common genes and their corresponding canonical pathways affected in IVP and 
SCNT embryos 
            
             The underlined and plain text genes respectively showed up- and down- regulation in each      
             pathway. 
             
 
 
Cannonical pathways  
-log 
(p-value) Ratio Molecules 
Tight junction signalling 3.30 0.055 
ARHGEF2, CEBPA, CLDN1, F2RL2, 
FOS,  JAM2, PRKAG2, TGFB3, 
INFRSF1A 
LPS/IL-1 inhibition of RXR 
function 2.98 0.04 
ABCB1, ACOX1, ACSL3, ALDH4A1, 
SCARB1, SLC10A1, SLC27A6, 
SULT1A1, TNFRSF1A 
Caveolar-mediated endocytosis 
signalling 2.94 0.071 
B2M, CD48, CD55, ITGA6, ITGAV, 
ITGB2 
Agrin interactions at 
neuromuscular junction 2.76 0.072 ERBB3, ITGA6, ITGB2, PAK6, RAC2 
MIF regulation of innate 
immunity 2.68 0.08 FOS, MIF, NFKBIA, PLA2G12A 
Integrin signalling 2.46 0.043 
ARF4, ITGA6, ITGAV, ITGB2, 
PAK6, 
RAC2, RHOB, TSPAN1, TSPAN2 
Virus entry via endocytic  
pathways 2.43 0.06 
B2M, CD55, ITGA6, CXADR, 
ITGB2, RAC2 
Relaxin signalling 2.34 0.044 
FOS, GNAI1, GNB4, MPPE1, 
NFKBIA, 
PRKAG2, VEGFA 
TNFR1 signalling 2.31 0.075 FOS, NFKBIA, PAK6, TNFRSF1A 
IL-8 signalling 2.29 0.041 
CCND2, GNAI, GNB4, GPLD1, 
ITGB2, 
RAC2, RHOB, VEGFA 
Germ cell-sertoli cell junction  
signalling 2.20 0.042 
ITGA6, PAK6, RAC2, RHOB, 
TGFB3, 
TNFRSF1A, TUBB6 
Glycolysis/gluconeogenesis 2.15 0.038 
ACSL3, ALDH4A1, DHRS9, ENO3, 
GALM 
MIF-mediated glucocorticoid 
regulation 2.13 0.071 MIF, NFKBIA, PLA2G12A 
Molecular mechanisms of 
cancer 2.09 0.029 
ARHGEF2, CCND2, CDKN1A, FOS, 
GNAI1, 
NFKBIA, PAK6, PRKAG2, RAC2, 
RHOB, TGFB3 
PTEN signalling 1.99 0.048 
CDKN1A, FGFR2, FOXO4, IGF2R, 
MAGI1, RAC2 
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4.8 Molecular networks affected in SCNT and IVP embryos 
 
To characterize the functional consequences of gene expression changes associated with 
SCNT and IVP derived embryos, a molecular network analysis of differentially expressed 
genes, based on IPA data bases was performed. The results indicated that 21, 16 and 12 top 
scored gene networks to be affected in SCNT, IVP and common to both SCNT and IVP 
embryos respectively. These gene networks were selected based on the criteria of IPA score 
of 10 or higher and containing 9 or more genes. Figure 11, 12 and 13 summarized the top 4 
gene networks found with IPA score greater than 25. Based on the identified gene networks, 
the top functional categories of transcripts in SCNT embryos are lipid metabolism, 
carbohydrate metabolism, DNA replication, recombination and repair and small molecules 
biochemistry. On the other hand, functional categories of transcripts in IVP embryos mostly 
related to cell and organ development, cellular movement, cellular growth and proliferation, 
small molecules biochemistry and carbohydrate metabolism while DNA replication 
recombination and repair were the commonly affected biological functions in both IVP and 
SCNT elongated embryos. 
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Figure 11. The top scored gene networks using differentially expressed transcripts in SCNT 
vs. AI elongated embryos. The IPA score = (-log (p-value)) is associated with the significance 
of the selected gene network. The higher the score the more reliable it is. 
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Figure 12. The top scored gene networks using differentially expressed transcripts in IVP vs. 
AI elongated embryos. The IPA score = (-log (p-value)) is associated with the significance of 
the selected gene network. The higher the score the more reliable it is. 
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Figure 13. The top scored gene networks for common differentially expressed transcripts in 
IVP and SCNT elongated embryos. The IPA score = (-log (p-value)) is associated with the 
significance of the selected gene network. The higher the score the more reliable it is. 
   
4.9 Identification of genes with different transcriptional reprogramming status 
 
To evaluate the possible effect of somatic cell nuclear transfer on transcriptome alteration due 
to genome reprogramming, a list of 193 genes which are exclusively differentially expressed 
in SCNT vs. AI embryos were filtered and  categorized in to various reprogramming status, 
based on their expression pattern namely: category 1: Transcriptionally not reprogrammed 
genes [genes which are differentially expressed between SCNT and AI conceptuses but not 
when SCNT is compared with FB (AI≠SCNT=FB)]. Category 2: Inappropriately 
reprogrammed genes [genes whose expressions resemble neither AI nor FB (AI≠SCNT≠FB)]. 
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Category 3: Partially or intermediately reprogrammed genes [genes with intermediate 
expression in SCNT embryos when compared to both AI and FB].  
Accordingly, out of 193 genes, 71 transcripts including GATM, HSPB1, FOLR1, GADD45B, 
MTFHD2, H2AFJ, TGFBR3, TSCNN1B, SCNN1G, CYP51A1 and RCN2 were found as 
transcriptionally not reprogrammed. Moreover, 91 transcripts including imprinted gene 
(CDKN1C), several genes associated with metabolism such as acyl-CoA thioesterase 
(ACOT4 and ACOT8), aldehyde dehydrogenase (ALDH2 and ALDH9A1), and solute carrier 
families (SLC10A, SLC16A3, SLC6A20) were incompletely reprogrammed.  The remaining 
31 transcripts which showed intermediate expression pattern in SCNT embryos including 
TKDP4, RBP4, RYPB, MYLCK, SLC2A5, SHMT2 and SUSD2 were classified as partially 
reprogrammed.  
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Figure 14. A) Heat-map representation of genes that are not transcriptionaly reprogrammed. 
The expression pattern of exclusively differentially expressed genes in SCNT elongated 
embryos that resemble donor fibroblasts (FBs) and differ from control (AI). B) Heat-map 
representation of intermediately reprogrammed genes whose expression in SCNT embryos is 
in between AI and FBs C)  Heat-map representation of incompletely reprogrammed genes 
whose expressions neither resembled AI nor FBs. The dendrogram on the top depicts the 
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grouping of samples based on their similarity. Red represents high, green represents low and 
black represents intermediate gene expression levels as shown by the colour code at the 
bottom of the figure. Some representative transcripts from up-and down-regulated genes from 
each category are indicated in the respective boxes.   
 
4.10 Pathways and gene networks affected due to incompletely reprogrammed transcripts  
 
Because of the biological significance and their relative large number, the pathway and gene 
network analysis was performed for 91 incompletely reprogrammed genes. Among the 
canonical pathways appeared in the analysis of the set of incompletely/abruptly 
reprogrammed transcripts, 4 major pathways are related to metabolism. These include 
glycerolipid, methane, ascorbate and aldarate and arginine and proline metabolism (Figure 
15). Moreover, 4 major networks were identified involving the 92 abruptly up- and down- 
regulated genes in SCNT embryos. Based on the identified gene networks with IPA score 
more than 25, the top functional categories affected are cell death, lipid metabolism, 
molecular transport, nucleic acid metabolism and cellular development (Figure 16).  
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Figure 15.  IPA-generated, top canonical pathways of 91 abruptly up- and down-regulated 
genes that are exclusively differentially expressed in SCNT elongated embryos. The line plot 
designates the ratio of the number of genes from our dataset that are available in the identified 
pathways divided by the total number of molecules that exist within the canonical pathway. 
Fischer's exact tests were used to calculate p-values (presented as -log10 P values).  
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Figure 16. Top scored networks using IPA and not reprogrammed transcriptome of SCNT 
elongated embryos. The IPA score = (-log (p-value)), is associated with the significance of the 
selected gene network. The higher the score the more reliable it is. 
      
4.11 Trophoblast elongation size dependent expression profile of selected genes in SCNT and  
        IVP day 16 embryos 
 
Even though the array analysis was performed using elongated embryos from SCNT, IVP and 
AI sources with comparable length, we were interested to check the expression of candidate 
genes in some of day 16 embryos with impeded growth from IVP and SCNT pregnancies. For 
this, we used disproportionally short size IVP (1-3 mm, n=3) and SCNT (1.25-5 mm, n=3) 
embryos, to compare the expression of candidate genes with their elongated counterparts. 
Candidate genes were selected based on their known function in relation to trophoblast 
development (FGFR2, TKDP2 and IFNtau) and their role in tight junction signaling pathway 
(CLDN1, CEBPA, ARHGEF2 and JAM2) which are hypothesized to be affected by pre-
elongation culture manipulation of both IVP and SCNT embryos. Even though the microarray 
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data did not show significant differences in expression of IFNt, between the three groups, this 
gene was included as main player in maternal recognition of pregnancy and trophoblast 
elongation.  
 
 
 
 
  
 
Figure 17. Quantitative real time PCR (qPCR) analysis of selected genes. Gene expression 
fold-change between SCNT-I (somatic cell nuclear transfer-impeded) embryos vs. SCNT-E 
(nuclear transfer-elongated) embryos, and gene expression fold-change of IVP-I (in vitro 
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produced-impeded) embryos vs. IVP-E (in vitro produced-elongated) embryos were 
compared.  Stars above the bar denote if that gene showed significant differential expression 
by Student’s t-test. **, -P< 0.01 and ***, -P < 0.001.  
 
Quantitative real time PCR results demonstrated that transcript abundance of IFNt, FGFR2, 
CLDN1 and ARHGEF2 was significantly lower in both IVP and SCNT impeded embryos 
compared to their respective elongated counterparts. On the other hand, high mRNA 
abundance of TKDP2, JAM2, and CEBPA were noticed in IVP and SCNT impeded embryos 
compared to the elongated embryos (Figure 17).  
In addition, the qPCR based gene expression comparison of all selected genes except IFNt 
showed no significant differences between IVP and SCNT impeded embryos (Figure 18). 
 
 
Figure 18. Quantitative real time PCR (qPCR) analysis of selected genes expression in IVP-I 
(in vitro produced-impeded: 1-3 mm) and SCNT-I (somatic cell nuclear transfer-impeded 
1.25-5 mm) embryos. Gene expression fold-change between IVP-I and SCNT-I embryos were 
compared.  Stars above the bar denote if that gene showed significant differential expression 
by Student’s t-test. *,-P < 0.05.  
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4.12 Validation of microarray data  
 
A total of 18 candidate transcripts were used for quantitative real time PCR analysis to 
validate the array results. Results revealed that all genes except ADD3 and CCND2 showed 
similar expression pattern with the microarray data. 
 
Table 7. Confirmation of microarray data using qPCR 
 
 
FC, fold change, p≤0.05 is considered as significant, negative and positive values indicate up 
and down regulated genes respectively, ‘*’ above p-value indicate genes whose expression are 
not validated by qPCR . 
Microarray qPCR Gene name  Accession number Comparison 
FC P FC P 
SPINK4 NM_001114522 NT Vs. AI -3.78 0.000000033 -104.04 0.002 
TSPAN1 NM_001034270 IVP Vs. AI -4.75 0.0000155 -235.1 0.01 
TSPO NM_175776 IVP Vs. AI -3.05 0.0000008 -34.2 0.04 
TDGF1 NM_001080358 IVP Vs. AI 2.61 0.000000065 11.70 0.04 
SULT1A1 NM_177521   IVP Vs. AI -2.15 0.00000116 -32.32 0.04 
GPX1 NM_174076 NT Vs. AI 2.79 0.00000106 202.42 0.0004 
ALAS2 NM_001035103 NT Vs. AI -4.22 0.000000662 -153 0.02 
ALAS2 NM_001035103 IVP Vs. AI -4.18 0.000000735 -68.95 0.001 
ARHGDIB NM_175797   IVP Vs. AI -2.22 0.00014 -9.39 0.04 
MRPL12 NM_201606 NT Vs. AI 1.35 0.0000256 1.48 0.02 
CADM1 NM_001038558   NT Vs. AI -3.40 0.00000577 -37.75 0.02 
CCND2 NM_001076372             IVP Vs. AI 3.07 0.0000000012 -5.42 0.05* 
CCND2 NM_001076372             NT Vs. AI 3.75   0.0000000001 6.09 0.008 
TKDP2 NM_001012683     IVP Vs. AI -7.68 0.0000000005 -534.06 0.001 
TKDP2 NM_001012683     NT Vs. AI -7.47 0.0000000006 -535.28 0.001 
ADD3 NM_001075194   NT Vs. AI -2.66 0.000000006 0.94 0.27* 
ADD3 NM_001075194   NT Vs. IVP -2.69 0.0000000061 72.3 0.0004 
FGF2R NM_001205310.1 NT vs. AI -2.02 0.0000067 -32.07 0.006 
CLDN1 NM_001001854.2 NT vs. AI -2.918 0.0000000003 -15.49 0.009 
JAM2 NM_001083736.1 NT vs. AI 1.459 0.00035 2.02 0.008 
CEBPA BC149006.1 IVP vs. AI -2.49 0.00035 6.02 0.016 
ARHGEF2 NM_001098881.2 IVP vs. AI -1.80 0.00001 -295.75 0.0003 
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5. Discussion 
 
Cloning and IVF technologies are important tools for production and manipulation of bovine 
pre-implanation embryos independent of the maternal environment. However, these 
technologies are limited by great inefficiency. The prominent aberration in IVP or SCNT 
derived embryos is that in vitro production systems and cloning technology, may lead to 
persistent alterations of gene expression patterns during embryonic and fetal development 
(Wrenzycki et al. 2004). In order to get a global overview of gene expression alteration 
induced by in vitro environment and somatic cell nuclear transfer, here we performed large 
scale gene expression analysis of day 16 conceptuses from SCNT, IVP and AI pregnancies as 
well as donor fibroblast cells. 
Results revealed that the majority of the differentially expressed genes found in IVP (n= 258) 
and SCNT (n= 315) embryos were down regulated compared to AI. This alteration in gene 
expression may be originating from all steps of manipulation procedures including in vitro 
maturation, in vitro fertilization, and in vitro culture as well as failure in genome 
reprogramming of donor cell after SCNT. Exposure of embryos to in vitro culture is believed 
to affect both IVP and SCNT embryos while transcriptional reprogramming error is specific 
to SCNT embryos. To understand the effect of each component (culture environment and 
genome reprogramming), differentially expressed genes were categorized in two groups. The 
first category includes genes commonly differentially expressed between IVP and SCNT as 
both compared to their AI counterparts, are considered to be affected by pre-transfer in vitro 
culture environment. The second category includes DE transcripts unique to SCNT vs. AI 
elongated embryos comparison, which were subsequently examined for their transcriptional 
reprogramming status based on their expression in donor fibroblast cell.  
 
5.1 Common differentially expressed transcripts found between IVP and SCNT elongated    
      embryos revealed the effect of pre-elongation culture condition   
In the last decade several transcriptome studies employing different array platforms were 
conducted in the blastocyst of various sources. Most of the comparisons which involved 
cloned embryos along with the respective donor cell used IVP as a control (Beyhan et al. 
2007, de et al. 2005, Pfister-Genskow et al. 2005, Rodriguez-Osorio et al. 2009, Somers et al. 
2006). However, both the IVP and SCNT embryos are derived from procedures that involve 
in vitro culture environment, which can significantly alter the transcriptome of the resulting 
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embryos. Identification of those genes may help to understand molecular mechanisms 
sensitive to the culture environment. Thus the present study identified 274 genes which were 
found to be commonly differentially expressed in IVP and SCNT compared to AI and those 
genes are believed to be sensitive to in vitro culture condition.  
Several genes known to be associated with normal embryo and placenta development are 
found to be dysregulated in both IVP and SCNT elongated embryos.  Among these, HAND1 
is expressed in trophoblast lineage and plays an important role in trophoblast development 
(Arnold et al. 2006a). Moreover,  gap junction protein 2 GJB2 (Cx26), which is known to be 
required for transplacental glucose uptake (Gabriel et al. 1998) and transcript which 
contribute to primitive endoderm differentiation and to the growth and maintenance of the 
inner cell mass (ICM) like fibroblast growth factor receptor 2 (FGFR2) are down regulated in 
both IVP and SCNT elongated embryos. Receptors for signalling molecules such as FGFR2 
enable the embryo to communicate with the surrounding environment and activate 
downstream pathways (Vesterlund et al. 2011). Results from FGFR2 knock out experiments 
showed that homozygous embryos died a few hours after implantation evidencing an 
important role of FGFR2 during post-implantation development (Arman et al. 1998). Among 
subtypes of FGFRs, FGFR2b was suggested to play a role in regulation of IFNt expression 
because of its high expression in day 14 and 17 bovine conceptuses coincident with peak IFNt 
expression (Cooke et al. 2009). However, such correlation of FGFR2 with IFNt expression 
was not evident in our expression study. The non differential expression of IFNt between the 
three embryo groups in our study is in agreement with the report of Arnold et al. (2006a), in 
which no differential expression IFNt was found between AI, IVP and SCNT day 17 
embryos. Trophoblast kunitz domain protein 2 (TKDP2) is down regulated in both IVP and 
SCNT groups.  Similar to IFNt, trophoblast kunitz domain proteins  are secreted by placenta 
in transient fashion, with maximal expression occurring  during  the time of apposition and 
adhesion of the trophoblast to the uterine luminal epithelium, a stage of pregnancy at which 
the mother shows uterine response to the presence of the adhering conceptus (MacLean et al. 
2003).  
The imprinted gene ASCL2 also known as MASH2, was found to be up regulated in both IVP 
and SCNT elongated embryos. MASH2 shows biallelic expression prior to implantation and 
maternal expression after implantation (Arnold et al. 2006b). Similar to our results, Arnold et 
al (2006a) showed an increased in relative amount of ASCL2 mRNA in day 17 bovine 
embryos produced by IVF or somatic cell nuclear transfer when compared with AI 
counterparts. Both in vitro culture and embryo transfer procedures affected genomic 
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imprinting in the extra embryonic tissues (Rivera et al. 2008). In mouse, ASCL2 could be one 
of the examples of this notion as it was expressed at a higher level in the placenta of the 
manipulated conceptuse than in the placenta of control conceptus (Rivera et al. 2008). 
 
5.2 Common and distinct pathways affected in IVP and SCNT elongated embryos may show     
      the inherent differences between the two embryo groups 
 
Early embryo culture conditions likely affect the same pathways and gene networks in both 
SCNT and IVP conceptuses (Chavatte-Palmer et al. 2012). As shown in Table 4 and Figure 8, 
tight junction signalling pathways and the genes associated with this pathway and top gene 
networks which have impact on small molecules biochemistry, carbohydrate metabolism and 
DNA replication recombination and repair were commonly affected in both IVP and SCNT 
elongated embryos. The role of tight and adherens junctions in ovine endometrial luminal for 
blastocyst elongation and adherence of the trophectoderm during implantation were suggested 
by Satterfield et al. (2007). In the present study  we identified 9 transcripts involved in tight 
junction signaling pathway (CLDN1, ARHGEF2, CEBPA, F2Rl2, FOS, JAM2, PRKAG2, 
TGFB3 and TNFRSF1A) and all genes  except JAM2 were found to be down regulated  in 
both IVP and SCNT embryos (Table 6). Based on these results it can be speculated that the 
development of both IVP and SCNT embryos was affected in a comparable manner during 
the elongation window. However, it can be suggested that both manipulated conceptuses may 
have different mechanism of compensation against the deleterious effect of pre-elongation 
culture. 
Cloned embryos are more sensitive to culture environment as compared to IVF embryos 
(Yamanaka et al. 2009)  as early as the one-cell stage (Chung et al. 2002). Cloned embryos 
also have higher energy demands than control embryos, a characteristic that may arise from 
aberrant expression of ATP-requiring processes expressed in the somatic donor cell type (Han 
et al. 2008). The results of the present study showed large number of genes to be differentially 
expressed in SCNT embryos which are known to be involved in 9 metabolic related 
pathways, as compared to the only  2 metabolic pathways appeared in IVP embryos  (Table  4 
and 5).                                 
Similarly, lipid and carbohydrate metabolism, DNA replication, recombination and repair and 
small molecules biochemistry were among the functions altered in SCNT elongated embryos 
as compared to the functional disturbance of cell and organ development, cellular movement 
and cellular growth and proliferation in IVP embryos (Figure 11  and 12).  These results 
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necessitate further optimization of in vitro culture environment for successful development of 
cloned embryos to generate healthy offspring after transfer to recipients. 
 
5.3 Transcriptional reprogramming status of genes may compromise their functional  
      contribution 
 
Depending on their expression pattern between embryos derived from SCNT and AI as well 
as FB donor cell, transcriptional reprogramming statuses of genes were determined. 
Surprisingly, 73.9% of gene expression difference was observed between SCNT embryos and 
FB. Similar studies at the blastocyst stage reported 82.4% difference in gene expression of 
SCNT compared to donor fibroblast cell (Smith et al. 2005). This suggests the dynamism of 
the reprogramming process during the pre-and peri-implantation development period. 
Transcriptome analysis showed exclusive differential expression of 193 genes between SCNT 
and AI embryos, of which 71 transcripts were classified as transcriptionally not 
reprogrammed (Figure 14A). Some of these transcriptionally not reprogrammed genes 
identified in our study are known to be involved in maternal-fetal nutrient exchange, 
trophoblast elongation and embryogenesis. The folate receptor 1 (FOLR1) transcript which 
was down regulated in SCNT embryos is known to be involved in maternal–fetal folate 
transport. Deletion of   FOLR1 in mice caused neural tube defects and death in utero at day 10 
of gestation (Piedrahita et al. 1999). Likewise, epithelial sodium channel (ENaC) also called 
sodium channel, non-voltage-gated 1 participated in the maintenance of sodium transport and 
ionic homeostasis for both mother and fetus (del Monaco et al. 2008). This gene encodes 
three sub units (SCNN1 alpha, beta and gamma) (Meisler et al. 1994). Two sub units of this 
gene TSCNN1B and SCNN1G are found to be down regulated in SCNT embryos. Moreover, 
transcript cytochrome P450, family 51, subfamily A, polypeptide 1 (CYP51A1), which was 
down regulated in SCNT embryos  in the present study is one of the critical gene at the 
initiation of bovine embryo elongation (Clemente et al. 2011).  
Further inspection of genes in this category showed that down regulation of wntless homolog 
drosophila WLS gene. By using the mouse orthologue (GPR177), recently  the function of  
this gene was investigated in mammalian tissues (Wang et al. 2012b). The result indicated 
that the expression of GPR177 mRNA in various tissues including cancer cells. Other studies 
demonstrated that mouse embryos with deficient GPR177 exhibit defects in establishment of 
the body axis, and homozygous (GPR177-/-) died during early embryogenesis (Fu et al. 2009, 
Fu et al. 2011), implicating the the role of wntless in embryo development. 
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Genes are assumed to be partially reprogrammed, when their transcript abundance is between 
normal fertilized and cloned embryos (Rodriguez-Osorio et al. 2009).  A set of 31 transcripts 
was found to be partially reprogrammed as their expression pattern was found to be 
intermediate between donor fibroblast cell and AI (Figure 14B). For instance, a transcript of 
myosin light chain kinase (MYLK) was found to be down regulated in donor cells as 
compared to cloned embryos and remained relatively higher in cloned embryos as compared 
to AI. Such kind of partial reprogramming reflects inadequate inhibition of transcription 
factors associated with the somatic cell phenotype (Wilmut et al. 2011). One of the two forms 
of MYLK is embryonic in which its expression declines at birth to low or undetectable levels 
in most adult tissues. The second form smooth muscle MYLK, a predominant form found in 
adult tissues (Gallagher et al. 1995). Therefore, the lower expression of this gene in our donor 
cells was to be expected.  However, the higher expression of this gene in cloned as compared 
to AI embryos may show the prevailing aberrant transcriptional reprogramming process. 
Additionally the mitochondrial enzyme serine hydroxymethyltransferase 2 (SHMT2) was 
found to be partially reprogrammed and showed up regulation in SCNT elongated embryos. 
On the other hand, genes such as RYBP required for early mouse embryo (Pirity et al. 2005) 
and retinal and lens development (Pirity et al. 2007), the metabolic related gene SLC2A5 and 
the placenta development and proliferation related gene TKDP4 were among the genes which 
were down regulated in SCNT embryos. 
Inspection of the list of incompletely reprogrammed genes showed several genes associated 
with metabolism to be affected. This was further supported by IPA analysis which identified 
the consequence of such transcript alteration in glycerolipid metabolism, ascorbate 
metabolism, arginine and proline metabolism and methane metabolism (Figure 15). In vitro 
stress factor is proposed to include metabolic and substrate deficiencies (Leese 2002). The 
evidence that in vitro culture environment affects embryo metabolism comes from 
experiments showing increased glucose uptake in mouse cloned blastocyst cultured in glucose 
supplemented media (Chung et al. 2002, Han et al. 2008). This characteristic greatly 
distinguishes SCNT embryos from normal fertilized embryos and indicates a failure of 
complete early reprogramming of gene expression. Consistent with this observation, the data 
of the present study showed exclusive disturbance of metabolic pathways in SCNT embryos 
suggesting the need of possible intervention in improving culture environment that could 
suppot cloned embryos’ pre-and post-hatching development.  
Apart from its effect on embryo metabolism, in vitro environment is known to cause oxidative 
stress (Gad et al. 2012, Nasr-Esfahani and Johnson 1991). In human early pregnancy, an 
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increase in oxygen tension is associated with increased in mRNA of the antioxidant enzymes 
such as CAT within placental tissues (Myatt and Cui 2004). Detoxification enzymes, such as 
CAT have also been reported in human placental tissues of early pregnancy failure, 
suggesting that such an antioxidative mechanism might be developed and operate against 
possible oxidative damage in patients with susceptibility for miscarriage (Biri et al. 2006). In 
the current study heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa) HSPA5 
expression was higher in NT embryos accompanied by increased level of antioxidant enzyme 
catalase gene (CAT). Such response operated only in cloned embryos as compared to 
fertilized conceptuses suggesting possible defence response of CAT protein, probably because 
of abnormal placental function (Al-Gubory et al. 2010).   
In addition, metallopeptidase inhibitor (TIMP2) protein was found to be aberrantly expressed   
in bovine and mouse cloned placentas (Kim et al. 2005, Kim et al. 2010).  Recently, Ulbrich 
et al. (2011) indicated TIMP2 contribution in maternal recognition of pregnancy. Similarly, 
glycerol-3-phosphate dehydrogenase 1 (GPD1L) which was reported to be aberrantly 
reprogrammed in pig blastocyst (Whitworth et al. 2011) was found to be incompletely 
reprogrammed. The imprinted gene CDKN1C is among the set of few genes identified by 
Hori et al. (2010) aberrantly imprinted and suggested to be cause of large offspring syndrome 
(LOS) in both NT and IVF derived calves. CDKN1 was not differentially expressed in IVP 
embryos in the present comparison showed the possible effect of reprogramming error on the 
alteration of expression of this gene in cloned embryos. However, the different SCNT 
procedures used, the variation in stage of gestation at sample collection and the different 
micro/macroarrays platforms used, make it difficult to identify sets of genes that are 
consistently affected in SCNT pregnancies (Chavatte-Palmer et al. 2012). 
 
5.4 Trophoblast elongation size dependent expression of candidates in IVP and SCNT  
      elongated embryos 
 
The process of elongation is required for conceptus survival in all ungulate species (Blomberg 
et al. 2008) and it is a prerequisite for successful implantation (Wilson et al. 2000). Studies 
probed SCNT embryos recapitulate elongation showed developmental retardation in SCNT 
embryos as compared to their equivalent in vivo or in vitro fertilized embryos (Alexopoulos et 
al. 2008, Rodriguez-Alvarez et al. 2010b). Similarly in the present study pronounced 
reduction in trophoblast size in day 16 SCNT embryos (93.3 mm) was observed as compared 
to IVP (186.6 mm) and AI (193.3 mm) embryos (Table 2). Though it is difficult to identify 
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putative genes associated with trophoblat size variation in different pregnancy groups in our 
study, we have investigated the expression of candidate genes in disproportionally short day 
16 embryos from IVP and SCNT groups, to find out any association of the transcript 
abundance of those genes with the size of embryos. 
Accordingly the expression of IFNt, FGFR2, CLDN1 and ARHGEF2 was significantly low in 
developmentally delayed IVP and SCNT embryos as compared their elongated counterparts 
(Figure 17). Higher expression of IFNt in the enlarged size trophoblast in the present study 
was in agreement with the previous observation in which expression of IFNt per cell was 
increased as the blastocyst enlarges and elongates (Farin et al. 1990, Kimura et al. 2004). This 
suggests that the lower expression of IFNt in disproportionally short embryos may result from 
retarded trophoblast development. Besides, the lower abundance of FGFR2, CLDN1 and 
ARHGEF2 in developmentally lagging embryos might indicate the importance of these genes 
during embryo elongation. However, further studies need to be done to determine their exact 
role in trophoblast development.  Surprisingly higher expression of trophoblast kunitz domain 
protein (TKDP2) was noticed in both IVP and SCNT impeded embryos as compared to their 
respective elongated counterparts. Despite higher expression of TKDP family genes during 
bovine and ovine peri-implantation period (MacLean et al. 2003), the exact role of individual 
TKDPs has not yet been determined. Like IFNt, TKDPs are products of trophoblast 
mononuclear cells (Blomberg et al. 2008). Our result showed that unlike IFNt, the expression 
of TKDP-2 may not depend on trophoblast size.  
Interestingly, junctional adhesion molecule 2 (JAM2) transcripts abundance showed an 
inverse relationship with trophoblast elongation size and was higher in both IVP and SCNT 
lagging conceptuses. The amount of JAM2 was initially higher in IVP and SCNT embryos as 
compared to AI (Figure 9). It can be suggested that an appropriate level of JAM2 mRNA 
might be important for better trophoblast elongation. Similarly, CCAAT/enhancer binding 
protein alpha (C/EBP) expression in developmentally delayed IVP and SCNT trophoblasts 
was significantly higher as compared to their respective elongated embryos. Experiments 
done in mice  have suggested a crucial role for C/EBP-α and -β in embryogenesis, deletion of 
both genes resulted in mortality around embryonic day 10–11 due to gross failure in placental 
development (Begay et al. 2004). The same author showed that a single copy of either 
C/EBP-α in the absence of C/EBP-β, or C/EBP-β in the absence of C/EBP α could rescue 
embryogenesis. Furthermore, the mRNA levels of all selected genes except IFNt showed no 
variation in expression between IVP and SCNT impeded embryos (Figure 18), strengthening 
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our hypothesis that these common differentially expressed transcripts could be sensitive to 
pre-embryo transfer in vitro procedures.   
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6. Summary 
 
In vitro produced embryos by either IVP or SCNT have been successfully used in many 
species to produce live offspring despite low efficency. The low efficiency of these 
technologies is ascribed to the profounding factors related to reprogramming of the donor 
genome and in vitro culture environment, which subsequently renders deviation in molecules 
and phenotypes as compared to non-manipulated control embryos. Although the specific 
effect of each component on transcriptome alteration is largely undefined, the use of various 
embryo groups’ comparison at any stage of embryo or fetal development may offer insight on 
the key molecules and pathways altered. The aim of this study was to uncover the molecular 
changes in conceptuses derived from SCNT, IVP and AI pregnancies at the time of maternal 
recognition of pregnancy. For this, day 7 blastocysts derived from SCNT, IVP and AI were 
transfered to oestrus synchronized recipients. Conceptuses were then recovered from 
slaughtered cows at day 16. Despite similar embryo recovery rates among various groups of 
pregnancies, morphological analysis of conceptuses at this stage showed that 37.5% of SCNT 
and 25% IVP embryos were underdeveloped. In addition, those SCNT and IVP conceptuses 
that recapitulated filamentous morphology had shorter trophoblast size as compared to the AI 
counterparts. In order to gain a comprehensive overview of the transcriptome changes, RNA 
extracted from three filamentous embryos from each pregnancy group were subjected to 
global gene expression analysis by using GeneChip® Bovine Genome Array. Gene 
expression analysis revealed a large number of differentially expressed genes in SCNT vs. AI 
comparison (477) followed by IVP vs. AI (365) and SCNT vs. IVP (26). Interestingly, more 
than 50% of transcripts from each comparison were down-regulated. Thus, the affected 
mRNAs span a variety of functional categories, most notably but not limited to metabolism 
and tight junction signalling pathways in SCNT and IVP conceptuses, respectively. To 
investigate the SCNT and IVP induced gene alteration on elongated embryos, unique and 
common differentially expressed transcripts were taken into further analysis. Common 
differentially expressed transcripts were involved in tight junction signaling pathways while 
genes exclusively differentially expressed in SCNT elongated embryos were scrutinized for 
their reprogramming status. If reprogramming is highly efficient, most or all somatic genes 
are silenced and the appropriate array of embryonic genes are programmed for expression, 
then transcriptional activation should result in cloned embryos with characteristics much like 
those of normal fertilized embryos. Based on this scenario, various research groups have 
reported the occurrence of global reprogramming at the bovine blastocyst stage. The question 
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is if reprogramming occurs in bovine somatic cell cloning, why would only a very small 
proportion of embryos be enabled to develop to term and survive? The present study 
hypothesis was there must be multiple stages of reprogramming process which could be 
addressed through different approaches. The current study opted to use transcriptomic 
approach to elucidate the global transcriptional reprogramming status of SCNT embryos at 
the critical stage of maternal recognition of pregnancy. Thus, our results show various 
transcriptional reprogramming statuses of differentially expressed genes namely 
transcriptional not reprogrammed (FOLR1, GATM, APOA2, SCNN1G, SCNN1, TKDP5, 
ALDOC and WLS), incompletely reprogrammed (ACTO4, ACTO8, ALDH9A1, CAT, 
CDKN1, TIMP2 and GAR) and partially reprogrammed (MYLK, TKDP4, RYBP, AHSG and 
TYRO3). Furthermore, to identify the association of putative genes with embryo elongation 
size, qPCR based quantification of candidate genes (IFNt, IGF2R, ARHGEF2, CLDN1, 
JAM2, TKDP2 and CEBPA) in disproportionally short size SCNT and IVP embryos was 
performed. Accordingly, IFNt, FGFR2, CLDN1 and ARHGEF2 were significantly lower in 
developmentally delayed IVP and SCNT embryos as compared their elongated counterparts. 
On the other hand, the expression of TKDP2, JAM2, and CEBP-α showed inverse 
relationships with trophoblast size. The mRNA abundance of these genes was higher in 
developmentally lagging embryos as compared to their elongated counterparts. The result 
implicates that various molecules might be involved during the elongation process and that 
the transcript abundance of these genes might be a response or cause of trophoblast size 
variation during embryo elongation. In general, the current gene expression profiling of 
SCNT, IVP and AI elongated conceptuses presented a list of candidate genes which can be 
utilized in procedures that involve in vitro culture environment as well as reprogramming cell 
fate experiments. The remaining challenge is to understand the functional contribution of 
these genes to facilitate the possible technical or molecular intervention to enhance the 
production of healthy and fertile offspring from these techniques. In this regard, the present 
study contributed detailed information about altered molecular signature and pathways in 
SCNT and IVP conceptus during the peri-implantation period which may contribute to a 
better understanding of IVP and SCNT induced changes in embryos or fetuses obtained from 
such procedures.  
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7. Zusammenfassung 
 
In vitro produzierte Embryonen durch IVP oder SCNT werden erfolgreich, trotz geringer 
Effizienzen, in unterschiedlichen Spezies eingesetzt um lebende Nachkommen zu erzeugen. 
Für die geringen Effizienzen dieser Technologien können viele tiefgründigere Faktoren 
verantwortlich sein. Diese Faktoren stehen im Zusammenhang mit der Reprogrammierung 
des Donor Genoms sowie mit dem in vitro Kulturmilieu und rufen anschließend 
Abweichungen in Molekülen und Phenotypen im Vergleich zu nicht manipulierten Kontroll-
Embryonen hervor. Obwohl der spezifische Effekt jedes einzelnen Faktors auf die 
Veränderungen des Genoms weitgehend ungeklärt ist, bietet der Einsatz von 
unterschiedlichen Embryogruppen im Vergleich zwischen verschiedenen 
Entwicklungsstadien des Embryos oder des Fetus einen Einblick in Veränderungen von 
wichtigen Schlüsselmolekülen und Signalwegen. Das Ziel dieser Studie waren die 
molekularen Veränderungen im Embryo hergeleitet aus SCNT, IVP und AI Trächtigkeiten 
zum Zeitpunkt der ersten embryomaternalen Kommunikation aufzudecken. Hierzu wurden 
durch SCNT, IVP und AI  Tag 7 erzeugte Blastozysten in Östrus synchronisierte Kühe 
übertragen. Am Tag 16 der Trächtigkeit wurden die Rezipienten geschlachtet und die 
Embryonen entnommen. Trotz ähnlicher Recovery Rate der Embryonen aus verschiedenen 
Trächtigkeitsgruppen wurden nach morphologischen Untersuchungen 37.5% der SCNT und 
25% der IVP Embryonen als unterentwickelt eingestuft. Darüber hinaus zeigten SCNT und 
IVP Embryonen mit einer verzögerten rekapitulierten filamentösen Morphologie kleinere 
Trophoblasten im Vergleich zu AI erzeugten Embryonen. Um einen umfassenden Überblick 
über die Tanskriptomveränderungen zu erlangen, wurden drei filamentöse Embryonen aus 
jeder Trächtigkeitsgruppe für eine globale Genexpressionsanalyse mittels bovine GeneChip® 
Genome Array ausgewählt. Die Auswertung der Transkriptomanalyse zeigte viele 
unterschiedlich expremierte Gene bei SCNT vs. AI (477), gefolgt von IVP vs. AI (365) und 
SCNT vs. IVP (26). Interessanterweise waren mehr als 50% der Transkripte aus jedem 
Vergleich herunterreguliert. Folglich umfassen die betroffenen mRNAs eine Vielzahl von 
funktionellen Gruppen. SCNT und IVP Embryonen zeigten neben vielen anderen 
funktionellen Gruppen sich besonders in Stoffwechsel und Tight-Junction Signalwegen. Um 
herauszufinden ob SCNT und IVP eine Genexpressionsveränderung auf elongierte 
Embryonen induziert, wurden einzigartige oder häufig unterschiedlich exprimierte Gene für 
weitere Analysen verwendet. Häufig unterschiedlich exprimierte Transkripte die in Tight-
Junction Signaling Wegen involviert waren,  zeigten ausschließlich in SCNT elongierten 
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Embryonen eine unterschiedliche Expression. Aufgrund dieses Resultates wurden SCNT auf 
ihren Reprogrammierungsstatus überprüft. Wenn die Reprogrammierung sehr effizient ist, 
sind die meisten oder alle somatischen Gene abgeschaltet und die entsprechenden Bereiche 
der embryonalen Gene sind auf Expression programmiert. Demnach sollte sich die 
transkritptionelle Aktivierung der geklonten Embryonen charakteristisch der Transkription 
von normal fertilisierten Embryonen ähneln. Basierend auf dieser Gegebenheit haben bereits 
verschiedene Forschungsgruppen über Vorkommen von globaler Reprogrammierung in 
bovinen Blotozysten berichtet. Die Frage ist: Wenn Reprogrammierung bei Rindern aus 
somatischer Klonierung auftritt, warum ist dann nur ein sehr kleiner Anteil der Embryonen 
fähig sich für eine gewisse Zeit zu entwickeln und zu überleben? Die Hypothese der 
vorliegenden Studie war, dass mehrere Stufen der Reprogrammierung durch unterschiedliche 
Ansätze angesprochen werden könnten. In der vorliegenden Studie wurde der genomische 
Ansatz ausgewählt, um den Status der globalen transkriptionellen Reprogrammierung in 
SCNT erzeugten Embryonen in der kritischen Phase der ersten embryomaternalen 
Kommunikation aufzuklären. Das Ergebnis zeigte verschiedene transkriptionelle 
Reprogrammierungzustände von differentiell exprimierten Transkripten, nicht 
reprogrammierte (FOLR1, GATM, APOA2, SCNN1G, SCNN1, TKDP5, Aldoc und WLS) 
unvollständig programmierte (ACTO4, ACTO8, ALDH9A1, CAT, CDKN1, TIMP2 und 
GAR ) und teilweise neu programmierte (MYLK, TKDP4, RYBP, AHSG und TYRO3). 
Darüber hinaus, um eine Assoziation von putativen Gene mit der Embryoelongationsgröße zu 
identifizieren, wurden qPCR Quantifizierungen von Kandidatengenen (IFNt, IGF2R, 
ARHGEF2, CLDN1, JAM2, TKDP2 und CEBPA) in entwicklungsverzögerten SCNT und 
IVP Embryonen durchgeführt. Dementsprechend waren IFNt, FGFR2, CLDN1 und 
ARHGEF2 signifikant niedriger expremiert in den entwicklungsverzögerten IVP und SCNT 
Embryonen gegenüber ihren elongierten Gegenspielern. Auf der anderen Seite zeigte die 
Expression von TKDP2, JAM2 und CEBP-α eine inverse Beziehung zur Trophoblstengröße. 
Die mRNA Expression dieser Gene war in entwicklungsverzögerten Embryonen höher im 
Vergleich zu ihren elongierten Gegenstücken. Das Ergebnis impliziert, dass verschiedene 
Moleküle in dem Prozess der Elongation involviert sein könnten und die Expression dieser 
Genen könnte eine Antwort oder Ursache für die Größenvariation der Trophobasten während 
der embryonalen Elongation sein. Im Allgemeinen hat die aktuelle Genexpressionsanalyse 
von SCNT, IVP und AI elongierten Embryonen eine Liste von Kandidatengene erbracht, 
welche für Verfahren die sowohl mit in-vitro Kulturbedingungen als auch 
Reprogrammierungen bei Zellkulturexperimenten verwendet werden können. Die 
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verbleibende Herausforderung ist es den funktionellen Beitrag dieser Gene zu verstehen, um 
mögliche technische oder molekulare Eingriffe zu erleichtern und dadurch die Produktion von 
gesunden und fruchtbaren Nachkommen aus dieser Techniken zu verbessern. In diesem 
Zusammenhang trug die vorliegende Studie dazu bei detaillierte Informationen über 
veränderte molekulare Signaturen und Signalwege in SCNT und IVP Embryonen während 
der peri-Implantationsperiode zusammeln, die zu einem besseren Verständnis der IVP und 
SCNT induzierten Veränderungen in Embryonen oder Feten aus solchen Verfahren beitragen 
können. 
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8. Conclusion 
 
In conclusion, the common deviation in development, transcripts and molecular pathways 
both in SCNT and IVP consuptuses as compared to their AI conterparts might indicate the 
influence of the common pre-elongation culture environment. In addition, the distinct 
alteration in gene expression and pathways related to metabolism in SCNT embryos in this 
window demonstrated the need for optimization of in vitro culture condition to support better 
development of cloned embryos. Moreover, the slight enhancement in transcriptome 
similarity between cloned and donor fibroblast cells in our study as compared to the 
difference observed at the blastocyst stage (Smith et al. 2005) showed the dynamism of 
reprogramming process during pre-and peri-implantation period. Our results collectively 
suggested that transcriptome analysis of different development stages of cloned and in vitro 
fertilized embryos may yield understanding of the effect in vitro environment, dynamics of 
genes regulation and transcriptional reprogramming. Thus, subsequently facilitates possible 
interventions to enhance the efficiency of healthy offspring production.  
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10. Appendices 
 
 
Appendix 1: Review of the array quality assessments, array intensity distribution and   
between array comparisons after normalization. A) Heatmap presentation of the 
the correlation of arrays within and between biological replicates. The blue and 
greay clour represent high and low correlation, respectively. B) Box-plot 
summay of the distribution of probe intensities across all arrays. Each box 
corresponds to one array. The boxes have similar size and Y (position) median. 
C) Density-plot shows density estimates (smoothed histograms) of the data and 
the distribution of the arrays have similar shape and edges.  
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Appendix 2:  Heat map illustration of gene expression difference between donor fibroblast     
                     cells (FBs) and the three embryo samples, namely artificial inseminated (AI),   
somatic cell nuclear transfer (SCNT) and in vitro producton (IVP). The number 
after each biological sample denotes their biological replicate. Red signifies high 
expression and green signifies low expression, and black signifies intermediate 
expression according to the colour bar shown below.  
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Appendix 3:  List of the top differentially expressed genes between SCNT and AI derived 
elongated embryos. The positive and negative (FC) describes the up-and down -
regulated genes respectively.    
 
 
 
     
 
 
 
 
          
 
 
 
 
 
 
 
 
UniGene.ID Gene.Title Gene.Symbol logFC P.Value 
Bt.22879 hydroxysteroid (17-beta) dehydrogenase 1 HSD17B1 4.8 4.59E-08 
Bt.26921 solute carrier family 27, member 6 SLC27A6 4.5 2.59E-06 
Bt.12809 immunoglobulin heavy constant mu IGHM 4.4 0.00556389 
Bt.4895 cyclin D2 CCND2 3.8 1.95E-10 
Bt.44195 solute carrier family 9, member 3 regulator 1 SLC9A3R1 2.8 1.15E-06 
Bt.102106 glutathione peroxidase 1 GPX1 2.8 1.06E-06 
Bt.27824 vestigial like 1 (Drosophila) VGLL1 2.8 1.36E-06 
Bt.28476 monoacylglycerol O-acyltransferase 1 MOGAT1 2.6 1.04E-06 
Bt.91427 glycerol-3-phosphate dehydrogenase 1-like GPD1L 2.5 1.74E-05 
Bt.856 deoxyribonuclease I-like 3 DNASE1L3 2.5 3.76E-06 
Bt.33613 single-stranded DNA binding protein 2 SSBP2 2.4 0.00014173 
Bt.22336 teratocarcinoma-derived growth factor 1 TDGF1 2.3 1.99E-07 
Bt.9728 
ATPase, Na+/K+ transporting, beta 3 
polypeptide ATP1B3 2.2 6.74E-07 
Bt.4520 scavenger receptor class B, member 1 SCARB1 2.2 5.10E-05 
Bt.555 carbonic anhydrase IV CA4 2.1 0.00010599 
Bt.4732 aldehyde dehydrogenase 1 family, member A1 ALDH1A1 2.0 0.00370295 
Bt.89521 
acyl-CoA synthetase long-chain family member 
3 ACSL3 2.0 2.54E-07 
Bt.64557 beta-2-microglobulin B2M 2.0 0.00346596 
Bt.23818 acyl-CoA oxidase 1, palmitoyl ACOX1 1.8 5.85E-05 
Bt.96910 phospholipid scramblase 1 PLSCR1 1.8 0.001411 
Bt.8953 prostaglandin E synthase PTGES 1.8 0.00089766 
Bt.51814 solute carrier family 10, member 1 SLC10A1 1.8 3.22E-07 
Bt.43859 acyl-CoA thioesterase 8 ACOT8 1.8 0.00031004 
Bt.37893 acyl-CoA thioesterase 4-like ACOT4 1.8 0.0001655 
Bt.16630 transmembrane protein 144 TMEM144 1.8 0.00018509 
Bt.25809 filamin A interacting protein 1-like FILIP1L 1.8 9.28E-07 
Bt.20330 protease, serine, 23 PRSS23 1.7 0.00020102 
Bt.3891 fatty acid desaturase 2 FADS2 1.7 0.00060879 
Bt.4804 cyclin-dependent kinase inhibitor 1C  CDKN1C 1.7 9.63E-05 
Bt.48854 Dihydrolipoamide dehydrogenase DLD 1.7 5.35E-08 
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Bt.5534 thioredoxin reductase 1 TXNRD1 1.6 5.30E-06 
Bt.25241 mucolipin 2 MCOLN2 1.6 8.82E-05 
Bt.27262 pitrilysin metallopeptidase 1 PITRM1 1.6 2.73E-06 
Bt.22589 phospholipase A2, group XIIA PLA2G12A 1.6 1.05E-06 
Bt.3898 isocitrate dehydrogenase 3 (NAD+) alpha IDH3A 1.6 4.74E-09 
Bt.46181 achaete-scute complex homolog 2  ASCL2 1.6 0.00026889 
Bt.24154 transcription factor Dp-2  TFDP2 1.6 8.38E-06 
Bt.23388 neuronal guanine nucleotide exchange factor NGEF 1.6 2.80E-05 
Bt.53492 tetraspanin 2 TSPAN2 1.5 0.00032153 
Bt.103235 transforming growth factor, beta receptor III TGFBR3 1.5 0.00102116 
Bt.53077 tropomyosin 2 (beta) TPM2 1.5 0.00265017 
Bt.13245 MAP/microtubule affinity-regulating kinase 1 MARK1 1.5 3.49E-05 
Bt.8643 
reticulocalbin 2, EF-hand calcium binding 
domain RCN2 1.5 1.88E-06 
Bt.18203 junctional adhesion molecule 2 JAM2 1.5 0.00035879 
Bt.3771 GAR1 ribonucleoprotein homolog (yeast) GAR1 1.4 7.31E-05 
Bt.26573 lysophosphatidylcholine acyltransferase 3 LPCAT3 1.4 8.49E-06 
Bt.97115 stearoyl-CoA desaturase  SCD 1.4 3.95E-06 
Bt.3254 tubulin folding cofactor E TBCE 1.4 1.07E-06 
Bt.60085 
N-acetylglucosamine-1-phosphate transferase, 
alpha and beta subunits GNPTAB 1.4 4.54E-05 
Bt.3248 aldehyde dehydrogenase 4 family, member A1 ALDH4A1 1.4 2.95E-05 
Bt.8177 mitochondrial ribosomal protein L12 MRPL12 1.4 2.56E-05 
Bt.97107 hypothetical protein LOC616423 MGC134282 1.3 4.73E-07 
Bt.3415 
chromosome 1 open reading frame 113 
ortholog C3H1orf113 1.3 0.00387299 
Bt.56545 
translocase of outer mitochondrial membrane 7 
homolog (yeast) TOMM7 1.3 1.52E-06 
Bt.979 myosin IB MYO1B 1.3 0.00014369 
Bt.47903 
ribosome production factor 2 homolog (S. 
cerevisiae) RPF2 1.3 1.62E-05 
Bt.557 solute carrier family 1 member 1 SLC1A1 1.3 3.23E-06 
Bt.26665 
pleckstrin homology domain containing, family 
A member 4 PLEKHA4 1.3 4.13E-05 
Bt.44554 BCL2-associated athanogene 2 BAG2 1.3 1.55E-05 
Bt.3562 low density lipoprotein receptor LDLR 1.3 1.26E-05 
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Bt.57506 
ATPase, H+ transporting,  
lysosomal V0 subunit a4 ATP6V0A4 1.3 0.00091373 
Bt.16175 caprin family member 2 CAPRIN2 1.3 0.00054616 
Bt.59278 zinc finger, HIT-type containing 3 ZNHIT3 1.3 9.63E-05 
Bt.22534 peripheral myelin protein 22 PMP22 1.3 5.79E-09 
Bt.5174 inositol polyphosphate-1-phosphatase INPP1 1.3 0.00028457 
Bt.4167 nucleobindin 2 NUCB2 1.2 0.00075405 
Bt.6685 
methylenetetrahydrofolate dehydrogenase  2, 
methenyl tetrahydrofolate cyclohydrolase MTHFD2 1.2 0.00010207 
Bt.44002 taspase, threonine aspartase, 1 TASP1 1.2 1.43E-05 
Bt.56241 CAP-GLY domain containing linker protein 1 CLIP1 1.2 0.0011491 
Bt.22969 serpin peptidase inhibitor, clade G member 1 SERPING1 1.2 0.00064208 
Bt.45288 src kinase associated phosphoprotein 1 SKAP1 1.2 0.00087323 
Bt.27485 frizzled homolog 10 (Drosophila) FZD10 1.2 0.00222668 
Bt.15528 macrophage migration inhibitory factor  MIF 1.2 0.00265086 
Bt.65105 pregnancy-associated glycoprotein 11-like LOC788843 1.2 3.38E-05 
Bt.5267 annexin A6 ANXA6 1.2 7.57E-05 
Bt.405 follistatin FST 1.2 0.00381559 
Bt.42564 zinc finger, DHHC-type containing 7 ZDHHC7 1.2 3.20E-05 
Bt.49065 ribonuclease/angiogenin inhibitor 1 RNH1 1.2 4.10E-06 
Bt.53256 phospholipase C-like 2 PLCL2 1.2 0.00029052 
Bt.4138 vascular endothelial growth factor A VEGFA 1.2 0.00026708 
Bt.91283 RUN and FYVE domain containing 3 RUFY3 1.2 0.00042659 
Bt.13913 1-acylglycerol-3-phosphate O-acyltransferase 3 AGPAT3 1.1 0.00048793 
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UniGene.ID Gene.Title Gene symbol logFC P.Value 
Bt.28030 trophoblast Kunitz domain protein 2 TKDP2 -7.5 6.98E-10 
Bt.13362 tetraspanin 1 TSPAN1 -5.2 7.00E-06 
Bt.23250 alpha-2-HS-glycoprotein AHSG -4.7 7.62E-06 
Bt.103200 gap junction protein, beta 4, 30.3kDa GJB4 -4.5 1.62E-08 
Bt.63143 integrin, beta 2  ITGB2 -4.3 6.43E-05 
Bt.49467 aminolevulinate, delta-, synthase 2 ALAS2 -4.2 6.62E-07 
Bt.4946 ras-related C3 botulinum toxin substrate 2  RAC2 -4.2 5.53E-05 
Bt.390 S100 calcium binding protein G S100G -3.8 3.97E-08 
Bt.9625 serine peptidase inhibitor, Kazal type 4 SPINK4 -3.8 3.18E-08 
Bt.14198 hypothetical protein LOC100270756 LOC100270756 -3.6 1.34E-08 
Bt.28194 glutathione S-transferase omega 1 GSTO1 -3.6 0.00037272 
Bt.89770 lysozyme (renal amyloidosis) LYZ1 -3.5 3.94E-05 
Bt.57922 CD48 molecule CD48 -3.5 3.61E-06 
Bt.49311 
family with sequence similarity 84, 
member A FAM84A -3.4 0.00012258 
Bt.41664 cell adhesion molecule 1 CADM1 -3.4 5.77E-06 
Bt.63969 
guanine nucleotide binding protein (G 
protein), beta polypeptide 4 GNB4 -3.3 8.06E-10 
Bt.87242 steroidogenic acute regulatory protein STAR -3.3 1.69E-06 
Bt.49341 translocator protein (18kDa) TSPO -3.1 6.17E-07 
Bt.12805 phospholipase B domain containing 1 PLBD1 -3.0 4.70E-07 
Bt.91089 
CD55 molecule, decay accelerating factor 
for complement (Cromer blood group) CD55 -3.0 7.18E-06 
Bt.11088 CD97 molecule CD97 -3.0 2.81E-06 
Bt.49689 claudin 1 CLDN1 -2.9 3.22E-10 
Bt.49713 
creatine kinase, mitochondrial 1 
(ubiquitous) CKMT1 -2.9 0.00023121 
Bt.7145 
granzyme B (granzyme 2, cytotoxic T-
lymphocyte-associated serine esterase 1) GZMB -2.9 0.00101952 
Bt.3435 
fin bud initiation factor homolog 
(zebrafish) FIBIN -2.9 4.33E-07 
Bt.5970 S100 calcium binding protein A2 S100A2 -2.8 1.45E-06 
Bt.23917 fibrinogen beta chain FGB -2.8 2.66E-05 
Bt.29416 ring finger protein 128 RNF128 -2.8 7.15E-09 
Bt.2046 sushi-repeat-containing protein, X-linked SRPX -2.8 1.07E-05 
Bt.88701 adducin 3 (gamma) ADD3 -2.7 6.83E-09 
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Bt.49700 allograft inflammatory factor 1 AIF1 -2.7 1.38E-05 
Bt.48905 fibrinogen gamma chain FGG -2.6 0.00077552 
Bt.3537 sulfotransferase family, cytosolic, 1A,  SULT1A1 -2.6 2.40E-07 
Bt.57034 5'-nucleotidase, ecto (CD73) NT5E -2.5 0.00293654 
Bt.4757 
Rho GDP dissociation inhibitor (GDI) 
beta ARHGDIB -2.5 6.25E-05 
Bt.4332 
CCAAT/enhancer binding protein 
(C/EBP), alpha CEBPA -2.5 0.00035306 
Bt.32520 brain expressed X-linked 2 BEX2 -2.4 0.00029245 
Bt.452 
glycosylphosphatidylinositol specific 
phospholipase D1 GPLD1 -2.4 1.03E-05 
Bt.53163 
Similar to trophoblast Kunitz domain 
protein 2 LOC515917 -2.4 0.00318993 
Bt.12764 
dehydrogenase/reductase (SDR family) 
member 9 DHRS9 -2.3 0.0002557 
Bt.52974 TIMP metallopeptidase inhibitor 2 TIMP2 -2.3 0.00013575 
Bt.17819 
Sodium channel, nonvoltage-gated 1, 
gamma SCNN1G -2.3 0.00015025 
Bt.2159 transmembrane protein 45A TMEM45A -2.3 2.49E-07 
Bt.24447 
coagulation factor II (thrombin) receptor-
like 2 F2RL2 -2.3 1.39E-07 
Bt.12327 thioredoxin interacting protein TXNIP -2.3 1.30E-06 
Bt.48365 
glycerol-3-phosphate dehydrogenase 2 
(mitochondrial) GPD2 -2.2 0.00041119 
Bt.48881 galactose mutarotase (aldose 1-epimerase) GALM -2.2 4.68E-05 
Bt.3890 
Tumor necrosis factor receptor 
superfamily, member 1A TNFRSF1A -2.2 0.00038944 
Bt.21759 
butyrobetaine (gamma), 2-oxoglutarate 
dioxygenase  BBOX1 -2.2 6.03E-06 
Bt.17182 gap junction protein, beta 5, 31.1kDa GJB5 -2.1 4.28E-11 
Bt.16382 calcitonin receptor-like CALCRL -2.1 5.66E-05 
Bt.52605 
FBJ murine osteosarcoma viral oncogene 
homolog FOS -2.1 7.37E-06 
Bt.1537 N-myc downstream regulated 1 NDRG1 -2.1 2.90E-05 
Bt.7873 
basal cell adhesion molecule (Lutheran 
blood group) BCAM -2.1 4.36E-07 
Bt.5044 apolipoprotein H (beta-2-glycoprotein I) APOH -2.1 0.00038253 
Bt.8247 parahox cluster neighbor PRHOXNB -2.1 6.16E-10 
Bt.8856 
Rh family, B glycoprotein 
(gene/pseudogene) RHBG -2.1 4.00E-07 
Bt.49731 carbonic anhydrase II CA2 -2.0 1.46E-07 
Bt.64701 gap junction protein, beta 2, 26kDa GJB2 -2.0 2.06E-06 
Bt.8088 fibroblast growth factor receptor 2 FGFR2 -2.0 6.71E-06 
Bt.23268 Niemann-Pick disease, type C2 NPC2 -2.0 2.82E-07 
Bt.26851 
DNA-damage regulated autophagy 
modulator 1 DRAM1 -2.0 1.34E-05 
Bt.1907 hypothetical LOC614490 LOC614490 -2.0 6.34E-06 
Bt.49475 enolase 3 (beta, muscle) ENO3 -2.0 0.00139207 
Bt.11748 
similar to family with sequence similarity 
20, member C LOC534672 -2.0 1.49E-05 
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Bt.51689 
similar to Formin-like protein 2 (Formin 
homology 2 domain-containing protein 2) LOC788312 -2.0 4.23E-05 
Bt.16830 leucine zipper, down-regulated in cancer 1 LDOC1 -2.0 0.00057688 
Bt.4622 mannosidase, alpha, class 2B, member 1 MAN2B1 -2.0 3.01E-06 
Bt.97059 phospholipase A2 receptor 1, 180kDa PLA2R1 -2.0 7.29E-06 
Bt.29568 ELL associated factor 2 EAF2 -1.9 1.58E-09 
Bt.10281 trophoblast Kunitz domain protein 5 TKDP5 -1.9 0.00332136 
Bt.393 cathepsin B CTSB -1.9 5.40E-06 
Bt.26628 RAP2C, member of RAS oncogene family RAP2C -1.9 6.48E-06 
Bt.5336 transferrin TF -1.9 0.00027372 
Bt.16137 
aldehyde dehydrogenase 9 family, 
member A1 ALDH9A1 -1.9 0.00158163 
Bt.44383 cannabinoid receptor 2 (macrophage) CNR2 -1.9 6.79E-07 
Bt.5250 milk fat globule-EGF factor 8 protein MFGE8 -1.8 7.66E-05 
Bt.10272 stanniocalcin 1 STC1 -1.8 8.15E-05 
Bt.49570 
ATPase, Na+/K+ transporting, beta 1 
polypeptide ATP1B1 -1.8 1.31E-06 
Bt.13676 
Serpin peptidase inhibitor, clade E (nexin, 
plasminogen activator inhibitor type 1), 
member 2 SERPINE2 -1.8 0.00011831 
Bt.2712 
Serpin peptidase inhibitor, clade A (alpha-
1 antiproteinase, antitrypsin), member 5 SERPINA5 -1.8 0.00298173 
Bt.49336 ras homolog gene family, member B RHOB -1.8 1.84E-06 
Bt.43926 
Rho/Rac guanine nucleotide exchange 
factor (GEF) 2 ARHGEF2 -1.8 1.02E-05 
Bt.2749 
Cyclin-dependent kinase inhibitor 1A 
(p21, Cip1) CDKN1A -1.8 1.41E-06 
Bt.27351 
solute carrier family 5 (sodium iodide 
symporter), member 5 SLC5A5 -1.8 0.00062041 
Bt.64779 
v-erb-b2 erythroblastic leukemia viral 
oncogene homolog 3 (avian) ERBB3 -1.8 4.72E-06 
Bt.55961 
hect (homologous to the E6-AP (UBE3A) 
carboxyl terminus) domain and RCC1 
(CHC1)-like domain (RLD) 1 HERC1 -1.8 2.87E-07 
Bt.3750 S100 calcium binding protein A11 S100A11 -1.8 0.00023127 
Bt.47778 MAX interactor 1 MXI1 -1.8 0.00023303 
Bt.7826 
pituitary tumor-transforming 1 interacting 
protein PTTG1IP -1.8 2.16E-05 
Bt.11861 
solute carrier family 25 (mitochondrial 
carrier, Aralar), member 12 SLC25A12 -1.7 2.16E-07 
Bt.102113 MARCKS-like 1 MARCKSL1 -1.7 4.86E-06 
Bt.53829 
retinoic acid receptor responder 
(tazarotene induced) 1 RARRES1 -1.7 0.00294362 
Bt.48977 RAS, dexamethasone-induced 1 RASD1 -1.7 3.84E-08 
Bt.11770 
solute carrier family 25 
(carnitine/acylcarnitine translocase), 
member 20 SLC25A20 -1.7 6.75E-05 
Bt.91163 ephrin-A1 EFNA1 -1.7 1.07E-05 
Bt.87081 similar to poliovirus receptor-related 3 LOC534360 -1.7 5.21E-07 
Bt.6087 transmembrane 4 L six family member 1 TM4SF1 -1.7 0.00059482 
Bt.5141 
UDP-Gal:betaGlcNAc beta 1,4- 
galactosyltransferase, polypeptide 1 B4GALT1 -1.7 3.19E-05 
Bt.46230 
heart and neural crest derivatives 
expressed 1 HAND1 -1.7 0.00190195 
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elongated embryos. The positive and negative (FC) describes the up-and down -
regulated genes respectively.  
 
 
 
 
 
UniGene.ID Gene.Title Gene symbol logFC P.Value 
Bt.26921 solute carrier family 27, member 6 SLC27A6 4.7 1.94E-06 
Bt.22879 hydroxysteroid (17-beta) dehydrogenase 1 HSD17B1 4.4 1.04E-07 
Bt.4895 cyclin D2 CCND2 3.1 1.25E-09 
Bt.856 deoxyribonuclease I-like 3 DNASE1L3 2.6 2.07E-06 
Bt.22336 teratocarcinoma-derived growth factor 1 TDGF1 2.6 6.50E-08 
Bt.27824 vestigial like 1 (Drosophila) VGLL1 2.5 3.03E-06 
Bt.64557 beta-2-microglobulin B2M 2.4 0.00101053 
Bt.44195 solute carrier family 9, member 3 regulator 1 SLC9A3R1 2.3 5.77E-06 
Bt.91427 glycerol-3-phosphate dehydrogenase 1-like GPD1L 2.1 7.03E-05 
Bt.102106 glutathione peroxidase 1 GPX1 2.1 1.30E-05 
Bt.4520 scavenger receptor class B, member 1 SCARB1 2.1 9.03E-05 
Bt.33613 single-stranded DNA binding protein 2 SSBP2 2.1 0.00039469 
Bt.28476 monoacylglycerol O-acyltransferase 1 MOGAT1 2.0 1.12E-05 
Bt.25809 filamin A interacting protein 1-like FILIP1L 1.9 4.40E-07 
Bt.12768 
phosphoenolpyruvate carboxykinase 1 
(soluble) PCK1 1.8 0.00032497 
Bt.9728 
ATPase, Na+/K+ transporting, beta 3 
polypeptide ATP1B3 1.8 4.13E-06 
Bt.8953 prostaglandin E synthase PTGES 1.7 0.00113962 
Bt.65578 BCL2-associated athanogene 3 BAG3 1.7 0.0001303 
Bt.555 carbonic anhydrase IV CA4 1.7 0.00059341 
Bt.89521 
acyl-CoA synthetase long-chain family 
member 3 ACSL3 1.7 1.27E-06 
Bt.3891 fatty acid desaturase 2 FADS2 1.6 0.00082384 
Bt.62616 
transporter 2, ATP-binding cassette, sub-
family B) TAP2 1.6 0.00147768 
Bt.54006 similar to RGC-32 MGC148992 1.6 0.00035373 
Bt.3562 low density lipoprotein receptor LDLR 1.6 1.86E-06 
Bt.53492 tetraspanin 2 TSPAN2 1.6 0.00025097 
Bt.17734 zinc finger, AN1-type domain 2A ZFAND2A 1.5 5.98E-07 
Bt.3248 
aldehyde dehydrogenase 4 family, member 
A1 ALDH4A1 1.5 1.35E-05 
Bt.16175 Caprin family member 2 CAPRIN2 1.4 0.0002091 
Bt.18203 junctional adhesion molecule 2 JAM2 1.4 0.00039628 
Bt.23388 neuronal guanine nucleotide exchange factor NGEF 1.4 5.68E-05 
Bt.16630 transmembrane protein 144 TMEM144 1.4 0.00110671 
Bt.6775 annexin A3 ANXA3 1.4 0.00031995 
Bt.46181 
achaete-scute complex homolog 2 
(Drosophila) ASCL2 1.4 0.00076924 
Bt.92178 transmembrane protein 88 TMEM88 1.4 0.00017692 
Bt.91186 Cysteine/tyrosine-rich 1 CYYR1 1.3 0.00098 
Bt.20330 protease, serine, 23 PRSS23 1.3 0.0014221 
Bt.3254 Tubulin folding cofactor E TBCE 1.3 1.60E-06 
Bt.49580 brain protein 44-like BRP44L 1.3 0.00015827 
Bt.4138 vascular endothelial growth factor A VEGFA 1.3 1.68E-06 
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Bt.15528 
macrophage migration inhibitory factor 
(glycosylation-inhibiting factor) MIF 1.3 0.00185713 
Bt.3898 isocitrate dehydrogenase 3 (NAD+) alpha IDH3A 1.3 3.52E-08 
Bt.1548 gamma-inducible protein 30 IFI30 1.3 0.00549349 
Bt.23818 acyl-CoA oxidase 1, palmitoyl ACOX1 1.3 0.00101928 
Bt.29621 glutathione peroxidase 2 GPX2 1.3 0.00213918 
Bt.633 sideroflexin 1 SFXN1 1.2 4.84E-06 
Bt.7490 
methylenetetrahydrofolate dehydrogenase 
(NADP+ dependent) 1-like MTHFD1L 1.2 9.50E-05 
Bt.405 Follistatin FST 1.2 0.00347891 
Bt.5534 thioredoxin reductase 1 TXNRD1 1.2 6.13E-05 
Bt.32740 laminin, alpha 1 LAMA1 1.2 0.00016033 
Bt.11195 palate, lung and nasal epithelium associated PLUNC 1.2 3.02E-07 
Bt.22534 peripheral myelin protein 22 PMP22 1.2 9.06E-09 
Bt.48892 gametocyte specific factor 1 GTSF1 1.2 0.00135376 
Bt.60085 
N-acetylglucosamine-1-phosphate 
transferase, alpha and beta subunits GNPTAB 1.2 0.00015139 
Bt.97115 
Stearoyl-CoA desaturase (delta-9-
desaturase) SCD 1.2 1.57E-05 
Bt.57506 
ATPase, H+ transporting, lysosomal V0 
subunit a4 ATP6V0A4 1.2 0.00162894 
Bt.22399 Arginase, type II ARG2 1.2 0.00011281 
Bt.49065 ribonuclease/angiogenin inhibitor 1 RNH1 1.2 4.18E-06 
Bt.29464 hypothetical protein LOC614047 LOC614047 1.2 3.75E-05 
Bt.11942 Collagen, type XVIII, alpha 1 COL18A1 1.2 8.86E-08 
Bt.17367 
DnaJ (Hsp40) homolog, subfamily B, 
member 1 DNAJB1 1.1 0.00061839 
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UniGene.ID Gene.Title Gene symbol logFC P.Value 
Bt.28030 trophoblast Kunitz domain protein 2 TKDP2 -7.7 5.39E-10 
Bt.262 trophoblast Kunitz domain protein 3 TKDP3 -5.1 0.00190812 
Bt.13362 tetraspanin 1 TSPAN1 -4.8 1.55E-05 
Bt.6410 Placenta-expressed transcript 1 protein PLET1 -4.3 8.10E-07 
Bt.103200 gap junction protein, beta 4, 30.3kDa GJB4 -4.3 2.37E-08 
Bt.49467 aminolevulinate, delta-, synthase 2 ALAS2 -4.2 7.35E-07 
Bt.390 S100 calcium binding protein G S100G -3.9 3.32E-08 
Bt.9625 serine peptidase inhibitor, Kazal type 4 SPINK4 -3.9 2.55E-08 
Bt.63143 Integrin, beta 2  ITGB2 -3.8 0.00017652 
Bt.14198 hypothetical protein LOC100270756 LOC100270756 -3.5 1.41E-08 
Bt.57922 CD48 molecule CD48 -3.5 3.59E-06 
Bt.87242 Steroidogenic acute regulatory protein STAR -3.4 1.47E-06 
Bt.49713 Creatine kinase, mitochondrial 1 (ubiquitous) CKMT1 -3.3 7.60E-05 
Bt.28194 glutathione S-transferase omega 1 GSTO1 -3.3 0.00061362 
Bt.4946 
ras-related C3 botulinum toxin substrate 2  
(rho family, small GTP binding protein Rac2) RAC2 -3.2 0.00037114 
Bt.89770 lysozyme (renal amyloidosis) LYZ1 -3.2 9.03E-05 
Bt.11088 CD97 molecule CD97 -3.1 1.78E-06 
Bt.49341 translocator protein (18kDa) TSPO -3.0 8.00E-07 
Bt.49689 claudin 1 CLDN1 -2.9 3.16E-10 
Bt.63969 
Guanine nucleotide binding protein (G 
protein), beta polypeptide 4 GNB4 -2.8 4.13E-09 
Bt.41664 cell adhesion molecule 1 CADM1 -2.7 3.57E-05 
Bt.49311 family with sequence similarity 84, member A FAM84A -2.7 0.0007314 
Bt.3435 fin bud initiation factor homolog (zebrafish) FIBIN -2.7 7.62E-07 
Bt.4332 
CCAAT/enhancer binding protein  
(C/EBP), alpha CEBPA -2.6 0.00023508 
Bt.29416 ring finger protein 128 RNF128 -2.6 1.55E-08 
Bt.452 
glycosylphosphatidylinositol specific  
phospholipase D1 GPLD1 -2.4 1.00E-05 
Bt.12764 
dehydrogenase/reductase (SDR family) 
member 9 DHRS9 -2.4 0.00017846 
Bt.89090 
pregnancy-associated glycoprotein 12-like /// 
pregnancy-associated glycoprotein 12 
LOC782451 /// 
 PAG12 -2.3 0.00497919 
Bt.2046 sushi-repeat-containing protein, X-linked SRPX -2.2 6.12E-05 
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Bt.4757 Rho GDP dissociation inhibitor (GDI) beta ARHGDIB -2.2 0.00014305 
Bt.16382 calcitonin receptor-like CALCRL -2.2 4.40E-05 
Bt.21759 
butyrobetaine (gamma), 2-oxoglutarate  
dioxygenase (gamma-butyrobetaine 
hydroxylase) 1 BBOX1 -2.2 5.95E-06 
Bt.3537 
sulfotransferase family, cytosolic, 1A, phenol-
preferring, member 1 SULT1A1 -2.2 1.16E-06 
Bt.49700 allograft inflammatory factor 1 AIF1 -2.1 8.01E-05 
Bt.17182 gap junction protein, beta 5, 31.1kDa GJB5 -2.1 4.63E-11 
Bt.64701 gap junction protein, beta 2, 26kDa GJB2 -2.1 1.61E-06 
Bt.27351 
Solute carrier family 5 (sodium iodide 
symporter), member 5 SLC5A5 -2.1 0.00020141 
Bt.91089 
CD55 molecule, decay accelerating factor for 
complement (Cromer blood group) CD55 -2.1 0.00014018 
Bt.26851 
DNA-damage regulated autophagy modulator 
1 DRAM1 -2.0 1.21E-05 
Bt.48881 galactose mutarotase (aldose 1-epimerase) GALM -2.0 9.44E-05 
Bt.12327 thioredoxin interacting protein TXNIP -2.0 3.37E-06 
Bt.12805 phospholipase B domain containing 1 PLBD1 -2.0 1.50E-05 
Bt.3890 
tumor necrosis factor receptor superfamily,  
member 1A TNFRSF1A -2.0 0.0006944 
Bt.1240 deoxyribonuclease II, lysosomal DNASE2 -2.0 1.66E-06 
Bt.4622 mannosidase, alpha, class 2B, member 1 MAN2B1 -2.0 2.84E-06 
Bt.16830 leucine zipper, down-regulated in cancer 1 LDOC1 -2.0 0.00057876 
Bt.8088 fibroblast growth factor receptor 2 FGFR2 -2.0 9.20E-06 
Bt.5970 S100 calcium binding protein A2 S100A2 -2.0 3.44E-05 
Bt.8247 parahox cluster neighbor PRHOXNB -1.9 1.02E-09 
Bt.53829 retinoic acid receptor responder 1 RARRES1 -1.9 0.0014012 
Bt.24447 coagulation factor II (thrombin) receptor-like 2 F2RL2 -1.9 6.42E-07 
Bt.1907 hypothetical LOC614490 LOC614490 -1.9 1.07E-05 
Bt.2712 
serpin peptidase inhibitor, clade A (alpha-1 
antiproteinase, antitrypsin), member 5 SERPINA5 -1.9 0.00253421 
Bt.9791 peptidylprolyl isomerase F PPIF -1.9 3.25E-05 
Bt.7873 basal cell adhesion molecule  BCAM -1.9 1.37E-06 
Bt.393 cathepsin B CTSB -1.8 7.10E-06 
Bt.29568 ELL associated factor 2 EAF2 -1.8 2.48E-09 
Bt.48977 RAS, dexamethasone-induced 1 RASD1 -1.8 2.28E-08 
Bt.10814 coagulation factor II (thrombin) receptor F2R -1.8 1.66E-05 
Bt.49475 enolase 3 (beta, muscle) ENO3 -1.8 0.00280978 
Bt.10272 stanniocalcin 1 STC1 -1.8 0.00010617 
Bt.44383 cannabinoid receptor 2  CNR2 -1.8 1.00E-06 
Bt.46230 heart and neural crest derivatives expressed 1 HAND1 -1.8 0.00129096 
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Bt.5546 
guanine nucleotide binding protein,  
alpha inhibiting activity polypeptide 1 GNAI1 -1.8 5.57E-06 
Bt.61173 histone cluster 2, H2be HIST2H2BE -1.8 0.00019048 
Bt.11861 solute carrier family 25, member 12 SLC25A12 -1.8 1.96E-07 
Bt.4725 B-cell translocation gene 1, anti-proliferative BTG1 -1.7 9.80E-09 
Bt.5336 transferrin TF -1.7 0.00047952 
Bt.6803 TRAF2 and NCK interacting kinase TNIK -1.7 1.93E-05 
Bt.1655 inositol(myo)-1(or 4)-monophosphatase 2 IMPA2 -1.7 0.00146599 
Bt.22869 
fatty acid binding protein 5 (psoriasis-
associated) FABP5 -1.7 3.21E-05 
Bt.61846 tumor protein p53 inducible protein 3 TP53I3 -1.7 0.00024078 
Bt.13162 Keratin 5 KRT5 -1.7 0.00013112 
Bt.51689 similar to Formin-like protein 2  LOC788312 -1.7 0.00014394 
Bt.11770 solute carrier family 25, member 20 SLC25A20 -1.7 8.16E-05 
Bt.49731 carbonic anhydrase II CA2 -1.7 9.01E-07 
Bt.4125 pregnancy-associated glycoprotein 8 PAG8 -1.6 0.00083399 
Bt.32520 brain expressed X-linked 2 BEX2 -1.6 0.00422438 
Bt.38271 Motile sperm domain containing 1 MOSPD1 -1.6 1.61E-05 
Bt.97059 phospholipase A2 receptor 1, 180kDa PLA2R1 -1.6 3.76E-05 
Bt.23268 Niemann-Pick disease, type C2 NPC2 -1.6 2.16E-06 
Bt.43926 
Rho/Rac guanine nucleotide  
exchange factor (GEF) 2 ARHGEF2 -1.6 2.86E-05 
Bt.7826 
pituitary tumor-transforming 1  
interacting protein PTTG1IP -1.6 4.76E-05 
Bt.48365 
glycerol-3-phosphate dehydrogenase 2 
(mitochondrial) GPD2 -1.6 0.0042225 
Bt.8856 Rh family, B glycoprotein (gene/pseudogene) RHBG -1.6 4.04E-06 
Bt.2159 transmembrane protein 45A TMEM45A -1.6 6.01E-06 
Bt.61523 similar to hCG27535 LOC539805 -1.5 0.00171722 
Bt.5250 milk fat globule-EGF factor 8 protein MFGE8 -1.5 0.00030725 
Bt.57867 N-acetylgalactosaminidase, alpha- NAGA -1.5 0.0001616 
Bt.30711 hypothetical LOC789163 LOC789163 -1.5 0.0002886 
Bt.65686 Jagged 1 JAG1 -1.5 0.00221115 
Bt.17819 Sodium channel, nonvoltage-gated 1, gamma SCNN1G -1.5 0.00253486 
Bt.52086 
solute carrier family 13 (sodium/sulfate 
symporters), member 4 SLC13A4 -1.5 0.00011492 
Bt.11748 
similar to family with sequence similarity 20, 
member C LOC534672 -1.5 0.00016924 
Bt.26241 tripartite motif-containing 36 TRIM36 -1.4 1.47E-08 
Bt.21732 ribonuclease T2 RNASET2 -1.4 0.00073685 
Bt.52605 
FBJ murine osteosarcoma viral oncogene 
homolog FOS -1.4 0.00019644 
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